| 1 | A (migalastat) | [1] Migalastat Migalastat | [2] Migalastat hydrochloride
Migalastat hydrochloride
,
Migalastat
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 2 | A fixed-dose combination of 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine | [3] Clarithromycin Clarithromycin, Clofazimine, Rifabutin | [3] Clarithromycin
Clarithromycin
,
Clofazimine
,
Rifabutin
💬
| - | - | [1] 96 96 💬
|
| 3 | A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) | - | - | - | - | [1] 60 60 💬
|
| 4 | A multistrain probiotic product (DSF) | - | - | - | - | [1] 97 97 💬
|
| 5 | A Natural Remedy for Rheumatoid Arthritis vs. Common Drugs | - | - | - | - | [1] 46 46 💬
|
| 6 | A novel synthetic, orally-administered, non-peptide small molecule, which acts as | - | - | - | - | [1] 254 254 💬
|
| 7 | A novel synthetic, orally-administered, non-peptide small molecule, which acts as an agonist of the melanocortin-1 receptor (MC1R) | - | - | - | - | [1] 51 51 💬
|
| 8 | A simulated agent of Jitongning tablets | - | - | - | - | [1] 271 271 💬
|
| 9 | A sterile aqueous solution of RAG - 17 preparation (sodium salt) | - | - | - | - | [1] 2 2 💬
|
| 10 | A-1293543.74 | - | - | - | - | [1] 96 96 💬
|
| 11 | A-319 | - | - | - | - | [2] 46 46, 49 💬
|
| 12 | A-623 | - | - | - | - | [1] 49 49 💬
|
| 13 | A-623 or AMG 623 | - | - | - | - | [1] 66 66 💬
|
| 14 | A-DOPAMINE | [1] Dopamine Dopamine | [2] Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 15 | A-F-A-F (NovoRapid-FIASP-NovoRapid-FIASP) | - | - | - | - | [1] 299 299 💬
|
| 16 | A-glucosidasi acida umana ricombinante coniugata con multiple copie di bis-mannosio-6- fosfato-tetra-mannosio glicano sintetico (NEOGAA) | - | - | - | - | [1] 256 256 💬
|
| 17 | A01AC02 | - | - | - | - | [1] 28 28 💬
|
| 18 | A04AD10 | - | - | - | - | [1] 298 298 💬
|
| 19 | A07DA03 | - | - | - | - | [1] 97 97 💬
|
| 20 | A07EA06 | - | - | - | - | [1] 66 66 💬
|
| 21 | A10BK03 | - | - | - | - | [1] 65 65 💬
|
| 22 | A11HA02 | - | - | - | - | [1] 93 93 💬
|
| 23 | A16AX06 | - | - | - | - | [1] 19 19 💬
|
| 24 | A16AX07 | - | - | - | - | [1] 240 240 💬
|
| 25 | A4250 | - | - | - | - | [4] 93 93, 296, 297, 338 💬
|
| 26 | A4250 (1200 µg) | - | - | - | - | [1] 338 338 💬
|
| 27 | A4250 (200 µg) | - | - | - | - | [1] 338 338 💬
|
| 28 | A4250 (400 µg) | - | - | - | - | [1] 338 338 💬
|
| 29 | A4250 (600 µg) | - | - | - | - | [1] 338 338 💬
|
| 30 | A4250 (odevixibat) | [1] Odevixibat Odevixibat | [2] Odevixibat
Odevixibat
,
Odevixibat hydrate
💬
| [1] SLC10A2 SLC10A2 💬
| [1] Bile secretion Bile secretion 💬 | [1] 338 338 💬
|
| 31 | A4250-015 | - | - | - | - | [1] 297 297 💬
|
| 32 | A4I Antagonist | - | - | - | - | [1] 13 13 💬
|
| 33 | A: 1 dosis | - | - | - | - | [1] 97 97 💬
|
| 34 | A: PTH (1-84) | - | - | - | - | [1] 235 235 💬
|
| 35 | AAC Hexal | - | - | - | - | [1] 299 299 💬
|
| 36 | Aadipose-Derived Mesenchymal Stem Cells | - | - | - | - | [1] 6 6 💬
|
| 37 | AADvac1 | - | - | - | - | [1] 5 5 💬
|
| 38 | AAV BBP-631 | - | - | - | - | [1] 81 81 💬
|
| 39 | AAV directed hLDLR gene therapy | - | - | - | - | [1] 79 79 💬
|
| 40 | AAV1-gamma-sarcoglycan vector injection | - | - | - | - | [1] 113 113 💬
|
| 41 | AAV2-GDNF | - | - | - | - | [1] 6 6 💬
|
| 42 | AAV2-GDNF gene therapy | - | - | - | - | [2] 6 6, 17 💬
|
| 43 | AAV2-hAADC | - | - | - | - | [1] 6 6 💬
|
| 44 | AAV2-REP1 | - | - | - | - | [1] 90 90 💬
|
| 45 | AAV2/5-hPDE6B | - | - | - | - | [1] 90 90 💬
|
| 46 | AAV2/5-hRKp.RPGR | - | - | - | - | [1] 90 90 💬
|
| 47 | AAV2/8.TBG.hARSB | - | - | - | - | [1] 19 19 💬
|
| 48 | AAV2CUhCLN2 (3x10^12 particle units) | - | - | - | - | [1] 19 19 💬
|
| 49 | AAV5-HRKP.RPGR | [1] Botaretigene sparoparvovec Botaretigene sparoparvovec | - | - | - | [1] 90 90 💬
|
| 50 | AAV8-RPGR | [1] Cotoretigene toliparvovec Cotoretigene toliparvovec | - | - | - | [1] 90 90 💬
|
| 51 | AAV8.TBG.hLDLR | - | - | - | - | [1] 79 79 💬
|
| 52 | AAV8hAAT(AVL) | - | - | - | - | [1] 231 231 💬
|
| 53 | AAV9 BBP-812 | [1] BBP-812 BBP-812 | - | - | - | [1] 307 307 💬
|
| 54 | AAV9 Gene therapy | - | - | - | - | [1] 2 2 💬
|
| 55 | AAV9-CAG-coh-SGSH | - | - | - | - | [1] 19 19 💬
|
| 56 | AAV9-GLB1 | - | - | - | - | [1] 19 19 💬
|
| 57 | AAVB-039 | - | - | - | - | [1] 301 301 💬
|
| 58 | AAVB-081 | - | - | - | - | [2] 90 90, 303 💬
|
| 59 | AAVrh.10-hMPSIIIA | - | - | - | - | [1] 19 19 💬
|
| 60 | AAVrh.10cuARSA | - | - | - | - | [1] 19 19 💬
|
| 61 | AAVrh.10CUCLN2 | - | - | - | - | [1] 19 19 💬
|
| 62 | AAVrh.10CUhCLN2 vector 2.85x10^11 genome copies | - | - | - | - | [1] 19 19 💬
|
| 63 | AAVrh.10CUhCLN2 vector 9.0x10^11 genome copies | - | - | - | - | [1] 19 19 💬
|
| 64 | AAVrh.10hFXN, serotype rh.10 adeno-associated virus (AAV) gene transfer vector expressing the cDNA coding for human FXN | - | - | - | - | [1] 18 18 💬
|
| 65 | AAVrh10-PCCA high dose | - | - | - | - | [1] 245 245 💬
|
| 66 | AAVrh10-PCCA low dose | - | - | - | - | [1] 245 245 💬
|
| 67 | AAVrh10-PCCA middle dose | - | - | - | - | [1] 245 245 💬
|
| 68 | AAVrh10.CAG.hCYP46A1 | - | - | - | - | [1] 8 8 💬
|
| 69 | AB (antibiotics) | - | - | - | - | [1] 97 97 💬
|
| 70 | AB 1003 | - | - | - | - | [1] 2 2 💬
|
| 71 | AB-1005 | - | - | - | - | [1] 6 6 💬
|
| 72 | AB-101 | - | - | - | - | [4] 35 35, 44, 46, 49 💬
|
| 73 | AB1010 | - | - | - | - | [6] 2 2, 5, 6, 13, 46, 96 💬
|
| 74 | ABA, open-label (OL) | - | - | - | - | [1] 46 46 💬
|
| 75 | ABA-101 | - | - | - | - | [1] 13 13 💬
|
| 76 | Abacavir | [1] Abacavir Abacavir | [2] Abacavir sulfate
Abacavir sulfate
,
Abacavir
💬
| - | - | [5] 2 2, 49, 135, 265, 325 💬
|
| 77 | Abacavir (ABC) | [1] Abacavir Abacavir | [2] Abacavir sulfate
Abacavir sulfate
,
Abacavir
💬
| - | - | [1] 325 325 💬
|
| 78 | Abacavir (ABC)+Lamivudine (3TC)+Zidovudine (AZT) | [3] Abacavir Abacavir, Lamivudine, Zidovudine | [4] Lamivudine
Lamivudine
,
Zidovudine
,
Abacavir sulfate
,
Abacavir
💬
| - | - | [1] 325 325 💬
|
| 79 | Abacavir 300mg twice daily | [1] Abacavir Abacavir | [2] Abacavir sulfate
Abacavir sulfate
,
Abacavir
💬
| - | - | [1] 265 265 💬
|
| 80 | Abacavir 600mg, Lamivudine 300mg and Dolutegravir 50mg (Triumeq) | [3] Abacavir Abacavir, Dolutegravir, Lamivudine | [5] Lamivudine
Lamivudine
,
Abacavir sulfate
,
Abacavir
,
Dolutegravir
,
Dolutegravir sodium
💬
| - | - | [1] 2 2 💬
|
| 81 | Abacavir sulfate | [1] Abacavir Abacavir | [2] Abacavir sulfate
Abacavir sulfate
,
Abacavir
💬
| - | - | [1] 265 265 💬
|
| 82 | Abacavir sulfate, Lamivudine and Zidovudine | [3] Abacavir Abacavir, Lamivudine, Zidovudine | [4] Lamivudine
Lamivudine
,
Zidovudine
,
Abacavir sulfate
,
Abacavir
💬
| - | - | [1] 265 265 💬
|
| 83 | Abatacept | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [28] 2 2, 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
|
| 84 | Abatacept (ABA) | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 97 97 💬
|
| 85 | Abatacept (ABA) + Methotrexate (MTX), double-blind (DB) | [2] Abatacept Abatacept, Methotrexate | [3] Methotrexate
Methotrexate
,
Methotrexate sodium
,
Abatacept
💬
| [4] CD80 CD80, CD86, DHFR, DHFR2 💬
| [17] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Folate biosynthesis, Folate transport and metabolism, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, One carbon pool by folate, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 46 46 💬
|
| 86 | Abatacept (BMS-188667) | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 46 46 💬
|
| 87 | Abatacept (CTLA4-Ig) | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 44 44 💬
|
| 88 | Abatacept (IV) | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 46 46 💬
|
| 89 | Abatacept (SC) | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 46 46 💬
|
| 90 | Abatacept (W12-W48) | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 46 46 💬
|
| 91 | Abatacept + csDMARD | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 46 46 💬
|
| 92 | Abatacept + Vaccines | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 46 46 💬
|
| 93 | Abatacept Active Treatment | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 50 50 💬
|
| 94 | Abatacept also known as Orencia also known as CTLA4-Ig | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 49 49 💬
|
| 95 | Abatacept combination product (ACP) | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 46 46 💬
|
| 96 | Abatacept Delayed-Onset Treatment | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 50 50 💬
|
| 97 | Abatacept Injection | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [3] 11 11, 46, 107 💬
|
| 98 | Abatacept Injection [Orencia] and Proleukin (aldesleukin) | [2] Abatacept Abatacept, Aldesleukin | [2] Aldesleukin
Aldesleukin
,
Abatacept
💬
| [5] CD80 CD80, CD86, IL2RA, IL2RB, IL2RG 💬
| [27] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cytokine-cytokine receptor interaction, Endocytosis, Graft-versus-host disease, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, IgSF CAM signaling, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rheumatoid arthritis, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬 | [1] 2 2 💬
|
| 99 | Abatacept Prefilled Syringe | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 46 46 💬
|
| 100 | Abatacept SC | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 53 53 💬
|
| 101 | Abatacept subcutaneous | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 50 50 💬
|
| 102 | Abatacept, rituximab or tocilizumab | [3] Abatacept Abatacept, Rituximab, Tocilizumab | [3] Tocilizumab
Tocilizumab
,
Rituximab
,
Abatacept
💬
| [4] CD80 CD80, CD86, IL6R, MS4A1 💬
| [25] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Coronavirus disease, Cytokine-cytokine receptor interaction, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, IgSF CAM signaling, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬 | [1] 46 46 💬
|
| 103 | ABBV-006 | - | - | - | - | [1] 97 97 💬
|
| 104 | ABBV-066 | - | - | - | - | [2] 96 96, 97 💬
|
| 105 | ABBV-0805 | - | - | - | - | [1] 6 6 💬
|
| 106 | ABBV-105 | - | - | - | - | [2] 46 46, 49 💬
|
| 107 | ABBV-105, A-1519938.0 | - | - | - | - | [1] 46 46 💬
|
| 108 | ABBV-119 | - | - | - | - | [1] 299 299 💬
|
| 109 | ABBV-142 | - | - | - | - | [1] 85 85 💬
|
| 110 | ABBV-154 | - | - | - | - | [2] 46 46, 96 💬
|
| 111 | ABBV-2222 | - | - | - | - | [1] 299 299 💬
|
| 112 | ABBV-257 | - | - | - | - | [1] 46 46 💬
|
| 113 | ABBV-3067 | - | - | - | - | [1] 299 299 💬
|
| 114 | ABBV-319 | - | - | - | - | [1] 49 49 💬
|
| 115 | ABBV-323 | - | - | - | - | [2] 53 53, 97 💬
|
| 116 | ABBV-323 Dose A | - | - | - | - | [1] 97 97 💬
|
| 117 | ABBV-323 Dose B | - | - | - | - | [1] 97 97 💬
|
| 118 | ABBV-3373 | - | - | - | - | [1] 46 46 💬
|
| 119 | ABBV-383 (Etentamig) | [1] Etentamig Etentamig | [1] Etentamig
Etentamig
💬
| [2] CD3E CD3E, TNFRSF17 💬
| [13] Chagas disease Chagas disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 28 28 💬
|
| 120 | ABBV-519 | - | - | - | - | [2] 46 46, 49 💬
|
| 121 | ABBV-576 | - | - | - | - | [1] 299 299 💬
|
| 122 | ABBV-668 | - | - | - | - | [1] 97 97 💬
|
| 123 | ABBV-8736 | - | - | - | - | [1] 96 96 💬
|
| 124 | ABBV-8E12 | - | - | - | - | [2] 5 5, 7 💬
|
| 125 | ABBV-951 | - | - | - | - | [1] 6 6 💬
|
| 126 | ABBV-CLS-628 | - | - | - | - | [1] 67 67 💬
|
| 127 | ABBV-CLS-7262 | - | - | - | - | [1] 2 2 💬
|
| 128 | ABBV-CLS-7262 Dose 1 | - | - | - | - | [1] 2 2 💬
|
| 129 | ABBV-CLS-7262 Dose 2 | - | - | - | - | [1] 2 2 💬
|
| 130 | ABC008 | - | - | - | - | [1] 15 15 💬
|
| 131 | Abcertin | - | - | - | - | [1] 19 19 💬
|
| 132 | Abdominal compression | - | - | - | - | [2] 6 6, 17 💬
|
| 133 | Abdominal ultrasound | - | - | - | - | [2] 19 19, 231 💬
|
| 134 | ABELCET | - | - | - | - | [1] 299 299 💬
|
| 135 | Abelmoschus manihot | - | - | - | - | [1] 66 66 💬
|
| 136 | Abemaciclib | [1] Abemaciclib Abemaciclib | [1] Abemaciclib
Abemaciclib
💬
| [2] CDK4 CDK4, CDK6 💬
| [28] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Breast cancer, Cell cycle, Cellular senescence, Chronic myeloid leukemia, Cushing syndrome, Epstein-Barr virus infection, Glioma, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Measles, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Small cell lung cancer, T cell receptor signaling pathway, Tight junction, Viral carcinogenesis, p53 signaling pathway 💬 | [1] 34 34 💬
|
| 137 | Abetimus | [1] Abetimus Abetimus | [1] Abetimus sodium
Abetimus sodium
💬
| - | - | [2] 49 49, 223 💬
|
| 138 | ABETIMUS SODIUM | [1] Abetimus Abetimus | [1] Abetimus sodium
Abetimus sodium
💬
| - | - | [1] 49 49 💬
|
| 139 | Abetimus sodium (LJP 394) | [1] Abetimus Abetimus | [1] Abetimus sodium
Abetimus sodium
💬
| - | - | [2] 49 49, 223 💬
|
| 140 | ABH001 | [1] ABH001 ABH001 | - | - | - | [1] 36 36 💬
|
| 141 | ABI-009 | - | - | - | - | [1] 21 21 💬
|
| 142 | ABI-M201 | - | - | - | - | [1] 97 97 💬
|
| 143 | Abilify | - | - | - | - | [1] 74 74 💬
|
| 144 | Abiraterone | [1] Abiraterone Abiraterone | [1] Abiraterone acetate
Abiraterone acetate
💬
| [1] CYP17A1 CYP17A1 💬
| [5] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬 | [2] 75 75, 81 💬
|
| 145 | Abiraterone Acetate | [2] Abiraterone Abiraterone, Acetate | [1] Abiraterone acetate
Abiraterone acetate
💬
| [1] CYP17A1 CYP17A1 💬
| [5] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬 | [2] 75 75, 81 💬
|
| 146 | Abiraterone acetato | [1] Abiraterone Abiraterone | [1] Abiraterone acetate
Abiraterone acetate
💬
| [1] CYP17A1 CYP17A1 💬
| [5] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬 | [1] 75 75 💬
|
| 147 | Abituzumab | [1] Abituzumab Abituzumab | - | - | - | [1] 51 51 💬
|
| 148 | Abituzumab 1500 mg | [1] Abituzumab Abituzumab | - | - | - | [1] 51 51 💬
|
| 149 | Abituzumab 500 mg | [1] Abituzumab Abituzumab | - | - | - | [1] 51 51 💬
|
| 150 | Ablation | - | - | - | - | [1] 84 84 💬
|
| 151 | ABMC | - | - | - | - | [1] 57 57 💬
|
| 152 | ABO-101 | - | - | - | - | [2] 19 19, 234 💬
|
| 153 | ABO-102 | [1] Rebisufligene etisparvovec Rebisufligene etisparvovec | - | - | - | [1] 19 19 💬
|
| 154 | Abobotulinumtoxin A | - | - | - | - | [1] 13 13 💬
|
| 155 | ABP 501 | - | - | - | - | [1] 46 46 💬
|
| 156 | ABP 692 | - | - | - | - | [1] 13 13 💬
|
| 157 | ABP 710 | - | - | - | - | [1] 46 46 💬
|
| 158 | ABP 710 - Biosimilar to infliximab | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 159 | ABP 798 | - | - | - | - | [1] 46 46 💬
|
| 160 | ABP 798 - Biosimilar to rituximab | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 161 | ABP 798 Biosimilar to Rituximab | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 162 | ABP 959 | - | - | - | - | [1] 62 62 💬
|
| 163 | ABP 959 - biosimilar to eculizumab | [1] Eculizumab Eculizumab | [1] Eculizumab
Eculizumab
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 62 62 💬
|
| 164 | ABP 959 - proposed biosimilar to eculizumab | [1] Eculizumab Eculizumab | [1] Eculizumab
Eculizumab
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 62 62 💬
|
| 165 | ABR-215062 | - | - | - | - | [1] 13 13 💬
|
| 166 | ABR-215062 sodium salt | - | - | - | - | [2] 13 13, 96 💬
|
| 167 | ABR-215757 | - | - | - | - | [2] 49 49, 51 💬
|
| 168 | Abrilumab | [1] Abrilumab Abrilumab | [1] Abrilumab
Abrilumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2] 96 96, 97 💬
|
| 169 | Abrocitinib | [1] Abrocitinib Abrocitinib | [1] Abrocitinib
Abrocitinib
💬
| [1] JAK1 JAK1 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [3] 39 39, 84, 162 💬
|
| 170 | Abrocitinib 200 mg | [1] Abrocitinib Abrocitinib | [1] Abrocitinib
Abrocitinib
💬
| [1] JAK1 JAK1 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 84 84 💬
|
| 171 | ABSK061 | - | - | - | - | [1] 276 276 💬
|
| 172 | ABT 494 | - | - | - | - | [1] 46 46 💬
|
| 173 | ABT 494 12mg | - | - | - | - | [2] 46 46, 96 💬
|
| 174 | ABT 494 3mg | - | - | - | - | [2] 46 46, 96 💬
|
| 175 | ABT Humira | - | - | - | - | [1] 96 96 💬
|
| 176 | ABT-122 | - | - | - | - | [1] 46 46 💬
|
| 177 | ABT-199 | - | - | - | - | [1] 49 49 💬
|
| 178 | ABT-494 | - | - | - | - | [7] 41 41, 46, 49, 96, 97, 107, 271 💬
|
| 179 | ABT-494 15mg | - | - | - | - | [1] 46 46 💬
|
| 180 | ABT-494 30mg | - | - | - | - | [1] 46 46 💬
|
| 181 | ABT-555 | - | - | - | - | [1] 13 13 💬
|
| 182 | ABT-874 | - | - | - | - | [1] 96 96 💬
|
| 183 | ABT-874/Human monoclonal antibody against IL-12 | - | - | - | - | [1] 13 13 💬
|
| 184 | ABT-Humira | - | - | - | - | [2] 46 46, 97 💬
|
| 185 | ABT-SLV187 | - | - | - | - | [1] 6 6 💬
|
| 186 | ABX-1431 | [1] ABX-1431 ABX-1431 | - | - | - | [1] 13 13 💬
|
| 187 | ABX-1431 HCl | [1] ABX-1431 ABX-1431 | - | - | - | [1] 13 13 💬
|
| 188 | ABX1100 | [1] ABX1100 ABX1100 | - | - | - | [1] 256 256 💬
|
| 189 | ABX1100 injection for IV infusion | [1] ABX1100 ABX1100 | - | - | - | [1] 256 256 💬
|
| 190 | ABX464 | - | - | - | - | [3] 46 46, 96, 97 💬
|
| 191 | ABX464 100mg | - | - | - | - | [2] 46 46, 97 💬
|
| 192 | ABX464 25mg | - | - | - | - | [1] 97 97 💬
|
| 193 | ABX464 50mg | - | - | - | - | [2] 46 46, 97 💬
|
| 194 | ABY-035 | - | - | - | - | [1] 271 271 💬
|
| 195 | AC-101 | - | - | - | - | [1] 97 97 💬
|
| 196 | AC-203 | - | - | - | - | [1] 36 36 💬
|
| 197 | AC-203 1% Topical Ointment | - | - | - | - | [1] 162 162 💬
|
| 198 | AC0058TA | - | - | - | - | [1] 49 49 💬
|
| 199 | AC430 | - | - | - | - | [1] 46 46 💬
|
| 200 | Acacia | [1] Acacia Acacia | [1] Acacia
Acacia
💬
| - | - | [1] 97 97 💬
|
| 201 | Acacia Gum | [1] Acacia Acacia | [1] Acacia
Acacia
💬
| - | - | [1] 97 97 💬
|
| 202 | Acalabrutinib | [1] Acalabrutinib Acalabrutinib | [2] Acalabrutinib
Acalabrutinib
,
Acalabrutinib maleate hydrate
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [2] 46 46, 61 💬
|
| 203 | Acamprosate | [1] Acamprosate Acamprosate | [2] Acamprosate calcium
Acamprosate calcium
,
Acamprosate
💬
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [3] 2 2, 6, 206 💬
|
| 204 | Acamprosate calcium | [2] Acamprosate Acamprosate, Calcium | [2] Acamprosate calcium
Acamprosate calcium
,
Acamprosate
💬
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 2 2 💬
|
| 205 | Acarbose | [1] Acarbose Acarbose | [1] Acarbose
Acarbose
💬
| [5] AMY2A AMY2A, AMY2B, GAA, GANC, MGAM 💬
| [6] Carbohydrate digestion and absorption Carbohydrate digestion and absorption, Galactose metabolism, Lysosome biogenesis, Pancreatic secretion, Salivary secretion, Starch and sucrose metabolism 💬 | [1] 298 298 💬
|
| 206 | Acazicolcept | [1] Acazicolcept Acazicolcept | [1] Acazicolcept
Acazicolcept
💬
| [2] CD28 CD28, ICOS 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, Type I diabetes mellitus, Viral myocarditis 💬 | [1] 49 49 💬
|
| 207 | ACC | - | - | - | - | [1] 299 299 💬
|
| 208 | ACC600Tabs | - | - | - | - | [1] 299 299 💬
|
| 209 | Accelerated 1 hour-infusion | - | - | - | - | [2] 96 96, 97 💬
|
| 210 | Accelerated 30 minutes-infusion | - | - | - | - | [2] 96 96, 97 💬
|
| 211 | Accelerated HBV Vaccine | - | - | - | - | [1] 97 97 💬
|
| 212 | Accelerometer | - | - | - | - | [1] 17 17 💬
|
| 213 | Access program - sildenafil citrate, Viagra, Revatio | [1] Sildenafil Sildenafil | [2] Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| [1] PDE5A PDE5A 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 214 | Accordion Pill Carbidopa/Levodopa | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 215 | Accordion Pill ¿ Carbidopa/Levodopa 50/400 mg | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 216 | Accordion Pill ¿ Carbidopa/Levodopa 50/500 mg | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 217 | Accordion Pill? Carbidopa/Levodopa 50/400 mg | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 218 | Accordion Pill? Carbidopa/Levodopa 50/500 mg | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 219 | Accordion Pill¿ Carbidopa/levodopa | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 220 | Accordion Pill™ Carbidopa/Levodopa | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 221 | Accordion Pill™ Carbidopa/Levodopa 50/400 mg | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 222 | Accordion Pill™ Carbidopa/Levodopa 50/500 mg | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 223 | Accu Chek | - | - | - | - | [2] 65 65, 257 💬
|
| 224 | AccuCinch Ventricular Restoration System | - | - | - | - | [1] 57 57 💬
|
| 225 | Accupro | - | - | - | - | [1] 19 19 💬
|
| 226 | Accuretic | - | - | - | - | [1] 19 19 💬
|
| 227 | ACDED + Modulen | - | - | - | - | [1] 96 96 💬
|
| 228 | ACDN-01 | - | - | - | - | [2] 90 90, 301 💬
|
| 229 | ACE I, ATA II and Statins | - | - | - | - | [1] 218 218 💬
|
| 230 | ACE inhibitor | - | - | - | - | [1] 66 66 💬
|
| 231 | ACE inhibitor + statin | - | - | - | - | [2] 66 66, 223 💬
|
| 232 | ACE Inhibitor or Angiotensin receptor antagonist | - | - | - | - | [1] 66 66 💬
|
| 233 | ACE Inhibitors | - | - | - | - | [1] 57 57 💬
|
| 234 | ACE Retino | - | - | - | - | [1] 90 90 💬
|
| 235 | ACE-011 | - | - | - | - | [1] 86 86 💬
|
| 236 | ACE-011 / ??-7962 | - | - | - | - | [1] 86 86 💬
|
| 237 | ACE-011 / MK - 7962 | - | - | - | - | [1] 86 86 💬
|
| 238 | ACE-011 / MK-7962 | - | - | - | - | [1] 86 86 💬
|
| 239 | ACE-011/ MK-7962 | - | - | - | - | [1] 86 86 💬
|
| 240 | ACE-031 (Extension of cohort 1 from core study, A031-03) | - | - | - | - | [1] 113 113 💬
|
| 241 | ACE-031 (Extension of cohort 2 from core study, A031-03) | - | - | - | - | [1] 113 113 💬
|
| 242 | ACE-031 (Extension of cohort 3 from core study, A031-03) | - | - | - | - | [1] 113 113 💬
|
| 243 | ACE-031 0.5 mg/kg q4wk | - | - | - | - | [1] 113 113 💬
|
| 244 | ACE-031 1.0 mg/kg q2wk | - | - | - | - | [1] 113 113 💬
|
| 245 | ACE-083 | - | - | - | - | [2] 10 10, 113 💬
|
| 246 | ACE-inhibitor | - | - | - | - | [1] 218 218 💬
|
| 247 | ACE/ARB | - | - | - | - | [1] 66 66 💬
|
| 248 | ACE1831 | - | - | - | - | [2] 49 49, 300 💬
|
| 249 | Acebilustat | [1] Acebilustat Acebilustat | - | - | - | [1] 299 299 💬
|
| 250 | Aceclofenac | [1] Aceclofenac Aceclofenac | [1] Aceclofenac
Aceclofenac
💬
| [3] PTGES PTGES, PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 💬
|
| 251 | ACEi | - | - | - | - | [2] 66 66, 224 💬
|
| 252 | ACEI / Angiotensin converting enzyme inhibitor | - | - | - | - | [1] 234 234 💬
|
| 253 | ACEI / ARB+finerenone | [1] Finerenone Finerenone | [1] Finerenone
Finerenone
💬
| [1] NR3C2 NR3C2 💬
| [1] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | [1] 224 224 💬
|
| 254 | ACEI, SGLT-2i | - | - | - | - | [1] 222 222 💬
|
| 255 | ACEI/ARB | - | - | - | - | [2] 222 222, 224 💬
|
| 256 | ACEI/ARB and corticosteroids | - | - | - | - | [1] 66 66 💬
|
| 257 | ACEI/ARB+ finerenone | [1] Finerenone Finerenone | [1] Finerenone
Finerenone
💬
| [1] NR3C2 NR3C2 💬
| [1] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | [1] 222 222 💬
|
| 258 | Acellbia | - | - | - | - | [1] 46 46 💬
|
| 259 | Acellular nerve allograft | [1] Acellular nerve allograft Acellular nerve allograft | - | - | - | [1] 149 149 💬
|
| 260 | Acemetacin | [1] Acemetacin Acemetacin | [1] Acemetacin
Acemetacin
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 💬
|
| 261 | ACENEURAMIC ACID | [1] Aceneuramic acid Aceneuramic acid | [1] Aceneuramic acid
Aceneuramic acid
💬
| - | - | [1] 30 30 💬
|
| 262 | Aceneuramic Acid Extended-Release | [1] Aceneuramic acid Aceneuramic acid | [1] Aceneuramic acid
Aceneuramic acid
💬
| - | - | [1] 30 30 💬
|
| 263 | Aceneuramic acid extended-release (Ace-ER) | [1] Aceneuramic acid Aceneuramic acid | [1] Aceneuramic acid
Aceneuramic acid
💬
| - | - | [1] 30 30 💬
|
| 264 | Aceneuramic Acid Extended-Release Tablets | [1] Aceneuramic acid Aceneuramic acid | [1] Aceneuramic acid
Aceneuramic acid
💬
| - | - | [1] 30 30 💬
|
| 265 | Acenocumarol | - | - | - | - | [1] 48 48 💬
|
| 266 | ACER-002 (celiprolol) 200 mg BID | [1] Celiprolol Celiprolol | [2] Celiprolol hydrochloride
Celiprolol hydrochloride
,
Celiprolol
💬
| [1] ADRB1 ADRB1 💬
| [13] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 168 168 💬
|
| 267 | Acetamide | [1] Acetamide Acetamide | - | - | - | [3] 65 65, 86, 154 💬
|
| 268 | Acetaminophen | [1] Acetaminophen Acetaminophen | [1] Acetaminophen
Acetaminophen
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [19] 11 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
|
| 269 | Acetaminophen and Diphenhydramine Only Product | [2] Acetaminophen Acetaminophen, Diphenhydramine | [5] Acetaminophen
Acetaminophen
,
Diphenhydramine
,
Diphenhydramine hydrochloride
,
Diphenhydramine salicylate
,
Diphenhydramine citrate
💬
| [3] HRH1 HRH1, PTGS1, PTGS2 💬
| [27] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 63 63 💬
|
| 270 | Acetaminophen Tablet 650mg | [1] Acetaminophen Acetaminophen | [1] Acetaminophen
Acetaminophen
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 13 13 💬
|
| 271 | Acetaminophen tablets | [1] Acetaminophen Acetaminophen | [1] Acetaminophen
Acetaminophen
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 💬
|
| 272 | Acetaminophen/ Paracetamol | [1] Acetaminophen Acetaminophen | [1] Acetaminophen
Acetaminophen
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 222 222 💬
|
| 273 | Acetaminophen/paracetamol | [1] Acetaminophen Acetaminophen | [1] Acetaminophen
Acetaminophen
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [2] 35 35, 49 💬
|
| 274 | Acetate | [1] Acetate Acetate | - | - | - | [52] 1 1, 2, 6, 10, 11, 13, 22, 35, 40, 46, 49, 51, 60, 63, 64, 65, 66, 67, 70, 71, 73, 75, 76, 77, 78, 79, 81, 83, 85, 86, 88, 89, 90, 96, 97, 113, 145, 156, 158, 162, 171, 206, 222, 223, 224, 225, 227, 235, 251, 265, 298, 299 💬
|
| 275 | Acetato de octreótida | - | - | - | - | [1] 77 77 💬
|
| 276 | ACETATO DI AMMONIO | - | - | - | - | [1] 97 97 💬
|
| 277 | Acetazolamide | [1] Acetazolamide Acetazolamide | [2] Acetazolamide
Acetazolamide
,
Acetazolamide sodium
💬
| [13] CA1 CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬
| [6] Bile secretion Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬 | [8] 13 13, 67, 90, 115, 155, 222, 225, 230 💬
|
| 278 | Acetazolamide and Hydrochlorothiazide Followed by Furosemide | [3] Acetazolamide Acetazolamide, Furosemide, Hydrochlorothiazide | [4] Acetazolamide
Acetazolamide
,
Furosemide
,
Hydrochlorothiazide
,
Acetazolamide sodium
💬
| [15] CA1 CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9, SLC12A2, SLC12A3 💬
| [9] Bile secretion Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Nitrogen metabolism, Pancreatic secretion, Parathyroid hormone synthesis, secretion and action, Proximal tubule bicarbonate reclamation, Salivary secretion, Vibrio cholerae infection 💬 | [1] 222 222 💬
|
| 279 | Acetazolamide Sandoz 250 | [1] Acetazolamide Acetazolamide | [2] Acetazolamide
Acetazolamide
,
Acetazolamide sodium
💬
| [13] CA1 CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬
| [6] Bile secretion Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬 | [1] 225 225 💬
|
| 280 | Acetic acid | [1] Acetic acid Acetic acid | [1] Acetic acid, glacial
Acetic acid, glacial
💬
| - | - | [3] 21 21, 97, 296 💬
|
| 281 | Acetohydroxamic Acid | [1] Acetohydroxamic acid Acetohydroxamic acid | [1] Acetohydroxamic acid
Acetohydroxamic acid
💬
| - | - | [1] 251 251 💬
|
| 282 | Acetohydroxamic Acid Oral Tablet [Lithostat] | [1] Acetohydroxamic acid Acetohydroxamic acid | [1] Acetohydroxamic acid
Acetohydroxamic acid
💬
| - | - | [1] 251 251 💬
|
| 283 | Acetominophen | - | - | - | - | [1] 63 63 💬
|
| 284 | ACETYL- L- CARNITINE | - | - | - | - | [1] 265 265 💬
|
| 285 | Acetyl-l-carnitine | - | - | - | - | [1] 2 2 💬
|
| 286 | Acetyl-L-carnitine 1000mg 2X per day for 3 months | - | - | - | - | [1] 298 298 💬
|
| 287 | Acetylcarnitine | [1] Acetylcarnitine Acetylcarnitine | - | - | - | [3] 2 2, 97, 265 💬
|
| 288 | Acetylcholine | [1] Acetylcholine Acetylcholine | [1] Acetylcholine chloride
Acetylcholine chloride
💬
| [21] CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬
| [17] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, Virion - Ebolavirus, Lyssavirus and Morbillivirus, cAMP signaling pathway 💬 | [1] 11 11 💬
|
| 289 | Acetylcysteine | [1] Acetylcysteine Acetylcysteine | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [25] 2 2, 6, 13, 19, 20, 21, 34, 49, 51, 53, 58, 63, 85, 90, 94, 97, 111, 164, 193, 233, 296, 298, 299, 303, 337 💬
|
| 290 | Acetylcysteine amide | [2] Acetylcysteine Acetylcysteine, Acetylcysteine amide | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [3] 19 19, 90, 303 💬
|
| 291 | ACETYLCYSTEINE SODIUM | [1] Acetylcysteine Acetylcysteine | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [1] 299 299 💬
|
| 292 | ACETYLSALICYLIC ACID | [1] Acetylsalicylic acid Acetylsalicylic acid | [1] Aspirin
Aspirin
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [5] 13 13, 46, 51, 62, 210 💬
|
| 293 | Acetylsalicylic acid at 1st visit, | [1] Acetylsalicylic acid Acetylsalicylic acid | [1] Aspirin
Aspirin
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 13 13 💬
|
| 294 | ACH-0144471 | [1] Danicopan Danicopan | [1] Danicopan
Danicopan
💬
| [1] CFD CFD 💬
| [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬 | [2] 62 62, 223 💬
|
| 295 | ACH-0144471 compresse | - | - | - | - | [1] 223 223 💬
|
| 296 | ACH-0145228 | - | - | - | - | [1] 62 62 💬
|
| 297 | ACH0144471 | - | - | - | - | [1] 223 223 💬
|
| 298 | ACH0144471 compresse | - | - | - | - | [1] 223 223 💬
|
| 299 | ACHIM | - | - | - | - | [1] 51 51 💬
|
| 300 | ACHIM as solute (10^9 intestinal microbes/ml) | - | - | - | - | [1] 51 51 💬
|
| 301 | ACHIM capsules | - | - | - | - | [1] 51 51 💬
|
| 302 | AchromoPhage | - | - | - | - | [1] 299 299 💬
|
| 303 | ACI-7104.056 at Dose A | - | - | - | - | [1] 6 6 💬
|
| 304 | ACI-7104.056 at Dose B (optional) | - | - | - | - | [1] 6 6 💬
|
| 305 | ACI-7104.056 at Dose C (optional) | - | - | - | - | [1] 6 6 💬
|
| 306 | Aciclin | - | - | - | - | [1] 28 28 💬
|
| 307 | Aciclovir | - | - | - | - | [3] 13 13, 28, 60 💬
|
| 308 | Acid mycophenolic (Myfortic) | - | - | - | - | [1] 222 222 💬
|
| 309 | Acide acétylsalicylique | - | - | - | - | [1] 63 63 💬
|
| 310 | Acide folique | - | - | - | - | [1] 46 46 💬
|
| 311 | ACIDE TRANEXAMIQUE MYLAN 0,5 g/ 5 mL, solution injectable | - | - | - | - | [1] 299 299 💬
|
| 312 | ACIDO ASCORBICO | - | - | - | - | [1] 10 10 💬
|
| 313 | ACIDO ASCORBICO DC.IT | - | - | - | - | [1] 10 10 💬
|
| 314 | ACIDO DEOSSICOLICO | - | - | - | - | [1] 94 94 💬
|
| 315 | ACIDO FUSIDICO/IDROCORTISONE ACETATO | - | - | - | - | [1] 272 272 💬
|
| 316 | Acido Micofenolico | [1] Mycophenolic acid Mycophenolic acid | [2] Mycophenolate sodium
Mycophenolate sodium
,
Mycophenolic acid
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [2] 49 49, 51 💬
|
| 317 | ACIDO OBETICOLICO | - | - | - | - | [3] 93 93, 94, 296 💬
|
| 318 | Acido Sialico - Sialic acid (INN: aceneuramic acid) | [1] Aceneuramic acid Aceneuramic acid | [1] Aceneuramic acid
Aceneuramic acid
💬
| - | - | [1] 30 30 💬
|
| 319 | ACIDO TAUROURSODESOSSICOLICO | - | - | - | - | [1] 2 2 💬
|
| 320 | Acido ursodessicolico | - | - | - | - | [1] 93 93 💬
|
| 321 | ACIDUM ASCORBICUM D6 | - | - | - | - | [1] 206 206 💬
|
| 322 | Acipimox | [1] Acipimox Acipimox | [1] Acipimox
Acipimox
💬
| - | - | [2] 78 78, 265 💬
|
| 323 | Acitretin | [1] Acitretin Acitretin | [1] Acitretin
Acitretin
💬
| [5] RARA RARA, RARB, RXRA, RXRB, RXRG 💬
| [20] Acute myeloid leukemia Acute myeloid leukemia, Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Efferocytosis, Estrogen signaling pathway, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬 | [1] 37 37 💬
|
| 324 | Aclasta | - | - | - | - | [4] 13 13, 97, 271, 274 💬
|
| 325 | Aclasta 5 mg Infusionslösung | - | - | - | - | [1] 13 13 💬
|
| 326 | Aclasta 5mg solution for infusion | - | - | - | - | [1] 13 13 💬
|
| 327 | ACM | - | - | - | - | [1] 49 49 💬
|
| 328 | ACN00177 | - | - | - | - | [1] 337 337 💬
|
| 329 | Acoltremon | [1] Acoltremon Acoltremon | [1] Acoltremon
Acoltremon
💬
| [1] TRPM8 TRPM8 💬
| [1] Inflammatory mediator regulation of TRP channels Inflammatory mediator regulation of TRP channels 💬 | [1] 53 53 💬
|
| 330 | ACOMPLIA 20 mg film-coated tablets | - | - | - | - | [1] 193 193 💬
|
| 331 | Acoramidis | [1] Acoramidis Acoramidis | [2] Acoramidis
Acoramidis
,
Acoramidis hydrochloride
💬
| [1] TTR TTR 💬
| [1] Thyroid hormone synthesis Thyroid hormone synthesis 💬 | [1] 28 28 💬
|
| 332 | Acoramidis (356 mg film-coated tablets) | [1] Acoramidis Acoramidis | [2] Acoramidis
Acoramidis
,
Acoramidis hydrochloride
💬
| [1] TTR TTR 💬
| [1] Thyroid hormone synthesis Thyroid hormone synthesis 💬 | [1] 28 28 💬
|
| 333 | Acoramidis (AG10) | [1] Acoramidis Acoramidis | [2] Acoramidis
Acoramidis
,
Acoramidis hydrochloride
💬
| [1] TTR TTR 💬
| [1] Thyroid hormone synthesis Thyroid hormone synthesis 💬 | [1] 28 28 💬
|
| 334 | Acotiamide | [1] Acotiamide Acotiamide | - | - | - | [2] 11 11, 51 💬
|
| 335 | ACP-103 | - | - | - | - | [1] 6 6 💬
|
| 336 | ACR16 | - | - | - | - | [1] 8 8 💬
|
| 337 | ACR16 10 mg | - | - | - | - | [1] 8 8 💬
|
| 338 | ACR16 22.5 mg | - | - | - | - | [1] 8 8 💬
|
| 339 | ACR16 45 mg | - | - | - | - | [1] 8 8 💬
|
| 340 | ACR16 hydrochloride, ASP2314 hydrochloride, FR310826 | - | - | - | - | [1] 8 8 💬
|
| 341 | ACR325 | - | - | - | - | [1] 6 6 💬
|
| 342 | ACT | - | - | - | - | [1] 13 13 💬
|
| 343 | ACT - 064992 | - | - | - | - | [1] 86 86 💬
|
| 344 | ACT-050089 | - | - | - | - | [1] 86 86 💬
|
| 345 | ACT-050089 (Ro 61-0612) | - | - | - | - | [1] 86 86 💬
|
| 346 | ACT-064992 | - | - | - | - | [5] 51 51, 85, 86, 88, 210 💬
|
| 347 | ACT-064992 (macitentan) | [1] Macitentan Macitentan | [1] Macitentan
Macitentan
💬
| [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 85 85 💬
|
| 348 | ACT-064992 / JNJ-67896062 | - | - | - | - | [1] 86 86 💬
|
| 349 | ACT-064992/ JNJ-67896062 | - | - | - | - | [1] 86 86 💬
|
| 350 | ACT-064992D | - | - | - | - | [1] 86 86 💬
|
| 351 | ACT-1 | - | - | - | - | [1] 13 13 💬
|
| 352 | ACT-128800 | - | - | - | - | [1] 13 13 💬
|
| 353 | ACT-128800 Dose 1 | - | - | - | - | [1] 13 13 💬
|
| 354 | ACT-128800 Dose 2 | - | - | - | - | [1] 13 13 💬
|
| 355 | ACT-128800 Dose 3 | - | - | - | - | [1] 13 13 💬
|
| 356 | ACT-178418 | - | - | - | - | [1] 86 86 💬
|
| 357 | ACT-293987 | - | - | - | - | [3] 51 51, 86, 88 💬
|
| 358 | ACT-293987 (NS-304) | - | - | - | - | [1] 86 86 💬
|
| 359 | ACT-293987 / JNJ-67896049 | - | - | - | - | [1] 84 84 💬
|
| 360 | ACT-334441 | - | - | - | - | [1] 49 49 💬
|
| 361 | ACT-385781A | - | - | - | - | [1] 86 86 💬
|
| 362 | ACT-385781A (Actelion Epoprostenol) | [1] Epoprostenol Epoprostenol | [2] Epoprostenol
Epoprostenol
,
Epoprostenol sodium
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 363 | ACT-434964 | - | - | - | - | [1] 19 19 💬
|
| 364 | Act-HiB | - | - | - | - | [3] 14 14, 62, 223 💬
|
| 365 | ACT-HIB Polvere e solvente per soluzione iniettabile in siringa preriempita 0,5 ml | - | - | - | - | [4] 61 61, 62, 63, 223 💬
|
| 366 | ACT100 Injection | - | - | - | - | [1] 49 49 💬
|
| 367 | Actavis FERROUS SULPHATE TABLETS BP 200mg | - | - | - | - | [1] 97 97 💬
|
| 368 | Actemra | - | - | - | - | [2] 46 46, 107 💬
|
| 369 | Actemra +MTX | - | - | - | - | [1] 46 46 💬
|
| 370 | Actemra(EU-licensed) | - | - | - | - | [1] 46 46 💬
|
| 371 | Actemra, MRA | - | - | - | - | [1] 107 107 💬
|
| 372 | Actemra® | - | - | - | - | [1] 46 46 💬
|
| 373 | Acteoside | [1] Acteoside Acteoside | - | - | - | [1] 66 66 💬
|
| 374 | ACTH | - | - | - | - | [3] 13 13, 145, 222 💬
|
| 375 | ACTH (Acthar) Gel | - | - | - | - | [1] 66 66 💬
|
| 376 | ACTH/Oral Steroids | - | - | - | - | [1] 145 145 💬
|
| 377 | Acthar | - | - | - | - | [6] 2 2, 13, 46, 49, 50, 222 💬
|
| 378 | Acthar 80 unit injection | - | - | - | - | [1] 66 66 💬
|
| 379 | Acthar Gel | - | - | - | - | [6] 13 13, 46, 49, 84, 222, 223 💬
|
| 380 | ACTHAR Gel (ACTH) | - | - | - | - | [1] 13 13 💬
|
| 381 | ACTHAR Gel (adrenocorticotropic hormone) | - | - | - | - | [1] 84 84 💬
|
| 382 | ACTHAR Gel 40 units twice weekly | - | - | - | - | [1] 84 84 💬
|
| 383 | ACTHAR Gel 80 units twice weekly. | - | - | - | - | [1] 84 84 💬
|
| 384 | Acthar Gel 80 UNT/ML Injectable Solution | - | - | - | - | [2] 222 222, 223 💬
|
| 385 | Acthar Gel and Tacrolimus | [1] Tacrolimus Tacrolimus | [2] Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 222 222 💬
|
| 386 | Acthar high dose (80 U) | - | - | - | - | [1] 49 49 💬
|
| 387 | Acthar Injectable Product | - | - | - | - | [1] 46 46 💬
|
| 388 | Acthar low dose (40 U) | - | - | - | - | [1] 49 49 💬
|
| 389 | ACTHIB - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONCINO POLVE | - | - | - | - | [1] 223 223 💬
|
| 390 | ACTHIB - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONCINO POLVERE+1 SIRINGA PRERIEMPITA SOLVENTE 0.5 ML | - | - | - | - | [2] 62 62, 66 💬
|
| 391 | Acthrel | - | - | - | - | [1] 75 75 💬
|
| 392 | ACTIMMUNE | - | - | - | - | [1] 326 326 💬
|
| 393 | Actimmune Registry | - | - | - | - | [1] 326 326 💬
|
| 394 | ActiMyo recording | - | - | - | - | [1] 6 6 💬
|
| 395 | Activated charcoal | [1] Activated charcoal Activated charcoal | [1] Charcoal, activated
Charcoal, activated
💬
| - | - | [2] 13 13, 85 💬
|
| 396 | Activated smart device | - | - | - | - | [1] 299 299 💬
|
| 397 | Active BMN 111: Subcutaneous injection of recommended dose of BMN 111 based on weight-band dosing once daily. | - | - | - | - | [1] 276 276 💬
|
| 398 | Active comparator | - | - | - | - | [3] 6 6, 46, 96 💬
|
| 399 | Active comparator (Agalsidase beta) | [1] Agalsidase beta Agalsidase beta | [1] Agalsidase beta
Agalsidase beta
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 400 | Active Comparator receiving Extavia® | - | - | - | - | [1] 13 13 💬
|
| 401 | Active Comparator: traditionnal arm: Weight-based dosing | - | - | - | - | [1] 46 46 💬
|
| 402 | Active Control | - | - | - | - | [1] 13 13 💬
|
| 403 | Active drug (BIIB014) at 10, 30, 100, or 300 mg once daily. | - | - | - | - | [1] 6 6 💬
|
| 404 | Active drug: pimavanserin 17mg (2 strength tablets) | [1] Pimavanserin Pimavanserin | [1] Pimavanserin tartrate
Pimavanserin tartrate
💬
| [2] HTR2A HTR2A, HTR2C 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | [1] 6 6 💬
|
| 405 | Active Investigational Treatment ENT-01 | - | - | - | - | [1] 6 6 💬
|
| 406 | Active Stimulation | - | - | - | - | [1] 46 46 💬
|
| 407 | Active tDCS | - | - | - | - | [1] 6 6 💬
|
| 408 | Active topical NS2 1% dermatologic cream | - | - | - | - | [1] 160 160 💬
|
| 409 | Active tPCS | - | - | - | - | [1] 6 6 💬
|
| 410 | Active Transcranial Direct Current Stimulation | - | - | - | - | [1] 6 6 💬
|
| 411 | Active Treatment Group 7% Hypertonic Saline | - | - | - | - | [1] 299 299 💬
|
| 412 | Active vitamin D | [1] Vitamin D Vitamin D | - | - | - | [1] 235 235 💬
|
| 413 | ActiveMatrix | - | - | - | - | [1] 70 70 💬
|
| 414 | Activity Monitor | - | - | - | - | [1] 113 113 💬
|
| 415 | Actonel 5mg Film Coated Tablets | - | - | - | - | [1] 274 274 💬
|
| 416 | Actonel Once a Week 35 mg film-coated tablets | - | - | - | - | [1] 274 274 💬
|
| 417 | Actonel Once a Week 35mg | - | - | - | - | [1] 97 97 💬
|
| 418 | Actonel Once a week 5mg film coated tablets | - | - | - | - | [1] 113 113 💬
|
| 419 | Actonel/Optinate 5mg film-coated tablets | - | - | - | - | [1] 274 274 💬
|
| 420 | ACTOS (Pioglitazone) | [1] Pioglitazone Pioglitazone | [2] Pioglitazone hydrochloride
Pioglitazone hydrochloride
,
Pioglitazone
💬
| [1] PPARG PPARG 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 13 13 💬
|
| 421 | Actos 15 mg | - | - | - | - | [1] 2 2 💬
|
| 422 | Actos 30 mg | - | - | - | - | [1] 2 2 💬
|
| 423 | Actos 45 mg | - | - | - | - | [1] 2 2 💬
|
| 424 | Actrapid 100 IU/ml, Solution for injection in a vial | - | - | - | - | [1] 299 299 💬
|
| 425 | Actrapid Penfill 100UI/ml | - | - | - | - | [1] 299 299 💬
|
| 426 | ActRIIA-IgG1Fc | - | - | - | - | [1] 86 86 💬
|
| 427 | ACTUS-101 | [1] ACTUS-101 ACTUS-101 | - | - | - | [1] 256 256 💬
|
| 428 | ACU-4429 | - | - | - | - | [1] 301 301 💬
|
| 429 | Acupuncture | - | - | - | - | [3] 46 46, 70, 97 💬
|
| 430 | Acute Antioxidant | - | - | - | - | [1] 299 299 💬
|
| 431 | Acycloguanosine | - | - | - | - | [2] 46 46, 53 💬
|
| 432 | Acyclovir | [1] Acyclovir Acyclovir | [2] Acyclovir
Acyclovir
,
Acyclovir sodium
💬
| - | - | [2] 13 13, 28 💬
|
| 433 | Acylated and unacylated ghrelin dosages | - | - | - | - | [3] 193 193, 201, 202 💬
|
| 434 | ACZ885 | - | - | - | - | [7] 46 46, 84, 106, 107, 108, 266, 267 💬
|
| 435 | ACZ885 (investigational) | - | - | - | - | [1] 46 46 💬
|
| 436 | ACZ885 150 mg (Canakinumab) | [1] Canakinumab Canakinumab | [1] Canakinumab
Canakinumab
💬
| [1] IL1B IL1B 💬
| [43] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [1] 107 107 💬
|
| 437 | ACZ885 Drug Substance | - | - | - | - | [3] 46 46, 106, 107 💬
|
| 438 | ACZ885, 150mg/1.0ml | - | - | - | - | [3] 108 108, 266, 267 💬
|
| 439 | ACZ885D | - | - | - | - | [1] 108 108 💬
|
| 440 | ACZ885G | - | - | - | - | [1] 107 107 💬
|
| 441 | AD 452 | - | - | - | - | [1] 46 46 💬
|
| 442 | AD 452 18 mg tablet | - | - | - | - | [1] 46 46 💬
|
| 443 | AD 452 4.5 mg Tablet | - | - | - | - | [1] 46 46 💬
|
| 444 | AD 452 9 mg tablet | - | - | - | - | [1] 46 46 💬
|
| 445 | AD-MSC transdifferentiated HSCs (AD-HSCs) | - | - | - | - | [1] 60 60 💬
|
| 446 | Ad26.COV2-S.02 | - | - | - | - | [1] 299 299 💬
|
| 447 | Ad26.COV2.S | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 448 | AD981 | - | - | - | - | [1] 230 230 💬
|
| 449 | Adagen | - | - | - | - | [1] 65 65 💬
|
| 450 | Adalimuab, Etanercept, Tocilizumab, or Abatacept | [3] Abatacept Abatacept, Etanercept, Tocilizumab | [3] Etanercept
Etanercept
,
Tocilizumab
,
Abatacept
💬
| [5] CD80 CD80, CD86, IL6R, LTA, TNF 💬
| [79] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, IgSF CAM signaling, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 451 | Adalimumab | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [22] 19 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
|
| 452 | Adalimumab (20mg) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 107 107 💬
|
| 453 | Adalimumab (40 mg) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 454 | Adalimumab (40mg) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 107 107 💬
|
| 455 | Adalimumab (ADA) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 456 | Adalimumab (D2E7) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 271 💬
|
| 457 | Adalimumab (Humira) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 222, 271 💬
|
| 458 | Adalimumab (HUMIRA®) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 459 | Adalimumab (up to 9 months exposure) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 460 | Adalimumab - GP2017 | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 461 | Adalimumab - US licensed Humira | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 462 | Adalimumab 40 mg | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 463 | Adalimumab 40 mg eow or ew | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 464 | Adalimumab 40 mg sc every other week | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 271 271 💬
|
| 465 | Adalimumab 40 mg subcutaneous (SC) every other week (EOW) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 466 | Adalimumab 40mg | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 467 | Adalimumab 40mg q2w | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 468 | Adalimumab 80 mg | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 469 | Adalimumab Ab | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 271 271 💬
|
| 470 | Adalimumab and Infliximab | [2] Adalimumab Adalimumab, Infliximab | [2] Adalimumab
Adalimumab
,
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 471 | Adalimumab and its biosimilars | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 271 271 💬
|
| 472 | Adalimumab biosimilare | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 107 107 💬
|
| 473 | Adalimumab delivered in current autoinjector | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 474 | Adalimumab delivered in current syringe | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 475 | Adalimumab delivered in Physiolis autoinjector | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 476 | Adalimumab delivered in Physiolis syringe | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 477 | Adalimumab Dose Intensification | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 478 | ADALIMUMAB HUMIRA | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 479 | Adalimumab Injection | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [5] 38 38, 40, 46, 96, 162 💬
|
| 480 | Adalimumab injection 40 mg | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 481 | Adalimumab Injection [Humira] | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 19 19 💬
|
| 482 | Adalimumab PFS and Pen | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 483 | Adalimumab PRN | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 484 | Adalimumab Solution for Injection | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 485 | Adalimumab with methotrexate | [2] Adalimumab Adalimumab, Methotrexate | [3] Methotrexate
Methotrexate
,
Methotrexate sodium
,
Adalimumab
💬
| [3] DHFR DHFR, DHFR2, TNF 💬
| [69] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Folate transport and metabolism, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 486 | Adalimumab, current formulation | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 487 | Adalimumab, Etanercept, Golimumab or infliximab | [4] Adalimumab Adalimumab, Etanercept, Golimumab, Infliximab | [4] Etanercept
Etanercept
,
Adalimumab
,
Infliximab
,
Golimumab
💬
| [2] LTA LTA, TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 271 271 💬
|
| 488 | Adalimumab, infliximab, ustekinumab, golimumab, and vedolizumab | [5] Adalimumab Adalimumab, Golimumab, Infliximab, Ustekinumab, Vedolizumab | [5] Adalimumab
Adalimumab
,
Infliximab
,
Golimumab
,
Vedolizumab
,
Ustekinumab
💬
| [6] IL12A IL12A, IL12B, IL23A, ITGA4, ITGB7, TNF 💬
| [83] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, IgSF CAM signaling, Inflammatory bowel disease, Influenza A, Insulin resistance, Integrin signaling, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 489 | Adalimumab, new formulation | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 490 | Adalimumab, plus prednisone | [2] Adalimumab Adalimumab, Prednisone | [2] Prednisone
Prednisone
,
Adalimumab
💬
| [2] NR3C1 NR3C1, TNF 💬
| [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 491 | Adalimumab, Solution for Injection 40 mg/ (0.8 ml) Pre-filled Syringe | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 492 | Adalimumab-680LT | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 493 | Adalimumab-680LT 25mg | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 494 | Adalimumab-800CW | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 97 💬
|
| 495 | ADALIMUMAB-EU | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 496 | Adalimumab-Pfizer | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 497 | Adalimummab | - | - | - | - | [1] 46 46 💬
|
| 498 | Adaptor: Hakko Adaptor | - | - | - | - | [1] 6 6 💬
|
| 499 | Adcirca | - | - | - | - | [1] 86 86 💬
|
| 500 | ADCIRCA 20 mg film-coated tablets | - | - | - | - | [1] 86 86 💬
|
| 501 | Adcirca® | - | - | - | - | [1] 86 86 💬
|
| 502 | Add-on sirolimus therapy | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 54 54 💬
|
| 503 | Adderall XR | - | - | - | - | [1] 13 13 💬
|
| 504 | Adderall XR 10 mg | - | - | - | - | [1] 13 13 💬
|
| 505 | Adderall XR 5mg | - | - | - | - | [1] 13 13 💬
|
| 506 | Addition of rituximab if recurrence | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 11 11 💬
|
| 507 | Additional blood collection during routine blood sampling at the inclusion (33.9 ml) and at the thrombotic recurrence (between 3.5 and 5 ml) | - | - | - | - | [1] 48 48 💬
|
| 508 | Additional blood samples | - | - | - | - | [1] 41 41 💬
|
| 509 | Adefovir | [1] Adefovir Adefovir | [1] Adefovir
Adefovir
💬
| - | - | [1] 46 46 💬
|
| 510 | Ademetionine | [1] Ademetionine Ademetionine | [1] Ademetionine
Ademetionine
💬
| - | - | [1] 58 58 💬
|
| 511 | Ademetionine 1,4-Butanedisulfonate | [1] Ademetionine Ademetionine | [1] Ademetionine
Ademetionine
💬
| - | - | [1] 58 58 💬
|
| 512 | Adempas | - | - | - | - | [5] 51 51, 86, 88, 225, 299 💬
|
| 513 | Adempas (Riociguat, BAY63-2521) | [1] Riociguat Riociguat | [1] Riociguat
Riociguat
💬
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
| [10] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 86 86, 88 💬
|
| 514 | ADEMPAS - 0,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | - | - | - | - | [1] 86 86 💬
|
| 515 | ADEMPAS - 1 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | - | - | - | - | [2] 51 51, 86 💬
|
| 516 | ADEMPAS - 1,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | - | - | - | - | [2] 51 51, 86 💬
|
| 517 | ADEMPAS - 2 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | - | - | - | - | [2] 51 51, 86 💬
|
| 518 | ADEMPAS - 2,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | - | - | - | - | [2] 51 51, 86 💬
|
| 519 | Adempas 0.125 mg | - | - | - | - | [1] 299 299 💬
|
| 520 | Adempas 0.5 mg | - | - | - | - | [2] 86 86, 299 💬
|
| 521 | Adempas 0.5 mg Film Coated Tablet | - | - | - | - | [1] 86 86 💬
|
| 522 | Adempas 1 mg Film Coated Tablet | - | - | - | - | [1] 86 86 💬
|
| 523 | Adempas 1.0 mg | - | - | - | - | [2] 86 86, 299 💬
|
| 524 | Adempas 1.5 mg | - | - | - | - | [1] 86 86 💬
|
| 525 | Adempas 1.5 mg Film Coated Tablet | - | - | - | - | [1] 86 86 💬
|
| 526 | Adempas 2 mg Film Coated Tablet | - | - | - | - | [1] 86 86 💬
|
| 527 | Adempas 2.0 mg | - | - | - | - | [2] 86 86, 299 💬
|
| 528 | Adempas 2.5 mg | - | - | - | - | [1] 86 86 💬
|
| 529 | Adempas 2.5 mg Film Coated Tablet | - | - | - | - | [1] 86 86 💬
|
| 530 | Adempas Filmtabletten | - | - | - | - | [1] 86 86 💬
|
| 531 | Adempas® | - | - | - | - | [2] 86 86, 88 💬
|
| 532 | Adempas® 0.5 mg film-coated tablets | - | - | - | - | [1] 86 86 💬
|
| 533 | Adempas® 1.0 mg film-coated tablets | - | - | - | - | [1] 86 86 💬
|
| 534 | Adempas® 1.5 mg film-coated tablets | - | - | - | - | [1] 86 86 💬
|
| 535 | Adempas® 2.0 mg film-coated tablets | - | - | - | - | [1] 86 86 💬
|
| 536 | Adempas® 2.5 mg film-coated tablets | - | - | - | - | [1] 86 86 💬
|
| 537 | Adempas¿ 0.5 mg compressa rivestita con film | - | - | - | - | [1] 86 86 💬
|
| 538 | Adempas¿ 1.0 | - | - | - | - | [1] 86 86 💬
|
| 539 | Adempas¿ 1.5 mg | - | - | - | - | [1] 86 86 💬
|
| 540 | Adempas¿ 2.0 mg | - | - | - | - | [1] 86 86 💬
|
| 541 | Adempas¿ 2.5 mg | - | - | - | - | [1] 86 86 💬
|
| 542 | Adenine | [1] Adenine Adenine | [1] Adenine
Adenine
💬
| - | - | [1] 63 63 💬
|
| 543 | ADENO-ASSOCIATED VIRAL (AAV) SEROTYPE 8 (AAV2/8) VECTOR WITH LIVER-SPECIFIC THYROXINE-BINDING GLOBULIN (TBG) PROMOTER, DRIVING THE EXPRESSION OF THE HUMAN ARSB GENE | - | - | - | - | [1] 19 19 💬
|
| 544 | Adeno-associated viral vector serotype 3B encoding shortened human ATP7B | - | - | - | - | [1] 171 171 💬
|
| 545 | Adeno-associated viral vector serotype 8 containing the human MD1 gene | - | - | - | - | [1] 113 113 💬
|
| 546 | Adeno-associated viral vector serotype 9 containing the human mini-dystrophin gene | - | - | - | - | [1] 113 113 💬
|
| 547 | Adeno-associated viral vector serotype 9 containing the human N-acetyl-alpha-glucosaminidase gene | - | - | - | - | [1] 19 19 💬
|
| 548 | Adeno-associated viral vector serotype 9 encoding human ATP7B | - | - | - | - | [1] 171 171 💬
|
| 549 | Adeno-associated viral vector serotype 9 expressing codon-optimized human GRN gene | - | - | - | - | [1] 127 127 💬
|
| 550 | ADENO-ASSOCIATED VIRAL VECTOR SEROTYPE RH10 CONTAINING THE HUMAN CHOLESTEROL 24-HYDROXYLASE GENE | [1] Cholesterol Cholesterol | [1] Cholesterol
Cholesterol
💬
| - | - | [1] 8 8 💬
|
| 551 | Adeno-associated virus (AAV) serotype rh.10 expressing human betagalactosidase (AAVrh.10-CAG-betagal) | - | - | - | - | [1] 19 19 💬
|
| 552 | Adeno-associated virus (AAV) serotype rh.10 expressing human betagalactosidase (AAVrh.10-CAG-ßgal) | - | - | - | - | [1] 19 19 💬
|
| 553 | Adeno-associated virus serotype 2/6 encoding human alpha-galactosidase A cDNA | - | - | - | - | [1] 19 19 💬
|
| 554 | Adeno-associated virus serotype 2/6 encoding Human Iduronate 2-sulfatase (hIDS) gene donor vector, SB-A6P-HNT Donor Vector | - | - | - | - | [1] 19 19 💬
|
| 555 | Adeno-associated virus serotype 2/6 encoding human iduronidase (hIDUA) gene donor vector, SB-A6P-HRL Donor Vector | - | - | - | - | [1] 19 19 💬
|
| 556 | Adeno-associated virus serotype 2/6 encoding Left side-zinc finger nuclease (ZFN1), SB-A6P-ZLEFT Vector | - | - | - | - | [1] 19 19 💬
|
| 557 | Adeno-associated virus serotype 2/6 encoding Right side-zinc finger nuclease (ZFN2), SB-A6P-ZRIGHT Vector | - | - | - | - | [1] 19 19 💬
|
| 558 | ADENO-ASSOCIATED VIRUS SEROTYPE 5 ENCODING A MICRORNA TARGETED TO HUMAN HUNTINGTIN GENE | - | - | - | - | [1] 8 8 💬
|
| 559 | Adeno-associated virus serotype 9 carrying the human Fukutin-Related protein and target sequence of the miR-208a | - | - | - | - | [1] 113 113 💬
|
| 560 | Adeno-associated virus serotype hu68 containing the human GALC gene | - | - | - | - | [1] 19 19 💬
|
| 561 | Adeno-associated virus serotype rh.10 expressing beta-galactosidase | - | - | - | - | [1] 19 19 💬
|
| 562 | Adeno-associated virus serotype rh74 containing the human delandistrogene moxeparvovec dystrophin gene | [1] Delandistrogene moxeparvovec Delandistrogene moxeparvovec | [1] Delandistrogene moxeparvovec
Delandistrogene moxeparvovec
💬
| [1] DMD DMD 💬
| [5] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | [1] 113 113 💬
|
| 563 | ADENO-ASSOCIATED VIRUS SEROTYPE RH74 CONTAINING THE HUMAN MICRO- DYSTROPHIN GENE | - | - | - | - | [1] 113 113 💬
|
| 564 | ADENO-ASSOCIATED VIRUS SEROTYPE RH74 CONTAINING THE HUMAN MICRO-DYSTROPHIN GENE | - | - | - | - | [1] 113 113 💬
|
| 565 | Adeno-associated virus type 2 vector encoding Rab escort protein 1 | - | - | - | - | [1] 90 90 💬
|
| 566 | Adeno-associated virus vector expressing a human RPGR gene | - | - | - | - | [1] 90 90 💬
|
| 567 | Adeno-associated virus-CFTR vector | - | - | - | - | [1] 299 299 💬
|
| 568 | Adenosine | [1] Adenosine Adenosine | [1] Adenosine
Adenosine
💬
| [4] ADORA1 ADORA1, ADORA2A, ADORA2B, ADORA3 💬
| [13] Alcoholism Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [4] 13 13, 57, 58, 65 💬
|
| 569 | Adezunap | - | - | - | - | [1] 13 13 💬
|
| 570 | Adezunap (AP707) | - | - | - | - | [1] 13 13 💬
|
| 571 | ADI-001 | - | - | - | - | [3] 46 46, 49, 51 💬
|
| 572 | Adipose derived allogenic mesenchymal stem cells (adAMSC) | - | - | - | - | [1] 96 96 💬
|
| 573 | Adipose derived mesenchymal stem cell | - | - | - | - | [1] 3 3 💬
|
| 574 | Adipose derived mesenchymal stem cells | - | - | - | - | [1] 86 86 💬
|
| 575 | Adipose derived mesenchymal stem cells ( AD-MSCs) | - | - | - | - | [1] 60 60 💬
|
| 576 | Adipose derived stromal cells intravenously injected | - | - | - | - | [1] 39 39 💬
|
| 577 | Adipose derived, autologous mesenchymal stem cells | - | - | - | - | [1] 97 97 💬
|
| 578 | Adipose Tissue Biopsy | - | - | - | - | [1] 77 77 💬
|
| 579 | Adipose tissue-derived mesenchymal stem cells | - | - | - | - | [1] 97 97 💬
|
| 580 | Adipose tissue-derived Mesenchymal Stromal Cells | - | - | - | - | [1] 13 13 💬
|
| 581 | Adipose-cord mesenchymal stromal cells (A-MSCs) | - | - | - | - | [1] 97 97 💬
|
| 582 | Adjunctive analgesics | - | - | - | - | [1] 70 70 💬
|
| 583 | Adjunctive anti-depressants | - | - | - | - | [1] 70 70 💬
|
| 584 | Adjuvant IM Therapy | - | - | - | - | [1] 19 19 💬
|
| 585 | Adjuvant Immunomodulatory (IM) Therapy | - | - | - | - | [1] 19 19 💬
|
| 586 | Adjuvant without active component | - | - | - | - | [2] 6 6, 17 💬
|
| 587 | Adjuvanted Recombinant Zoster Vaccine (RZV) | - | - | - | - | [1] 97 97 💬
|
| 588 | ADL5859 | [1] ADL5859 ADL5859 | - | - | - | [1] 46 46 💬
|
| 589 | Administration Kit | - | - | - | - | [1] 19 19 💬
|
| 590 | Administration of a high dose of desipramine | [1] Desipramine Desipramine | [2] Desipramine hydrochloride
Desipramine hydrochloride
,
Desipramine
💬
| [2] SLC6A2 SLC6A2, SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 156 156 💬
|
| 591 | Administration of a low dose of desipramine | [1] Desipramine Desipramine | [2] Desipramine hydrochloride
Desipramine hydrochloride
,
Desipramine
💬
| [2] SLC6A2 SLC6A2, SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 156 156 💬
|
| 592 | Administration of an ACE-inhibitor or not | - | - | - | - | [1] 210 210 💬
|
| 593 | Administration of Carbidopa/levodopa | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [2] 6 6, 17 💬
|
| 594 | Administration of Cimzia® | - | - | - | - | [1] 46 46 💬
|
| 595 | Administration of drug (Interferon-gamma 1-b) subcutaneously | - | - | - | - | [1] 65 65 💬
|
| 596 | Administration of Methylprednisolone + Prednisone + Mycophenolate mofetil | [3] Methylprednisolone Methylprednisolone, Mycophenolate mofetil, Prednisone | [5] Methylprednisolone
Methylprednisolone
,
Prednisone
,
Mycophenolate mofetil
,
Methylprednisolone acetate
,
Mycophenolate mofetil hydrochloride
💬
| [3] IMPDH1 IMPDH1, IMPDH2, NR3C1 💬
| [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬 | [1] 49 49 💬
|
| 597 | Administration of methylprednisolone, paracetamol and dexchlorpheniramine | [2] Dexchlorpheniramine Dexchlorpheniramine, Methylprednisolone | [3] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
,
Dexchlorpheniramine
💬
| [2] HRH1 HRH1, NR3C1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 49 49 💬
|
| 598 | Administration of rituximab and methylprednisolone | [2] Methylprednisolone Methylprednisolone, Rituximab | [3] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
,
Rituximab
💬
| [2] MS4A1 MS4A1, NR3C1 💬
| [2] Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | [1] 51 51 💬
|
| 599 | Administration of stable isotope-labelled leucine- | [1] Leucine Leucine | [1] Leucine
Leucine
💬
| - | - | [1] 6 6 💬
|
| 600 | AdMSC | - | - | - | - | [1] 51 51 💬
|
| 601 | AdMSC (CellReady®) | - | - | - | - | [1] 96 96 💬
|
| 602 | Adoport | - | - | - | - | [1] 222 222 💬
|
| 603 | Adrabetadex | - | - | - | - | [1] 19 19 💬
|
| 604 | Adrenal cortical hormone | - | - | - | - | [1] 224 224 💬
|
| 605 | Adrenalina | - | - | - | - | [1] 299 299 💬
|
| 606 | Adrenergic receptor binder (ARB) | - | - | - | - | [1] 224 224 💬
|
| 607 | Adrenocorticotrophic Hormone | - | - | - | - | [1] 222 222 💬
|
| 608 | Adrenocorticotrophic hormone ACTH | - | - | - | - | [2] 222 222, 223 💬
|
| 609 | Adrenocorticotropic Hormone | - | - | - | - | [1] 13 13 💬
|
| 610 | Adrenocorticotropic hormone (ACTH) gel (H.P. Acthar®) | - | - | - | - | [1] 13 13 💬
|
| 611 | Adrenocorticotropic Hormone Gel | - | - | - | - | [1] 50 50 💬
|
| 612 | Adrenocorticotropin hormone | - | - | - | - | [1] 145 145 💬
|
| 613 | Adrenomedullin | [1] Adrenomedullin Adrenomedullin | - | - | - | [3] 96 96, 97, 124 💬
|
| 614 | Adrulipase | - | - | - | - | [1] 299 299 💬
|
| 615 | ADS-001 | - | - | - | - | [1] 231 231 💬
|
| 616 | ADS-5102 | - | - | - | - | [2] 6 6, 13 💬
|
| 617 | ADS-5102 (extended release amantadine HCl) | [1] Amantadine Amantadine | [2] Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 618 | ADS-5102, 137 mg | - | - | - | - | [1] 13 13 💬
|
| 619 | ADS-5102, 274 mg | - | - | - | - | [1] 13 13 💬
|
| 620 | ADSVF | - | - | - | - | [2] 15 15, 96 💬
|
| 621 | ADSVF application in the right hand | - | - | - | - | [1] 51 51 💬
|
| 622 | Adult human bone marrow derived, cultured, pooled, allogeneic mesenchymal stromal cells | - | - | - | - | [1] 47 47 💬
|
| 623 | Adult human mesenchymal stem cells | - | - | - | - | [1] 96 96 💬
|
| 624 | Advagraf 0,5mg | - | - | - | - | [1] 222 222 💬
|
| 625 | Advagraf 1mg | - | - | - | - | [1] 222 222 💬
|
| 626 | Advagraf 5mg | - | - | - | - | [1] 222 222 💬
|
| 627 | Advagraf prolonged-release hard capsules | - | - | - | - | [1] 299 299 💬
|
| 628 | Advanced therapy | - | - | - | - | [1] 97 97 💬
|
| 629 | Advanced therapy only without dietary intervention | - | - | - | - | [1] 97 97 💬
|
| 630 | Advancement plasty | - | - | - | - | [1] 96 96 💬
|
| 631 | Adverse Reactions of Gammagard subcutaneously at Week 12 | - | - | - | - | [1] 65 65 💬
|
| 632 | Adverse Reactions of Gammagard subcutaneously at Week 24 | - | - | - | - | [1] 65 65 💬
|
| 633 | Adverse Reactions of Gammagard subcutaneously at Week 36 | - | - | - | - | [1] 65 65 💬
|
| 634 | Adverse Reactions of Gammagard subdermally at Week 12 | - | - | - | - | [1] 65 65 💬
|
| 635 | Adverse Reactions of Gammagard subdermally at Week 24 | - | - | - | - | [1] 65 65 💬
|
| 636 | Adverse Reactions of Gammagard subdermally at Week 36 | - | - | - | - | [1] 65 65 💬
|
| 637 | ADX-038 | - | - | - | - | [2] 62 62, 223 💬
|
| 638 | ADX-038 Dose Level 1 | - | - | - | - | [2] 66 66, 223 💬
|
| 639 | ADX-038 Dose Level 2 | - | - | - | - | [2] 66 66, 223 💬
|
| 640 | ADX-097 | - | - | - | - | [1] 66 66 💬
|
| 641 | ADX-102 1% Topical Dermal Cream (reproxalap) | [1] Reproxalap Reproxalap | [1] Reproxalap
Reproxalap
💬
| - | - | [1] 160 160 💬
|
| 642 | ADX-2191 | - | - | - | - | [1] 90 90 💬
|
| 643 | ADX-324 | - | - | - | - | [1] 65 65 💬
|
| 644 | ADX-324 Dose Level 1 | - | - | - | - | [1] 65 65 💬
|
| 645 | ADX-324 Dose Level 2 | - | - | - | - | [1] 65 65 💬
|
| 646 | ADX-629 | - | - | - | - | [2] 160 160, 222 💬
|
| 647 | ADX48621 | - | - | - | - | [1] 6 6 💬
|
| 648 | AEB071 | - | - | - | - | [1] 97 97 💬
|
| 649 | AEB071A | - | - | - | - | [1] 97 97 💬
|
| 650 | AED | - | - | - | - | [1] 158 158 💬
|
| 651 | AEGR-733 | - | - | - | - | [1] 79 79 💬
|
| 652 | AER-901 Solution for Nebulization | - | - | - | - | [1] 86 86 💬
|
| 653 | AER002 | - | - | - | - | [1] 299 299 💬
|
| 654 | Aero-red 100 mg/ml gotas orales en solución | - | - | - | - | [2] 96 96, 97 💬
|
| 655 | Aerobic exercise | - | - | - | - | [1] 46 46 💬
|
| 656 | Aerolised Liposomal Ciclosporin A | - | - | - | - | [1] 228 228 💬
|
| 657 | Aerolised Liposomal Ciclosporin A 10mg | - | - | - | - | [1] 228 228 💬
|
| 658 | Aerolised Liposomal Ciclosporin A 5mg | - | - | - | - | [1] 228 228 💬
|
| 659 | Aeroquin | - | - | - | - | [1] 299 299 💬
|
| 660 | Aerosol interferon-gamma | - | - | - | - | [1] 85 85 💬
|
| 661 | Aerosolized human Alpha-1 Antitrypsin | - | - | - | - | [1] 231 231 💬
|
| 662 | Aerosolized iloprost | [1] Iloprost Iloprost | [2] Iloprost
Iloprost
,
Iloprost tromethamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 663 | Aerosolized, human, plasma-derived Alpha-1 Antitrypsin | - | - | - | - | [1] 299 299 💬
|
| 664 | Aerosoltherapy | - | - | - | - | [1] 299 299 💬
|
| 665 | AeroVanc | - | - | - | - | [1] 299 299 💬
|
| 666 | AERT, (R)-Baclofen | [1] Baclofen Baclofen | [1] Baclofen
Baclofen
💬
| [2] GABBR1 GABBR1, GABBR2 💬
| [8] Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | [1] 13 13 💬
|
| 667 | Aesculus Hippocastanum / Horse Chestnut | [1] Horse chestnut Horse chestnut | [1] Horse chestnut
Horse chestnut
💬
| - | - | [1] 210 210 💬
|
| 668 | AF056 | - | - | - | - | [1] 206 206 💬
|
| 669 | AF37702 Injection | - | - | - | - | [1] 283 283 💬
|
| 670 | AF37702, Hematide | [1] Peginesatide Peginesatide | [2] Peginesatide
Peginesatide
,
Peginesatide acetate
💬
| [1] EPOR EPOR 💬
| [7] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [1] 283 283 💬
|
| 671 | AFAMELANOTIDE | [1] Afamelanotide Afamelanotide | [2] Afamelanotide
Afamelanotide
,
Afamelanotide acetate
💬
| [1] MC1R MC1R 💬
| [3] Hormone signaling Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬 | [2] 159 159, 254 💬
|
| 672 | Afamelanotide (16 mg implant) | [1] Afamelanotide Afamelanotide | [2] Afamelanotide
Afamelanotide
,
Afamelanotide acetate
💬
| [1] MC1R MC1R 💬
| [3] Hormone signaling Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬 | [1] 159 159 💬
|
| 673 | Afamelanotide 16 MG | [1] Afamelanotide Afamelanotide | [2] Afamelanotide
Afamelanotide
,
Afamelanotide acetate
💬
| [1] MC1R MC1R 💬
| [3] Hormone signaling Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬 | [1] 254 254 💬
|
| 674 | Afamelanotide 16mg implant | [1] Afamelanotide Afamelanotide | [2] Afamelanotide
Afamelanotide
,
Afamelanotide acetate
💬
| [1] MC1R MC1R 💬
| [3] Hormone signaling Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬 | [1] 254 254 💬
|
| 675 | Afamelanotide Implant | [1] Afamelanotide Afamelanotide | [2] Afamelanotide
Afamelanotide
,
Afamelanotide acetate
💬
| [1] MC1R MC1R 💬
| [3] Hormone signaling Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬 | [1] 254 254 💬
|
| 676 | Afatinib | [1] Afatinib Afatinib | [2] Afatinib
Afatinib
,
Afatinib dimaleate
💬
| [3] EGFR EGFR, ERBB2, ERBB4 💬
| [51] Adherens junction Adherens junction, Amyotrophic lateral sclerosis, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease, Cushing syndrome, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction, Virion - Hepatitis viruses 💬 | [1] 285 285 💬
|
| 677 | Afegostat | [1] Afegostat Afegostat | [2] Afegostat
Afegostat
,
Afegostat tartrate
💬
| - | - | [1] 19 19 💬
|
| 678 | Afegostat tartrate | [1] Afegostat Afegostat | [2] Afegostat
Afegostat
,
Afegostat tartrate
💬
| - | - | [1] 19 19 💬
|
| 679 | AFFITOPE® PD01A | - | - | - | - | [1] 6 6 💬
|
| 680 | AFFITOPE® PD01A + Adjuvant | - | - | - | - | [2] 6 6, 17 💬
|
| 681 | AFFITOPE® PD03A + Adjuvant | - | - | - | - | [1] 17 17 💬
|
| 682 | Aficamten | [1] Aficamten Aficamten | [1] Aficamten
Aficamten
💬
| [5] MYH6 MYH6, MYH7, MYL2, MYL3, MYL4 💬
| [17] Adherens junction Adherens junction, Adrenergic signaling in cardiomyocytes, Apelin signaling pathway, Cardiac muscle contraction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Focal adhesion, Hypertrophic cardiomyopathy, Leukocyte transendothelial migration, Motor proteins, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Viral myocarditis, cGMP-PKG signaling pathway 💬 | [1] 58 58 💬
|
| 683 | Aficamten (5 - 20 mg) | [1] Aficamten Aficamten | [1] Aficamten
Aficamten
💬
| [5] MYH6 MYH6, MYH7, MYL2, MYL3, MYL4 💬
| [17] Adherens junction Adherens junction, Adrenergic signaling in cardiomyocytes, Apelin signaling pathway, Cardiac muscle contraction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Focal adhesion, Hypertrophic cardiomyopathy, Leukocyte transendothelial migration, Motor proteins, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Viral myocarditis, cGMP-PKG signaling pathway 💬 | [1] 58 58 💬
|
| 684 | Aficamten (5 mg, 10 mg, 15 mg, and 20 mg) | [1] Aficamten Aficamten | [1] Aficamten
Aficamten
💬
| [5] MYH6 MYH6, MYH7, MYL2, MYL3, MYL4 💬
| [17] Adherens junction Adherens junction, Adrenergic signaling in cardiomyocytes, Apelin signaling pathway, Cardiac muscle contraction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Focal adhesion, Hypertrophic cardiomyopathy, Leukocyte transendothelial migration, Motor proteins, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Viral myocarditis, cGMP-PKG signaling pathway 💬 | [1] 58 58 💬
|
| 685 | Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg) | [1] Aficamten Aficamten | [1] Aficamten
Aficamten
💬
| [5] MYH6 MYH6, MYH7, MYL2, MYL3, MYL4 💬
| [17] Adherens junction Adherens junction, Adrenergic signaling in cardiomyocytes, Apelin signaling pathway, Cardiac muscle contraction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Focal adhesion, Hypertrophic cardiomyopathy, Leukocyte transendothelial migration, Motor proteins, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Viral myocarditis, cGMP-PKG signaling pathway 💬 | [1] 58 58 💬
|
| 686 | Afimetoran | [1] Afimetoran Afimetoran | [1] Afimetoran
Afimetoran
💬
| - | - | [1] 49 49 💬
|
| 687 | Afimetoran (10mg) | [1] Afimetoran Afimetoran | [1] Afimetoran
Afimetoran
💬
| - | - | [1] 49 49 💬
|
| 688 | Afimetoran (2.5mg) | [1] Afimetoran Afimetoran | [1] Afimetoran
Afimetoran
💬
| - | - | [1] 49 49 💬
|
| 689 | Afimkibart | [1] Afimkibart Afimkibart | [1] Afimkibart
Afimkibart
💬
| [1] TNFSF15 TNFSF15 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [3] 46 46, 96, 97 💬
|
| 690 | Afinitor | - | - | - | - | [3] 34 34, 89, 158 💬
|
| 691 | Afinitor (everolimus) | [1] Everolimus Everolimus | [1] Everolimus
Everolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 137 137 💬
|
| 692 | Afinitor 5mg Tablets | - | - | - | - | [2] 89 89, 158 💬
|
| 693 | Aflibercept | [1] Aflibercept Aflibercept | [1] Aflibercept
Aflibercept
💬
| [3] PGF PGF, VEGFA, VEGFB 💬
| [24] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | [2] 90 90, 166 💬
|
| 694 | AFQ056 | - | - | - | - | [3] 6 6, 8, 206 💬
|
| 695 | AFQ056 with L-dopa | - | - | - | - | [1] 6 6 💬
|
| 696 | AFQ065 | - | - | - | - | [1] 6 6 💬
|
| 697 | After exclusion of relevant contraindications, participants received subcutaneous ustekinumab/secukinumab therapy. | [2] Secukinumab Secukinumab, Ustekinumab | [2] Ustekinumab
Ustekinumab
,
Secukinumab
💬
| [4] IL12A IL12A, IL12B, IL17A, IL23A 💬
| [29] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 37 37 💬
|
| 698 | After preconditioning with chemotherapy, F01 will be evaluated. | - | - | - | - | [1] 49 49 💬
|
| 699 | After surgery for Crohn's disease, eligible patients will be randomized 1:1 to receive oral EXL01 | - | - | - | - | [1] 96 96 💬
|
| 700 | Afucosylated IgG1 kappa monoclonal antibody | - | - | - | - | [1] 300 300 💬
|
| 701 | AG-181 | - | - | - | - | [1] 240 240 💬
|
| 702 | AG011 | - | - | - | - | [1] 97 97 💬
|
| 703 | AG011 - Capsules | - | - | - | - | [1] 97 97 💬
|
| 704 | AG011 - Enema | - | - | - | - | [1] 97 97 💬
|
| 705 | AG10 | - | - | - | - | [1] 28 28 💬
|
| 706 | AG10 HCI | - | - | - | - | [1] 28 28 💬
|
| 707 | AG10 HCL | - | - | - | - | [1] 28 28 💬
|
| 708 | AGA2115 | [1] AGA2115 AGA2115 | - | - | - | [1] 274 274 💬
|
| 709 | Agalsidase | - | - | - | - | [1] 19 19 💬
|
| 710 | AGALSIDASE ALFA | [1] Agalsidase alfa Agalsidase alfa | [1] Agalsidase alfa
Agalsidase alfa
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 711 | Agalsidase Alpha | - | - | - | - | [1] 19 19 💬
|
| 712 | AGALSIDASE BETA | [1] Agalsidase beta Agalsidase beta | [1] Agalsidase beta
Agalsidase beta
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 713 | AGALSIDASE BETA (GZ419828) | [1] Agalsidase beta Agalsidase beta | [1] Agalsidase beta
Agalsidase beta
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 714 | Agalsidase beta (recombinant form) | [1] Agalsidase beta Agalsidase beta | [1] Agalsidase beta
Agalsidase beta
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 715 | Agalsidase beta from Biosidus 1 mg/kg | [1] Agalsidase beta Agalsidase beta | [1] Agalsidase beta
Agalsidase beta
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 716 | AGALSIDASI ALFA | - | - | - | - | [1] 19 19 💬
|
| 717 | AGALSIDASI BETA | - | - | - | - | [1] 19 19 💬
|
| 718 | Agamree | - | - | - | - | [1] 113 113 💬
|
| 719 | AGB101 | - | - | - | - | [1] 6 6 💬
|
| 720 | AGEE cream | - | - | - | - | [1] 13 13 💬
|
| 721 | AGLE-102 | - | - | - | - | [1] 36 36 💬
|
| 722 | AGM 719 | - | - | - | - | [1] 46 46 💬
|
| 723 | AGMB-129 | - | - | - | - | [1] 96 96 💬
|
| 724 | AGMB-447 | - | - | - | - | [1] 85 85 💬
|
| 725 | AGN 203818 | - | - | - | - | [1] 226 226 💬
|
| 726 | AGN-151597 | - | - | - | - | [1] 90 90 💬
|
| 727 | Agomelatine | [1] Agomelatine Agomelatine | [1] Agomelatine
Agomelatine
💬
| [3] HTR2C HTR2C, MTNR1A, MTNR1B 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | [1] 6 6 💬
|
| 728 | Agomelatine or PIacebo | [1] Agomelatine Agomelatine | [1] Agomelatine
Agomelatine
💬
| [3] HTR2C HTR2C, MTNR1A, MTNR1B 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | [1] 6 6 💬
|
| 729 | Agri-King Synbiotic (AKSB) | - | - | - | - | [1] 96 96 💬
|
| 730 | Agrippal S1 (Influenza vaccination) | - | - | - | - | [1] 46 46 💬
|
| 731 | AGS-009 | - | - | - | - | [1] 49 49 💬
|
| 732 | AGT-181 | - | - | - | - | [1] 19 19 💬
|
| 733 | AGT-181 (HIRMAb-IDUA) | - | - | - | - | [1] 19 19 💬
|
| 734 | AGT-182 | [1] AGT-182 AGT-182 | - | - | - | [1] 19 19 💬
|
| 735 | AGTC-501 (high dose and modified corticosteroid regimen) | - | - | - | - | [1] 90 90 💬
|
| 736 | AGTC-501 (high dose and standard corticosteroid regimen) | - | - | - | - | [1] 90 90 💬
|
| 737 | AGTC-501 (low dose and standard corticosteroid regimen) | - | - | - | - | [1] 90 90 💬
|
| 738 | AHSC | - | - | - | - | [1] 13 13 💬
|
| 739 | AI Device | - | - | - | - | [1] 13 13 💬
|
| 740 | AI-1000 G2 | - | - | - | - | [1] 46 46 💬
|
| 741 | AIDSVAX® B/E | - | - | - | - | [1] 49 49 💬
|
| 742 | AIMSPRO | - | - | - | - | [2] 13 13, 51 💬
|
| 743 | AIN | - | - | - | - | [1] 13 13 💬
|
| 744 | AIN457 | - | - | - | - | [9] 13 13, 37, 41, 46, 56, 96, 97, 107, 271 💬
|
| 745 | AIN457 150 mg | - | - | - | - | [1] 271 271 💬
|
| 746 | AIN457, 150 mg | - | - | - | - | [1] 271 271 💬
|
| 747 | AIN457, 150mg | - | - | - | - | [1] 37 37 💬
|
| 748 | AIN457, 75 mg | - | - | - | - | [1] 271 271 💬
|
| 749 | AIN457A | - | - | - | - | [1] 271 271 💬
|
| 750 | AIN457F | - | - | - | - | [3] 46 46, 107, 271 💬
|
| 751 | AIR DNase | - | - | - | - | [1] 299 299 💬
|
| 752 | AIR DNase™ | - | - | - | - | [1] 299 299 💬
|
| 753 | Air insufflation insertion | - | - | - | - | [1] 97 97 💬
|
| 754 | AIR-001 MD dose level 1 | - | - | - | - | [1] 231 231 💬
|
| 755 | AIR-001 MD dose level 2 | - | - | - | - | [1] 231 231 💬
|
| 756 | AIR-001 MD dose level 3 | - | - | - | - | [1] 231 231 💬
|
| 757 | AIR-001 MD dose level 4 | - | - | - | - | [1] 231 231 💬
|
| 758 | AIR-001 MD dose level 5 | - | - | - | - | [1] 231 231 💬
|
| 759 | AIR-001 MD dose level 6 | - | - | - | - | [1] 231 231 💬
|
| 760 | AIR-001 SAD dose level 1 | - | - | - | - | [1] 231 231 💬
|
| 761 | AIR-001 SAD dose level 2 | - | - | - | - | [1] 231 231 💬
|
| 762 | AIR-001 SAD dose level 3 | - | - | - | - | [1] 231 231 💬
|
| 763 | AIR-001 SAD dose level 4 | - | - | - | - | [1] 231 231 💬
|
| 764 | AIR001 | - | - | - | - | [1] 86 86 💬
|
| 765 | AIR001 (sodium nitrite inhalation solution) | [2] Nitrite Nitrite, Nitrous acid | [1] Sodium nitrite
Sodium nitrite
💬
| - | - | [1] 86 86 💬
|
| 766 | AIR001 Inhalation Solution | - | - | - | - | [1] 86 86 💬
|
| 767 | AIR001 Inhalation Solution (Expansion arm) | - | - | - | - | [1] 86 86 💬
|
| 768 | AIRE-2 Portable breath analyzer | - | - | - | - | [1] 97 97 💬
|
| 769 | Airway Basal Stem Cells | - | - | - | - | [1] 228 228 💬
|
| 770 | Airway clearance technique | - | - | - | - | [1] 299 299 💬
|
| 771 | Airway-clearance vest | - | - | - | - | [1] 299 299 💬
|
| 772 | AJ201 | - | - | - | - | [1] 1 1 💬
|
| 773 | AJM300 | - | - | - | - | [1] 97 97 💬
|
| 774 | AK002 | - | - | - | - | [1] 98 98 💬
|
| 775 | AK101 IV | - | - | - | - | [1] 97 97 💬
|
| 776 | AK101 IV/AK101 SC | - | - | - | - | [1] 97 97 💬
|
| 777 | AK101 SC | - | - | - | - | [1] 97 97 💬
|
| 778 | AK102 | - | - | - | - | [1] 79 79 💬
|
| 779 | AK106-001616 | [1] AK106-001616 AK106-001616 | - | - | - | [1] 46 46 💬
|
| 780 | AK111 | - | - | - | - | [1] 271 271 💬
|
| 781 | AK1320 MS | - | - | - | - | [1] 70 70 💬
|
| 782 | AKBM-3031 | - | - | - | - | [1] 49 49 💬
|
| 783 | AKCEA-ANGPTL3-LRX | - | - | - | - | [2] 79 79, 265 💬
|
| 784 | AKCEA-TTR-LRx | [1] Eplontersen Eplontersen | [1] Eplontersen sodium
Eplontersen sodium
💬
| [1] TTR TTR 💬
| [1] Thyroid hormone synthesis Thyroid hormone synthesis 💬 | [1] 28 28 💬
|
| 785 | AKF2328 | - | - | - | - | [2] 222 222, 223 💬
|
| 786 | Akkermansia muciniphila + Infliximab | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 787 | Aknemin 50 | - | - | - | - | [1] 201 201 💬
|
| 788 | AKR-501, YM-477 | - | - | - | - | [1] 63 63 💬
|
| 789 | AKST4290 | - | - | - | - | [2] 6 6, 162 💬
|
| 790 | AL-108 | - | - | - | - | [1] 5 5 💬
|
| 791 | AL001 | [1] Latozinemab Latozinemab | [1] Latozinemab
Latozinemab
💬
| [1] SORT1 SORT1 💬
| [3] Cholesterol metabolism Cholesterol metabolism, Lysosome biogenesis, Neurotrophin signaling pathway 💬 | [2] 2 2, 127 💬
|
| 792 | AL01211 | - | - | - | - | [2] 19 19, 67 💬
|
| 793 | AL2846 capsules | - | - | - | - | [1] 34 34 💬
|
| 794 | ALAC, inulin, FOS, and sodium butyrate | [2] Butyric Acid Butyric Acid, Inulin | [2] Inulin
Inulin
,
Sodium butyrate
💬
| - | - | [1] 156 156 💬
|
| 795 | Alanine | [1] Alanine Alanine | [1] Alanine
Alanine
💬
| - | - | [8] 6 6, 13, 70, 94, 97, 251, 298, 299 💬
|
| 796 | Albendazole | [1] Albendazole Albendazole | [1] Albendazole
Albendazole
💬
| - | - | [1] 96 96 💬
|
| 797 | Albendazole (Eskazole) | [1] Albendazole Albendazole | [1] Albendazole
Albendazole
💬
| - | - | [1] 96 96 💬
|
| 798 | Albumin | - | - | - | - | [3] 2 2, 20, 51 💬
|
| 799 | Albumin (Human) 20%, United States Pharmacopeia (USP) | - | - | - | - | [1] 231 231 💬
|
| 800 | Albumin (Human) 25%, United States Pharmacopeia (USP) | - | - | - | - | [2] 13 13, 14 💬
|
| 801 | Albumin solution | - | - | - | - | [1] 20 20 💬
|
| 802 | ALBUMINE HUMAINE | - | - | - | - | [1] 96 96 💬
|
| 803 | Albunorm® 5%, | - | - | - | - | [1] 20 20 💬
|
| 804 | Albutein 5% | - | - | - | - | [1] 2 2 💬
|
| 805 | Albuterol | [1] Albuterol Albuterol | [2] Albuterol sulfate
Albuterol sulfate
,
Albuterol
💬
| [1] ADRB2 ADRB2 💬
| [11] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [9] 12 12, 13, 86, 89, 113, 231, 256, 299, 340 💬
|
| 806 | Albuterol inhaler | [1] Albuterol Albuterol | [2] Albuterol sulfate
Albuterol sulfate
,
Albuterol
💬
| [1] ADRB2 ADRB2 💬
| [11] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 89 89 💬
|
| 807 | Albuterol inhaler. | [1] Albuterol Albuterol | [2] Albuterol sulfate
Albuterol sulfate
,
Albuterol
💬
| [1] ADRB2 ADRB2 💬
| [11] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 231 231, 299 💬
|
| 808 | Albuterol nebulizer | [1] Albuterol Albuterol | [2] Albuterol sulfate
Albuterol sulfate
,
Albuterol
💬
| [1] ADRB2 ADRB2 💬
| [11] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 89 89 💬
|
| 809 | Albuterol. | [1] Albuterol Albuterol | [2] Albuterol sulfate
Albuterol sulfate
,
Albuterol
💬
| [1] ADRB2 ADRB2 💬
| [11] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 810 | Albúmina humana | - | - | - | - | [1] 2 2 💬
|
| 811 | ALC01 therapy | - | - | - | - | [1] 6 6 💬
|
| 812 | Alcohol | - | - | - | - | [1] 285 285 💬
|
| 813 | Alcohol Septal Ablation | - | - | - | - | [1] 58 58 💬
|
| 814 | Alcohol Wipes vs. No Alcohol Wipes | - | - | - | - | [1] 13 13 💬
|
| 815 | Alcoholic drink | - | - | - | - | [1] 6 6 💬
|
| 816 | ALD518 | - | - | - | - | [1] 46 46 💬
|
| 817 | ALD518 monoclonal antibody (anti IL-6 mAb) | - | - | - | - | [1] 46 46 💬
|
| 818 | ALDACTONE*10CONF 100MG | - | - | - | - | [1] 57 57 💬
|
| 819 | Aldafermin | [1] Aldafermin Aldafermin | [1] Aldafermin
Aldafermin
💬
| [1] FGF19 FGF19 💬
| [10] Breast cancer Breast cancer, Calcium signaling pathway, Gastric cancer, MAPK signaling pathway, Melanoma, PI3K-Akt signaling pathway, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton 💬 | [1] 94 94 💬
|
| 820 | ALDESLEUCHINA | - | - | - | - | [1] 49 49 💬
|
| 821 | Aldesleukin | [1] Aldesleukin Aldesleukin | [1] Aldesleukin
Aldesleukin
💬
| [3] IL2RA IL2RA, IL2RB, IL2RG 💬
| [14] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | [5] 2 2, 49, 65, 96, 97 💬
|
| 822 | Aldosterone | [1] Aldosterone Aldosterone | [1] Aldosterone
Aldosterone
💬
| [1] NR3C2 NR3C2 💬
| [1] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | [3] 57 57, 75, 222 💬
|
| 823 | Aldosterone Antagonists | [1] Aldosterone Aldosterone | [1] Aldosterone
Aldosterone
💬
| [1] NR3C2 NR3C2 💬
| [1] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | [1] 57 57 💬
|
| 824 | Aldurazyme | - | - | - | - | [1] 19 19 💬
|
| 825 | Aldurazyme (laronidase) | [1] Laronidase Laronidase | [1] Laronidase
Laronidase
💬
| [1] IDUA IDUA 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [2] 19 19, 256 💬
|
| 826 | Aldurazyme (Recombinant Human Alpha-L-Iduronidase) | - | - | - | - | [1] 19 19 💬
|
| 827 | ALDURAZYME*INFUS 1FL 5ML 500U | - | - | - | - | [1] 19 19 💬
|
| 828 | Aldurazyme® | - | - | - | - | [1] 19 19 💬
|
| 829 | ALE.F02 | - | - | - | - | [1] 223 223 💬
|
| 830 | ALE1 | - | - | - | - | [1] 172 172 💬
|
| 831 | Aleeto | - | - | - | - | [2] 2 2, 17 💬
|
| 832 | Alefacept | [1] Alefacept Alefacept | [1] Alefacept
Alefacept
💬
| [1] CD58 CD58 💬
| [2] Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction, Epstein-Barr virus infection 💬 | [6] 37 37, 60, 65, 164, 284, 285 💬
|
| 833 | ALEMTUZUMAB | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬
| - | - | [21] 13 13, 14, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 107, 164, 283, 284, 285, 326 💬
|
| 834 | Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994 | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬
| - | - | [1] 46 46 💬
|
| 835 | Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994) | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬
| - | - | [1] 46 46 💬
|
| 836 | Alemtuzumab (Campath ) | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬
| - | - | [1] 60 60 💬
|
| 837 | Alemtuzumab (Campath) | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬
| - | - | [1] 15 15 💬
|
| 838 | Alemtuzumab (GZ402673) | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬
| - | - | [1] 13 13 💬
|
| 839 | Alemtuzumab 0.2 mg | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬
| - | - | [2] 65 65, 164 💬
|
| 840 | Alemtuzumab 0.3 mg | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬
| - | - | [2] 65 65, 164 💬
|
| 841 | Alemtuzumab 12 mg | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬
| - | - | [1] 13 13 💬
|
| 842 | Alemtuzumab 24 mg | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬
| - | - | [1] 13 13 💬
|
| 843 | Alemtuzumab and Rituximab | [2] Alemtuzumab Alemtuzumab, Rituximab | [2] Alemtuzumab
Alemtuzumab
,
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 60 60 💬
|
| 844 | Alemtuzumab GZ402673 | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬
| - | - | [1] 13 13 💬
|
| 845 | Alemtuzumab immunotherapy | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬
| - | - | [1] 13 13 💬
|
| 846 | Alemtuzumab infusion | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬
| - | - | [1] 14 14 💬
|
| 847 | Alemtuzumab Injection | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬
| - | - | [1] 13 13 💬
|
| 848 | Alemtuzumab Injection [Lemtrada] | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬
| - | - | [1] 13 13 💬
|
| 849 | Alemtuzumab, Rituximab | [2] Alemtuzumab Alemtuzumab, Rituximab | [2] Alemtuzumab
Alemtuzumab
,
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 63 63 💬
|
| 850 | Alendronat Teva | - | - | - | - | [1] 46 46 💬
|
| 851 | Alendronate | - | - | - | - | [4] 46 46, 271, 274, 299 💬
|
| 852 | Alendronate (Fosamax) | - | - | - | - | [1] 71 71 💬
|
| 853 | Alendronate sodium | [1] Alendronic acid Alendronic acid | [2] Alendronate sodium
Alendronate sodium
,
Alendronic acid
💬
| [1] FDPS FDPS 💬
| [3] Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | [4] 19 19, 46, 223, 299 💬
|
| 854 | Alendronate versus alfacalcidol (1-alpha OH vitamin D) | [2] Alfacalcidol Alfacalcidol, Vitamin D | [1] Alfacalcidol
Alfacalcidol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [3] 41 41, 46, 50 💬
|
| 855 | ALENDRONIC ACID | [1] Alendronic acid Alendronic acid | [2] Alendronate sodium
Alendronate sodium
,
Alendronic acid
💬
| [1] FDPS FDPS 💬
| [3] Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | [2] 46 46, 274 💬
|
| 856 | Alequel | - | - | - | - | [2] 96 96, 97 💬
|
| 857 | Alesse | - | - | - | - | [1] 77 77 💬
|
| 858 | Alfa-manosidadas humana recombinante | - | - | - | - | [1] 19 19 💬
|
| 859 | Alfa-tocotrienolo chinone | - | - | - | - | [1] 21 21 💬
|
| 860 | Alfacalcidol | [1] Alfacalcidol Alfacalcidol | [1] Alfacalcidol
Alfacalcidol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [10] 41 41, 46, 49, 50, 96, 107, 222, 223, 235, 238 💬
|
| 861 | Alfacalcidol 2 micrograms/ml | [1] Alfacalcidol Alfacalcidol | [1] Alfacalcidol
Alfacalcidol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [2] 50 50, 107 💬
|
| 862 | Alfacalcidol tablets | [1] Alfacalcidol Alfacalcidol | [1] Alfacalcidol
Alfacalcidol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 46 46 💬
|
| 863 | Alfuzosin | [1] Alfuzosin Alfuzosin | [2] Alfuzosin hydrochloride
Alfuzosin hydrochloride
,
Alfuzosin
💬
| [1] ADRA1A ADRA1A 💬
| [9] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 13 13 💬
|
| 864 | Alga Dunaliella Bardawil | - | - | - | - | [1] 90 90 💬
|
| 865 | Alga Dunaliella Bardawil powder | - | - | - | - | [1] 90 90 💬
|
| 866 | Alga Dunaliella Bardawill | - | - | - | - | [1] 90 90 💬
|
| 867 | Alginate oligosaccharide | - | - | - | - | [1] 299 299 💬
|
| 868 | Alginic acid | [1] Alginic acid Alginic acid | [2] Alginic acid
Alginic acid
,
Sodium alginate
💬
| - | - | [1] 51 51 💬
|
| 869 | Algisyl | - | - | - | - | [1] 57 57 💬
|
| 870 | Algisyl-LVR | - | - | - | - | [1] 57 57 💬
|
| 871 | ALGLUCOSIDASE ALFA | [1] Alglucosidase alfa Alglucosidase alfa | [1] Alglucosidase alfa
Alglucosidase alfa
💬
| [1] GAA GAA 💬
| [3] Galactose metabolism Galactose metabolism, Lysosome biogenesis, Starch and sucrose metabolism 💬 | [1] 256 256 💬
|
| 872 | Alglucosidase alfa (GZ419829) | [1] Alglucosidase alfa Alglucosidase alfa | [1] Alglucosidase alfa
Alglucosidase alfa
💬
| [1] GAA GAA 💬
| [3] Galactose metabolism Galactose metabolism, Lysosome biogenesis, Starch and sucrose metabolism 💬 | [1] 256 256 💬
|
| 873 | ALGLUCOSIDASE ALFA (MYOZYME) | [1] Alglucosidase alfa Alglucosidase alfa | [1] Alglucosidase alfa
Alglucosidase alfa
💬
| [1] GAA GAA 💬
| [3] Galactose metabolism Galactose metabolism, Lysosome biogenesis, Starch and sucrose metabolism 💬 | [1] 256 256 💬
|
| 874 | Alglucosidase alfa (recombinant human acid alpha-glucosidase [rhGAA]) | [1] Alglucosidase alfa Alglucosidase alfa | [1] Alglucosidase alfa
Alglucosidase alfa
💬
| [1] GAA GAA 💬
| [3] Galactose metabolism Galactose metabolism, Lysosome biogenesis, Starch and sucrose metabolism 💬 | [1] 256 256 💬
|
| 875 | Alglucosidase alfa GZ419829 | [1] Alglucosidase alfa Alglucosidase alfa | [1] Alglucosidase alfa
Alglucosidase alfa
💬
| [1] GAA GAA 💬
| [3] Galactose metabolism Galactose metabolism, Lysosome biogenesis, Starch and sucrose metabolism 💬 | [1] 256 256 💬
|
| 876 | Alglucosidase alfa or Avalglucosidase alfa | [2] Alglucosidase alfa Alglucosidase alfa, Avalglucosidase alfa | [2] Alglucosidase alfa
Alglucosidase alfa
,
Avalglucosidase alfa
💬
| [1] GAA GAA 💬
| [3] Galactose metabolism Galactose metabolism, Lysosome biogenesis, Starch and sucrose metabolism 💬 | [1] 256 256 💬
|
| 877 | Alglucosidase alpha | - | - | - | - | [1] 256 256 💬
|
| 878 | ALGLUCOSIDASI ALFA UMANA RICOMBINANTE | - | - | - | - | [1] 256 256 💬
|
| 879 | Algucosidase alfa 20 mg/kg once every 4 weeks instead of once every 2 weeks | - | - | - | - | [1] 256 256 💬
|
| 880 | Alicaforsen | [1] Alicaforsen Alicaforsen | [1] Alicaforsen sodium
Alicaforsen sodium
💬
| [1] ICAM1 ICAM1 💬
| [19] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Cell adhesion molecule (CAM) interaction, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, Human T-cell leukemia virus 1 infection, IgSF CAM signaling, Influenza A, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Rheumatoid arthritis, Staphylococcus aureus infection, TNF signaling pathway, Viral myocarditis 💬 | [2] 96 96, 97 💬
|
| 881 | Alicalm (polymeric liquid formula) | - | - | - | - | [1] 96 96 💬
|
| 882 | Align Extra Strength Probiotic Supplement | - | - | - | - | [1] 46 46 💬
|
| 883 | ALIROCUMAB | [1] Alirocumab Alirocumab | [1] Alirocumab
Alirocumab
💬
| [1] PCSK9 PCSK9 💬
| [1] Cholesterol metabolism Cholesterol metabolism 💬 | [1] 79 79 💬
|
| 884 | Alirocumab SAR236553 (REGN727) | [1] Alirocumab Alirocumab | [1] Alirocumab
Alirocumab
💬
| [1] PCSK9 PCSK9 💬
| [1] Cholesterol metabolism Cholesterol metabolism 💬 | [1] 79 79 💬
|
| 885 | ALISERIN - 25 MG GRANULATO EFFERVESCENTE 20 BUSTINE | - | - | - | - | [1] 19 19 💬
|
| 886 | Aliskiren | [1] Aliskiren Aliskiren | [2] Aliskiren
Aliskiren
,
Aliskiren fumarate
💬
| [1] REN REN 💬
| [3] Diabetic cardiomyopathy Diabetic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [4] 66 66, 167, 222, 223 💬
|
| 887 | Aliskiren generic | [1] Aliskiren Aliskiren | [2] Aliskiren
Aliskiren
,
Aliskiren fumarate
💬
| [1] REN REN 💬
| [3] Diabetic cardiomyopathy Diabetic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [1] 223 223 💬
|
| 888 | ALITRETINOIN | [1] Alitretinoin Alitretinoin | [1] Alitretinoin
Alitretinoin
💬
| [5] RARA RARA, RARB, RXRA, RXRB, RXRG 💬
| [20] Acute myeloid leukemia Acute myeloid leukemia, Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Efferocytosis, Estrogen signaling pathway, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬 | [1] 49 49 💬
|
| 889 | ALK-001 | - | - | - | - | [1] 301 301 💬
|
| 890 | ALK-001 (No generic name) | - | - | - | - | [1] 301 301 💬
|
| 891 | Alkaline Phosphatase | [1] Alkaline Phosphatase Alkaline Phosphatase | - | - | - | [4] 46 46, 93, 97, 172 💬
|
| 892 | Alkalinized Lidocaine-Heparin | [2] Heparin Heparin, Lidocaine | [5] Lidocaine
Lidocaine
,
Lidocaine hydrochloride
,
Heparin sodium
,
Heparin calcium
,
Lidocaine hydrochloride monohydrate
💬
| [7] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A, SERPINC1 💬
| [6] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Complement and coagulation cascades, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [1] 226 226 💬
|
| 893 | ALKERAN | - | - | - | - | [2] 28 28, 60 💬
|
| 894 | ALKS 8700 | - | - | - | - | [1] 13 13 💬
|
| 895 | ALKS 8700 Delayed Release (DR) | - | - | - | - | [1] 13 13 💬
|
| 896 | ALKS 8700 Delayed Release (DR) Capsule | - | - | - | - | [1] 13 13 💬
|
| 897 | All patients in the study will be treated with ocrelizumab | [1] Ocrelizumab Ocrelizumab | [1] Ocrelizumab
Ocrelizumab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 💬
|
| 898 | All subjects will receive maraviroc 300mg orally twice a day for 6 weeks | [1] Maraviroc Maraviroc | [1] Maraviroc
Maraviroc
💬
| [1] CCR5 CCR5 💬
| [11] Chemokine signaling pathway Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | [1] 84 84 💬
|
| 899 | All trans retinoic acid | - | - | - | - | [1] 63 63 💬
|
| 900 | All-P-ambo-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'-O->5'-O)-2'-O-(2- methoxyethyl)-5-methylcytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O- >5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5- methyluridylyl-(3'-O->5'-O)-2'-deoxy-P- | - | - | - | - | [1] 2 2 💬
|
| 901 | All-P-ambo-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-deoxy-P-thioguanylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-P-thioadenylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-P-thioadenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidine | - | - | - | - | [1] 2 2 💬
|
| 902 | All-P-ambo-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-deoxy-P-thioguanylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-Pthioadenylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy- | - | - | - | - | [1] 2 2 💬
|
| 903 | All-trans retinoic acid | - | - | - | - | [2] 63 63, 94 💬
|
| 904 | All-trans retinoic acid (ATRA) | - | - | - | - | [1] 63 63 💬
|
| 905 | All-Trans Retinoid Acid(ATRA) | - | - | - | - | [1] 63 63 💬
|
| 906 | All-trans-retinoid acid | - | - | - | - | [1] 63 63 💬
|
| 907 | ALLANTOIN | [1] Allantoin Allantoin | [1] Allantoin
Allantoin
💬
| - | - | [1] 36 36 💬
|
| 908 | ALLANTOINA | - | - | - | - | [1] 36 36 💬
|
| 909 | Allergy immunotherapy (allergy shots) | - | - | - | - | [1] 98 98 💬
|
| 910 | Allergy skin prick testing | - | - | - | - | [1] 340 340 💬
|
| 911 | ALLN-177 | - | - | - | - | [1] 234 234 💬
|
| 912 | Allo BMT | - | - | - | - | [1] 65 65 💬
|
| 913 | Allo-APZ2-EB | [1] Skin-derived ABCB5-positive Mesenchymal Stem cells Skin-derived ABCB5-positive Mesenchymal Stem cells | - | - | - | [1] 36 36 💬
|
| 914 | Allo-APZ2-OTS | - | - | - | - | [1] 36 36 💬
|
| 915 | ALLO-ASC | - | - | - | - | [1] 96 96 💬
|
| 916 | ALLO-ASC-CD | - | - | - | - | [1] 96 96 💬
|
| 917 | ALLO-ASC-DFU | - | - | - | - | [1] 36 36 💬
|
| 918 | ALLO-ASC-SHEET | - | - | - | - | [1] 36 36 💬
|
| 919 | Allo-hMSCs | - | - | - | - | [2] 211 211, 299 💬
|
| 920 | AlloEx | - | - | - | - | [1] 6 6 💬
|
| 921 | AlloEx exosomes | - | - | - | - | [1] 12 12 💬
|
| 922 | AlloGen-LI | - | - | - | - | [1] 70 70 💬
|
| 923 | Allogeneic adipose tissue-derived mesenchymal stem cells | - | - | - | - | [1] 97 97 💬
|
| 924 | ALLOGENEIC ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS EXPANDED | - | - | - | - | [5] 36 36, 38, 53, 96, 162 💬
|
| 925 | Allogeneic adipose tissue-derived MSC | - | - | - | - | [1] 36 36 💬
|
| 926 | Allogeneic adipose tissue-derived stromal/stem cells | - | - | - | - | [1] 53 53 💬
|
| 927 | Allogeneic adipose-derived stromal cells (CSCC_ASC) | - | - | - | - | [1] 57 57 💬
|
| 928 | Allogeneic Adult Human Mesenchymal Stem Cells (hMSCs) | - | - | - | - | [1] 85 85 💬
|
| 929 | Allogeneic Bone Marrow derived Human Mesenchymal Stem Cells (hMSCs) | - | - | - | - | [1] 96 96 💬
|
| 930 | Allogeneic bone marrow transplant | - | - | - | - | [1] 49 49 💬
|
| 931 | Allogeneic Bone Marrow Transplantation | - | - | - | - | [8] 60 60, 62, 65, 96, 164, 284, 285, 286 💬
|
| 932 | Allogeneic bone marrow-derived mesenchymal stem cells | - | - | - | - | [1] 6 6 💬
|
| 933 | Allogeneic bone marrow-derived mesenchymal stromal cells | - | - | - | - | [1] 97 97 💬
|
| 934 | Allogeneic bone marrow-derived MSCs (1 x 10 6 MSC/kg) | - | - | - | - | [1] 6 6 💬
|
| 935 | Allogeneic bone marrow-derived MSCs (10 x 10 6 MSC/kg) | - | - | - | - | [1] 6 6 💬
|
| 936 | Allogeneic bone marrow-derived MSCs (3 x 10 6 MSC/kg) | - | - | - | - | [1] 6 6 💬
|
| 937 | Allogeneic bone marrow-derived MSCs (6 x 10 6 MSC/kg) | - | - | - | - | [1] 6 6 💬
|
| 938 | Allogeneic Cardiosphere-Derived Cells | [1] Allogeneic Cardiosphere-Derived Cells Allogeneic Cardiosphere-Derived Cells | - | - | - | [2] 57 57, 113 💬
|
| 939 | Allogeneic Cardiosphere-Derived Cells (CAP-1002) | [1] Allogeneic Cardiosphere-Derived Cells Allogeneic Cardiosphere-Derived Cells | - | - | - | [1] 113 113 💬
|
| 940 | Allogeneic Cardiosphere-Derived Cells (CDCs) | [1] Allogeneic Cardiosphere-Derived Cells Allogeneic Cardiosphere-Derived Cells | - | - | - | [1] 57 57 💬
|
| 941 | Allogeneic CD19/BCMA-targeted CAR-?dT cell injection | - | - | - | - | [2] 49 49, 51 💬
|
| 942 | Allogeneic donor derived B-lymphocytes | - | - | - | - | [1] 60 60 💬
|
| 943 | Allogeneic dopaminergic neural precursor cell(iDAP) | - | - | - | - | [1] 6 6 💬
|
| 944 | Allogeneic dopaminergic neural precursor cell(NCR201) | - | - | - | - | [1] 6 6 💬
|
| 945 | Allogeneic embryonic stem cell-derived ventral midbrain dopaminergic progenitor cells | - | - | - | - | [1] 6 6 💬
|
| 946 | Allogeneic fecal microbiota | [1] Fecal microbiota Fecal microbiota | - | - | - | [1] 13 13 💬
|
| 947 | Allogeneic hematopoietic stem cell transplantation | - | - | - | - | [8] 28 28, 51, 60, 62, 65, 164, 284, 285 💬
|
| 948 | Allogeneic hematopoietic stem cell transplantation Stem cell source only Bone Marrow | - | - | - | - | [1] 60 60 💬
|
| 949 | Allogeneic hMSCs | - | - | - | - | [1] 57 57 💬
|
| 950 | Allogeneic Hope Biosciences adipose-derived mesenchymal stem cells | - | - | - | - | [1] 107 107 💬
|
| 951 | Allogeneic HSC | - | - | - | - | [1] 65 65 💬
|
| 952 | Allogeneic HSCT | - | - | - | - | [1] 65 65 💬
|
| 953 | Allogeneic Human Cardiosphere-Derived Stem Cells | - | - | - | - | [1] 86 86 💬
|
| 954 | Allogeneic human mesenchymal stem cells (hMSCs) | - | - | - | - | [1] 57 57 💬
|
| 955 | Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells | - | - | - | - | [1] 13 13 💬
|
| 956 | ALLOGENEIC MESENCHYMAL PRECURSOR CELLS | - | - | - | - | [1] 46 46 💬
|
| 957 | Allogeneic Mesenchymal Stem Cells | - | - | - | - | [1] 47 47 💬
|
| 958 | Allogeneic Mesenchymal Stem Cells (AlloMSC) | - | - | - | - | [2] 51 51, 53 💬
|
| 959 | Allogeneic mesenchymal stromal cells | - | - | - | - | [1] 36 36 💬
|
| 960 | ALLOGENEIC MESENCHYMAL STROMAL CELLS DERIVED FROM THE UMBILICAL CORD | - | - | - | - | [1] 49 49 💬
|
| 961 | Allogeneic MSC (AlloMSC) | - | - | - | - | [1] 49 49 💬
|
| 962 | Allogeneic Neonatal mesenchymal stromal cells (nMSCs) | - | - | - | - | [1] 57 57 💬
|
| 963 | ALLOGENEIC NEURAL RETINA-DERIVED HUMAN NEURAL RETINAL PROGENITOR CELLS EX VIVO EXPANDED | - | - | - | - | [1] 90 90 💬
|
| 964 | Allogeneic NK Cells | - | - | - | - | [3] 46 46, 51, 53 💬
|
| 965 | Allogeneic peripheral blood stem cell | - | - | - | - | [1] 65 65 💬
|
| 966 | Allogeneic skin-derived ABCB5-positive mesenchymal stem cells | [1] Skin-derived ABCB5-positive Mesenchymal Stem cells Skin-derived ABCB5-positive Mesenchymal Stem cells | - | - | - | [1] 36 36 💬
|
| 967 | Allogeneic Stem Cell Therapy | - | - | - | - | [1] 96 96 💬
|
| 968 | Allogeneic Stem Cell Transplant | - | - | - | - | [3] 53 53, 56, 60 💬
|
| 969 | Allogeneic stem cell transplantation | - | - | - | - | [5] 19 19, 20, 49, 62, 84 💬
|
| 970 | Allogeneic umbilical cord blood-derived CAR-T targeting CD19 and BCMA | - | - | - | - | [1] 49 49 💬
|
| 971 | Allogeneic Umbilical Cord Mesenchymal Stem Cell and Adipose Secretome Implantation | - | - | - | - | [1] 17 17 💬
|
| 972 | Allogeneic Umbilical Cord Mesenchymal Stem Cell Implantation | - | - | - | - | [1] 17 17 💬
|
| 973 | Allogeneic umbilical cord mesenchymal stem cells | [1] Allogeneic umbilical cord mesenchymal stem cells Allogeneic umbilical cord mesenchymal stem cells | - | - | - | [1] 13 13 💬
|
| 974 | Allogenic eASCs 5 milion cells/ml suspension for injection. Cx601 | - | - | - | - | [1] 96 96 💬
|
| 975 | Allogenic eASCs 5 million cells/ml suspension for injection CX601 | - | - | - | - | [1] 96 96 💬
|
| 976 | Allogenic eASCs 5 million cells/ml suspension for injection. CX601 | - | - | - | - | [1] 96 96 💬
|
| 977 | Allogenic eASCs 5 million/ml suspension for injection. | - | - | - | - | [1] 96 96 💬
|
| 978 | Allogenic embryonic stem cell-derived A9 dopamine progenitor cell (A9-DPC) High Dose | [1] Dopamine Dopamine | [2] Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 979 | Allogenic embryonic stem cell-derived A9 dopamine progenitor cell (A9-DPC) Low Dose | [1] Dopamine Dopamine | [2] Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 980 | Allogenic embryonic stem cellderived A9 dopamine progenitor cell (A9-DPC)_High Dose | [1] Dopamine Dopamine | [2] Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 981 | Allogenic embryonic stem cellderived A9 dopamine progenitor cell (A9-DPC)_Low Dose | [1] Dopamine Dopamine | [2] Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 982 | ALLOGENIC HUMAN HETEROLOGOUS LIVER CELLS | - | - | - | - | [1] 251 251 💬
|
| 983 | Allogenic mesenchymal stem cell isolated from adipose tissue | - | - | - | - | [3] 38 38, 96, 162 💬
|
| 984 | Allogenic MESENCHYMAL STEM CELLS | - | - | - | - | [1] 71 71 💬
|
| 985 | Allogenic mesenchymal stromal cells | - | - | - | - | [1] 36 36 💬
|
| 986 | Allogenic parathyroid cells | - | - | - | - | [1] 235 235 💬
|
| 987 | Allogenic placenta derived mesenchymal stem cells | - | - | - | - | [1] 13 13 💬
|
| 988 | Allogenic Stem Cell Transplantation | - | - | - | - | [1] 60 60 💬
|
| 989 | Allograft | - | - | - | - | [1] 70 70 💬
|
| 990 | Allopregnanolone | - | - | - | - | [2] 6 6, 205 💬
|
| 991 | Allopurinol | [1] Allopurinol Allopurinol | [2] Allopurinol
Allopurinol
,
Allopurinol sodium
💬
| [1] XDH XDH 💬
| [4] Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | [7] 6 6, 46, 57, 60, 66, 96, 97 💬
|
| 992 | Allopurinol Sandoz 100 mg, tabletten | [1] Allopurinol Allopurinol | [2] Allopurinol
Allopurinol
,
Allopurinol sodium
💬
| [1] XDH XDH 💬
| [4] Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | [1] 96 96 💬
|
| 993 | ALLOPURINOL SODIUM | [1] Allopurinol Allopurinol | [2] Allopurinol
Allopurinol
,
Allopurinol sodium
💬
| [1] XDH XDH 💬
| [4] Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | [2] 96 96, 97 💬
|
| 994 | Allopurinol Tablet | [1] Allopurinol Allopurinol | [2] Allopurinol
Allopurinol
,
Allopurinol sodium
💬
| [1] XDH XDH 💬
| [4] Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | [1] 57 57 💬
|
| 995 | AlloRx | - | - | - | - | [8] 2 2, 13, 46, 51, 85, 90, 97, 226 💬
|
| 996 | Almond | [1] Almond Almond | - | - | - | [1] 46 46 💬
|
| 997 | ALN-51547 | - | - | - | - | [1] 28 28 💬
|
| 998 | ALN-60212 | - | - | - | - | [1] 79 79 💬
|
| 999 | ALN-60519 | - | - | - | - | [1] 254 254 💬
|
| 1000 | ALN-61444 | - | - | - | - | [1] 231 231 💬
|
| 1001 | ALN-62643 | - | - | - | - | [1] 62 62 💬
|
| 1002 | ALN-6400 | - | - | - | - | [1] 227 227 💬
|
| 1003 | ALN-65492 | - | - | - | - | [1] 28 28 💬
|
| 1004 | ALN-65585 | - | - | - | - | [1] 234 234 💬
|
| 1005 | ALN-77412 | - | - | - | - | [1] 231 231 💬
|
| 1006 | ALN-AAT | - | - | - | - | [1] 231 231 💬
|
| 1007 | ALN-AAT02 | - | - | - | - | [1] 231 231 💬
|
| 1008 | ALN-AS1 | - | - | - | - | [1] 254 254 💬
|
| 1009 | ALN-CC5 | - | - | - | - | [4] 11 11, 62, 66, 109 💬
|
| 1010 | ALN-CFB | - | - | - | - | [1] 62 62 💬
|
| 1011 | ALN-GO1 | - | - | - | - | [1] 234 234 💬
|
| 1012 | ALN-HTT02 | - | - | - | - | [1] 8 8 💬
|
| 1013 | ALN-PCSSC | - | - | - | - | [1] 79 79 💬
|
| 1014 | ALN-SNCA | - | - | - | - | [1] 6 6 💬
|
| 1015 | ALN-SOD | - | - | - | - | [1] 2 2 💬
|
| 1016 | ALN-TTR02 | - | - | - | - | [1] 28 28 💬
|
| 1017 | ALN-TTRSC | - | - | - | - | [1] 28 28 💬
|
| 1018 | ALN-TTRSC02 | - | - | - | - | [1] 28 28 💬
|
| 1019 | Alnuctamab | [1] Alnuctamab Alnuctamab | - | - | - | [1] 49 49 💬
|
| 1020 | AloASC | - | - | - | - | [1] 97 97 💬
|
| 1021 | Aloe Barbadensis Miller | - | - | - | - | [1] 97 97 💬
|
| 1022 | Aloe vera gel | - | - | - | - | [1] 97 97 💬
|
| 1023 | Alofisel | - | - | - | - | [1] 96 96 💬
|
| 1024 | AlofiselProduct Name: Cx601Product Code: [Cx601]Pharmaceutical Form: Suspension for injectionINN or Proposed INN: DarvadstrocelCurrent Sponsor code: Allogenic eASCsOther descriptive name: Expanded human allogenic mesenchymal adult stem cells extracted from adiposetissue (eASCs)Concentration unit: OtherConcentration type: equalConcentration number: 5000000-Pharmaceutical form of the placebo: Solution for injectionRoute of administration of the placebo: Intralesional use | - | - | - | - | [1] 96 96 💬
|
| 1025 | Alogabat | [1] Alogabat Alogabat | [1] Alogabat
Alogabat
💬
| [1] GABRA5 GABRA5 💬
| [8] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Taste transduction 💬 | [1] 201 201 💬
|
| 1026 | Alovudine | [1] Alovudine Alovudine | [1] Alovudine
Alovudine
💬
| - | - | [1] 6 6 💬
|
| 1027 | Alpelisib | [1] Alpelisib Alpelisib | [1] Alpelisib
Alpelisib
💬
| [1] PIK3CA PIK3CA 💬
| [106] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phagocytosis, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | [4] 138 138, 278, 279, 280 💬
|
| 1028 | Alpelisib (BYL719) | [1] Alpelisib Alpelisib | [1] Alpelisib
Alpelisib
💬
| [1] PIK3CA PIK3CA 💬
| [106] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phagocytosis, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | [1] 138 138 💬
|
| 1029 | Alpha 1-Antitrypsin | - | - | - | - | [2] 231 231, 298 💬
|
| 1030 | Alpha 1-proteinase inhibitor (human) | - | - | - | - | [1] 231 231 💬
|
| 1031 | Alpha beta depletion | - | - | - | - | [2] 60 60, 284 💬
|
| 1032 | Alpha interferon | - | - | - | - | [1] 56 56 💬
|
| 1033 | Alpha Lipoic Acid | [1] Lipoic acid Lipoic acid | [1] Thioctic acid
Thioctic acid
💬
| - | - | [1] 13 13 💬
|
| 1034 | Alpha-1 15% | - | - | - | - | [1] 231 231 💬
|
| 1035 | Alpha-1 Antitrypsin (AAT) | - | - | - | - | [1] 231 231 💬
|
| 1036 | Alpha-1 Antitrypsin (human) | - | - | - | - | [1] 231 231 💬
|
| 1037 | Alpha-1 HC 100 mg | - | - | - | - | [1] 299 299 💬
|
| 1038 | Alpha-1 HC 200 mg | - | - | - | - | [1] 299 299 💬
|
| 1039 | Alpha-1 MP | - | - | - | - | [1] 231 231 💬
|
| 1040 | Alpha-1 proteinase inhibitor (human) | - | - | - | - | [1] 231 231 💬
|
| 1041 | ALPHA-1-ANTITRYPSIN | - | - | - | - | [1] 231 231 💬
|
| 1042 | Alpha-2C AR antagonist | - | - | - | - | [1] 51 51 💬
|
| 1043 | Alpha-ethylchenodeoxycholic acid (6-EDCA), OCA, INT-747 | - | - | - | - | [1] 93 93 💬
|
| 1044 | ALPHA-LIPOIC ACID | [1] Lipoic acid Lipoic acid | [1] Thioctic acid
Thioctic acid
💬
| - | - | [2] 2 2, 13 💬
|
| 1045 | Alpha-lipoic acid and L-acetyl carnitine | [1] Lipoic acid Lipoic acid | [1] Thioctic acid
Thioctic acid
💬
| - | - | [1] 5 5 💬
|
| 1046 | Alpha-proteinase inhibitor | - | - | - | - | [1] 98 98 💬
|
| 1047 | Alpha-tocopherol | [1] Tocopherol Tocopherol | [1] Tocopherol
Tocopherol
💬
| - | - | [2] 49 49, 215 💬
|
| 1048 | Alpha-tocotrienol quinone | [2] Tocotrienol Tocotrienol, Vatiquinone | [1] Vatiquinone
Vatiquinone
💬
| - | - | [3] 18 18, 21, 156 💬
|
| 1049 | Alpha-tocotrienolquinone | - | - | - | - | [1] 18 18 💬
|
| 1050 | Alpha/Beta T Cell-Depleted Hematopoietic Stem Cells | - | - | - | - | [1] 34 34 💬
|
| 1051 | Alpha1-antitrypsin | - | - | - | - | [1] 13 13 💬
|
| 1052 | Alpha1-Proteinase Inhibitor | - | - | - | - | [1] 231 231 💬
|
| 1053 | Alpha1-Proteinase Inhibitor (Human) | - | - | - | - | [2] 231 231, 299 💬
|
| 1054 | ALPN-101 | - | - | - | - | [1] 49 49 💬
|
| 1055 | Alprazolam | [1] Alprazolam Alprazolam | [1] Alprazolam
Alprazolam
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [2] 8 8, 75 💬
|
| 1056 | Alprostadil | [1] Alprostadil Alprostadil | [1] Alprostadil
Alprostadil
💬
| [1] PTGER1 PTGER1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer 💬 | [2] 51 51, 70 💬
|
| 1057 | ALS medications and other medications | - | - | - | - | [2] 2 2, 4 💬
|
| 1058 | Also referred to as 'MEDI2070' | - | - | - | - | [2] 96 96, 97 💬
|
| 1059 | Also referred to as 'MEDI2070'Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 1440- | - | - | - | - | [1] 97 97 💬
|
| 1060 | Also referred to as 'MEDI2070'Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 240-Product Name: BrazikumabProduct Code: MEDI2070Pharmaceutical Form: Solution for injection/infusionINN or Proposed INN: BRAZIKUMABCAS Number: 1610353-18-8Other descriptive name: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody | - | - | - | - | [1] 97 97 💬
|
| 1061 | Also referred to as MED2070 | - | - | - | - | [1] 96 96 💬
|
| 1062 | Also referred to as MEDI2070 | - | - | - | - | [2] 96 96, 97 💬
|
| 1063 | ALT001 | - | - | - | - | [1] 17 17 💬
|
| 1064 | Altanserin | [1] Altanserin Altanserin | - | - | - | [1] 6 6 💬
|
| 1065 | ALTB-168 | - | - | - | - | [1] 97 97 💬
|
| 1066 | ALTB-268 | - | - | - | - | [1] 97 97 💬
|
| 1067 | Alternating, 10 sec High-Frequency, 10 sec Low-Frequency Stimulation | - | - | - | - | [1] 6 6 💬
|
| 1068 | Alternating, 10 sec High-Frequency, 50 sec Low-Frequency Stimulation | - | - | - | - | [1] 6 6 💬
|
| 1069 | Alternating, 50 sec High-Frequency, 10 sec Low-Frequency Stimulation | - | - | - | - | [1] 6 6 💬
|
| 1070 | Alternating, 50 sec High-Frequency, 50 sec Low-Frequency Stimulation | - | - | - | - | [1] 6 6 💬
|
| 1071 | Alternative osteoporosis medications | - | - | - | - | [1] 274 274 💬
|
| 1072 | ALTH12-1:4 | - | - | - | - | [1] 97 97 💬
|
| 1073 | ALTH12-2:4 | - | - | - | - | [1] 97 97 💬
|
| 1074 | ALTRI FARMACI DEL SISTEMA NERVOSO | - | - | - | - | [1] 13 13 💬
|
| 1075 | Altropane | [1] Altropane Altropane | - | - | - | [1] 6 6 💬
|
| 1076 | Altropane (123I) Injection | [1] Altropane Altropane | - | - | - | [1] 6 6 💬
|
| 1077 | ALTROPANE® | [1] Altropane Altropane | - | - | - | [1] 6 6 💬
|
| 1078 | ALTU-135 | [1] ALTU-135 ALTU-135 | - | - | - | [1] 299 299 💬
|
| 1079 | ALTUS-135 | - | - | - | - | [1] 299 299 💬
|
| 1080 | Aluminium | [1] Aluminium Aluminium | - | - | - | [2] 11 11, 46 💬
|
| 1081 | Aluminium phosphate | [2] Aluminium Aluminium, Aluminium phosphate | [1] Aluminum phosphate
Aluminum phosphate
💬
| - | - | [1] 46 46 💬
|
| 1082 | Aluminum hydroxide | [1] Aluminum hydroxide Aluminum hydroxide | [3] Aluminum hydroxide
Aluminum hydroxide
,
Algeldrate
,
Almagate
💬
| - | - | [1] 11 11 💬
|
| 1083 | Alvarez 2 | - | - | - | - | [1] 37 37 💬
|
| 1084 | ALVELESTAT | [1] Alvelestat Alvelestat | - | - | - | [1] 231 231 💬
|
| 1085 | Alvelestat (MPH966) | [1] Alvelestat Alvelestat | - | - | - | [1] 231 231 💬
|
| 1086 | Alvelestat oral tablet - dose 1 | [1] Alvelestat Alvelestat | - | - | - | [1] 231 231 💬
|
| 1087 | Alvelestat oral tablet - dose 2 | [1] Alvelestat Alvelestat | - | - | - | [1] 231 231 💬
|
| 1088 | Alvelestat tosylate | [1] Alvelestat Alvelestat | - | - | - | [1] 231 231 💬
|
| 1089 | Alwextin cream | - | - | - | - | [1] 36 36 💬
|
| 1090 | ALX-0061 | - | - | - | - | [2] 46 46, 49 💬
|
| 1091 | ALX-0061 150 mg/mL | - | - | - | - | [1] 49 49 💬
|
| 1092 | ALX-0061 Nanobody | - | - | - | - | [1] 46 46 💬
|
| 1093 | ALX-0081 | - | - | - | - | [1] 64 64 💬
|
| 1094 | ALX-009 | [1] ALX-009 ALX-009 | - | - | - | [1] 299 299 💬
|
| 1095 | ALX-0600 | - | - | - | - | [1] 96 96 💬
|
| 1096 | ALX0081 | - | - | - | - | [1] 64 64 💬
|
| 1097 | ALXN1007 | - | - | - | - | [1] 48 48 💬
|
| 1098 | ALXN1102 | - | - | - | - | [1] 62 62 💬
|
| 1099 | ALXN1103 | - | - | - | - | [1] 62 62 💬
|
| 1100 | ALXN1210 | - | - | - | - | [7] 2 2, 11, 13, 50, 62, 66, 109 💬
|
| 1101 | ALXN1720 | - | - | - | - | [1] 11 11 💬
|
| 1102 | ALXN1830 | - | - | - | - | [3] 11 11, 35, 61 💬
|
| 1103 | ALXN1840 | - | - | - | - | [1] 171 171 💬
|
| 1104 | ALXN1850 | - | - | - | - | [1] 172 172 💬
|
| 1105 | ALXN1920 | - | - | - | - | [1] 222 222 💬
|
| 1106 | ALXN2040 | - | - | - | - | [1] 62 62 💬
|
| 1107 | ALXN2040 (ACH-0144471) | [1] Danicopan Danicopan | [1] Danicopan
Danicopan
💬
| [1] CFD CFD 💬
| [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬 | [1] 62 62 💬
|
| 1108 | ALXN2050 | - | - | - | - | [3] 11 11, 62, 66 💬
|
| 1109 | ALXN2060 | - | - | - | - | [1] 28 28 💬
|
| 1110 | ALXN2220 | - | - | - | - | [1] 28 28 💬
|
| 1111 | ALXN2350 | - | - | - | - | [1] 57 57 💬
|
| 1112 | ALXN2420 | - | - | - | - | [1] 77 77 💬
|
| 1113 | ALZT-OP1a (cromolyn) | - | - | - | - | [1] 2 2 💬
|
| 1114 | AM-01 | - | - | - | - | [1] 51 51 💬
|
| 1115 | Amantadin-ratiopharm 100mg | - | - | - | - | [1] 6 6 💬
|
| 1116 | Amantadine | [1] Amantadine Amantadine | [2] Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [5] 2 2, 6, 8, 13, 127 💬
|
| 1117 | Amantadine (100mg) as add on therapy. | [1] Amantadine Amantadine | [2] Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1118 | Amantadine 300 mg | [1] Amantadine Amantadine | [2] Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1119 | Amantadine HCl ER | [1] Amantadine Amantadine | [2] Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1120 | Amantadine HCl Extended Release | [1] Amantadine Amantadine | [2] Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1121 | Amantadine HCl Extended Release Capsule | [1] Amantadine Amantadine | [2] Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1122 | AMANTADINE HYDROCHLORIDE | [1] Amantadine Amantadine | [2] Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [2] 6 6, 13 💬
|
| 1123 | Amantadine hydrochloride (HCl) | [1] Amantadine Amantadine | [2] Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1124 | Amantadine Hydrochloride 100 mg (milligrams) Oral Capsule | [1] Amantadine Amantadine | [2] Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 13 13 💬
|
| 1125 | Amantadine Hydrochloride Oral Solution | [1] Amantadine Amantadine | [2] Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 2 2 💬
|
| 1126 | Amantadine Level | [1] Amantadine Amantadine | [2] Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 13 13 💬
|
| 1127 | Amantadine sulfate | [1] Amantadine Amantadine | [2] Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1128 | AMB-05X | - | - | - | - | [1] 85 85 💬
|
| 1129 | Ambirix | - | - | - | - | [1] 107 107 💬
|
| 1130 | Ambrisentan | [1] Ambrisentan Ambrisentan | [1] Ambrisentan
Ambrisentan
💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [10] 51 51, 66, 84, 85, 86, 88, 210, 211, 218, 222 💬
|
| 1131 | Ambrisentan - high dose | [1] Ambrisentan Ambrisentan | [1] Ambrisentan
Ambrisentan
💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 1132 | Ambrisentan - low dose | [1] Ambrisentan Ambrisentan | [1] Ambrisentan
Ambrisentan
💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 1133 | Ambrisentan 5 mg | [1] Ambrisentan Ambrisentan | [1] Ambrisentan
Ambrisentan
💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 88 88 💬
|
| 1134 | Ambrisentan 5 mg film-coated tablets | [1] Ambrisentan Ambrisentan | [1] Ambrisentan
Ambrisentan
💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 1135 | Ambrisentan 5mg film-coated tablets [marketed product] | [1] Ambrisentan Ambrisentan | [1] Ambrisentan
Ambrisentan
💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 1136 | Ambrisentan mimic | [1] Ambrisentan Ambrisentan | [1] Ambrisentan
Ambrisentan
💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 1137 | Ambrisentan plus Spironolactone | [2] Ambrisentan Ambrisentan, Spironolactone | [2] Spironolactone
Spironolactone
,
Ambrisentan
💬
| [2] EDNRA EDNRA, NR3C2 💬
| [8] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 1138 | Ambrisentan Tablet | [1] Ambrisentan Ambrisentan | [1] Ambrisentan
Ambrisentan
💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 1139 | AMBROSAN 60mg Tablets | - | - | - | - | [1] 6 6 💬
|
| 1140 | Ambroxol | [1] Ambroxol Ambroxol | [2] Ambroxol hydrochloride
Ambroxol hydrochloride
,
Ambroxol
💬
| - | - | [3] 2 2, 6, 19 💬
|
| 1141 | AMBROXOL CLORIDRATO | [1] Ambroxol Ambroxol | [2] Ambroxol hydrochloride
Ambroxol hydrochloride
,
Ambroxol
💬
| - | - | [1] 6 6 💬
|
| 1142 | Ambroxol Hydrochloride | [1] Ambroxol Ambroxol | [2] Ambroxol hydrochloride
Ambroxol hydrochloride
,
Ambroxol
💬
| - | - | [2] 6 6, 19 💬
|
| 1143 | Ambroxol Hydrochloride (420mg) | [1] Ambroxol Ambroxol | [2] Ambroxol hydrochloride
Ambroxol hydrochloride
,
Ambroxol
💬
| - | - | [1] 6 6 💬
|
| 1144 | Ambroxol Hydrochloride 30 mg tablet - 18 mg/kg/day | [1] Ambroxol Ambroxol | [2] Ambroxol hydrochloride
Ambroxol hydrochloride
,
Ambroxol
💬
| - | - | [1] 19 19 💬
|
| 1145 | Ambroxol Hydrochloride 30 mg tablet - 27 mg/kg/day | [1] Ambroxol Ambroxol | [2] Ambroxol hydrochloride
Ambroxol hydrochloride
,
Ambroxol
💬
| - | - | [1] 19 19 💬
|
| 1146 | Ambroxol Hydrochloride 30 mg tablet - 9 mg/kg/day | [1] Ambroxol Ambroxol | [2] Ambroxol hydrochloride
Ambroxol hydrochloride
,
Ambroxol
💬
| - | - | [1] 19 19 💬
|
| 1147 | AMBROXOL HYDROCHLORIDE PH. EUR. | [1] Ambroxol Ambroxol | [2] Ambroxol hydrochloride
Ambroxol hydrochloride
,
Ambroxol
💬
| - | - | [1] 19 19 💬
|
| 1148 | AmCell CliniMACs | - | - | - | - | [1] 285 285 💬
|
| 1149 | AMD3100 | - | - | - | - | [1] 285 285 💬
|
| 1150 | AMDX2011P | - | - | - | - | [2] 2 2, 6 💬
|
| 1151 | American ginseng extract HT-1001 | [1] Ginseng Ginseng | [2] Red ginseng
Red ginseng
,
Ginseng
💬
| - | - | [1] 13 13 💬
|
| 1152 | AMG 108 | [1] AMG 108 AMG 108 | - | - | - | [1] 46 46 💬
|
| 1153 | AMG 139 | - | - | - | - | [1] 96 96 💬
|
| 1154 | AMG 145 | - | - | - | - | [1] 79 79 💬
|
| 1155 | AMG 157 | [1] Tezepelumab Tezepelumab | [1] Tezepelumab
Tezepelumab
💬
| [1] TSLP TSLP 💬
| [2] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | [1] 98 98 💬
|
| 1156 | AMG 162 | - | - | - | - | [1] 274 274 💬
|
| 1157 | AMG 181 | - | - | - | - | [2] 96 96, 97 💬
|
| 1158 | AMG 357 | - | - | - | - | [1] 46 46 💬
|
| 1159 | AMG 407 | - | - | - | - | [2] 56 56, 107 💬
|
| 1160 | AMG 531 | - | - | - | - | [1] 63 63 💬
|
| 1161 | AMG 557 | - | - | - | - | [1] 49 49 💬
|
| 1162 | AMG 557/MEDI5872 | - | - | - | - | [1] 53 53 💬
|
| 1163 | AMG 570 | - | - | - | - | [1] 49 49 💬
|
| 1164 | AMG 592 | - | - | - | - | [3] 46 46, 49, 97 💬
|
| 1165 | AMG 623 | - | - | - | - | [1] 49 49 💬
|
| 1166 | AMG 714 | - | - | - | - | [1] 46 46 💬
|
| 1167 | AMG 719 | - | - | - | - | [1] 46 46 💬
|
| 1168 | AMG 785 | - | - | - | - | [1] 274 274 💬
|
| 1169 | AMG 811 | - | - | - | - | [2] 49 49, 223 💬
|
| 1170 | AMG 827 | - | - | - | - | [2] 46 46, 96 💬
|
| 1171 | AMG 827 140 mg | - | - | - | - | [1] 46 46 💬
|
| 1172 | AMG 827 210 mg | - | - | - | - | [2] 46 46, 96 💬
|
| 1173 | AMG 827 350 MG | - | - | - | - | [1] 96 96 💬
|
| 1174 | AMG 827 70 mg | - | - | - | - | [1] 46 46 💬
|
| 1175 | AMG 827 700 MG | - | - | - | - | [1] 96 96 💬
|
| 1176 | AMG-407 | - | - | - | - | [2] 56 56, 107 💬
|
| 1177 | AMG145 | - | - | - | - | [1] 79 79 💬
|
| 1178 | AMG157 | - | - | - | - | [1] 98 98 💬
|
| 1179 | AMG181 | - | - | - | - | [1] 97 97 💬
|
| 1180 | AMG407 | - | - | - | - | [2] 56 56, 107 💬
|
| 1181 | AMG531 | - | - | - | - | [2] 60 60, 63 💬
|
| 1182 | AMG592 | - | - | - | - | [2] 46 46, 49 💬
|
| 1183 | AMG811 | - | - | - | - | [1] 49 49 💬
|
| 1184 | Amgevita | - | - | - | - | [2] 96 96, 97 💬
|
| 1185 | AMGEVITA (Adalimumab biosimilar ) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 1186 | Amgevita 40 mg Injektionslösung im Fertigpen | - | - | - | - | [2] 96 96, 97 💬
|
| 1187 | Amgevita 40 mg Injektionslösung in einer Fertigspritze | - | - | - | - | [2] 96 96, 97 💬
|
| 1188 | Amgevita 40Mg Solution for Injection | - | - | - | - | [2] 96 96, 97 💬
|
| 1189 | AMGEVITA® | - | - | - | - | [2] 96 96, 97 💬
|
| 1190 | AMIAS | - | - | - | - | [1] 67 67 💬
|
| 1191 | AMIFAMPRIDINA | - | - | - | - | [2] 3 3, 11 💬
|
| 1192 | Amifampridina fosfato | - | - | - | - | [2] 3 3, 11 💬
|
| 1193 | Amifampridine | [1] Amifampridine Amifampridine | [2] Amifampridine
Amifampridine
,
Amifampridine phosphate
💬
| [7] KCNA1 KCNA1, KCNA2, KCNA4, KCNA6, KCNC3, KCND2, KCND3 💬
| [5] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬 | [3] 3 3, 11, 12 💬
|
| 1194 | Amifampridine (base) with modified release | [1] Amifampridine Amifampridine | [2] Amifampridine
Amifampridine
,
Amifampridine phosphate
💬
| [7] KCNA1 KCNA1, KCNA2, KCNA4, KCNA6, KCNC3, KCND2, KCND3 💬
| [5] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 11 11 💬
|
| 1195 | Amifampridine Phosphate | [1] Amifampridine Amifampridine | [2] Amifampridine
Amifampridine
,
Amifampridine phosphate
💬
| [7] KCNA1 KCNA1, KCNA2, KCNA4, KCNA6, KCNC3, KCND2, KCND3 💬
| [5] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬 | [3] 3 3, 11, 12 💬
|
| 1196 | Amifampridine Phosphate 10 MG Oral Tablet | [1] Amifampridine Amifampridine | [2] Amifampridine
Amifampridine
,
Amifampridine phosphate
💬
| [7] KCNA1 KCNA1, KCNA2, KCNA4, KCNA6, KCNC3, KCND2, KCND3 💬
| [5] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 3 3 💬
|
| 1197 | Amifostine | [1] Amifostine Amifostine | [2] Amifostine
Amifostine
,
Amifostine
💬
| - | - | [2] 28 28, 63 💬
|
| 1198 | Amifostine trihydrate | [1] Amifostine Amifostine | [2] Amifostine
Amifostine
,
Amifostine
💬
| - | - | [1] 28 28 💬
|
| 1199 | AMIKACIN | [1] Amikacin Amikacin | [2] Amikacin sulfate
Amikacin sulfate
,
Amikacin
💬
| - | - | [2] 60 60, 299 💬
|
| 1200 | Amikacin (Inhalation) | [1] Amikacin Amikacin | [2] Amikacin sulfate
Amikacin sulfate
,
Amikacin
💬
| - | - | [1] 299 299 💬
|
| 1201 | Amikacin Injection | [1] Amikacin Amikacin | [2] Amikacin sulfate
Amikacin sulfate
,
Amikacin
💬
| - | - | [1] 299 299 💬
|
| 1202 | Amikacin nebulization | [1] Amikacin Amikacin | [2] Amikacin sulfate
Amikacin sulfate
,
Amikacin
💬
| - | - | [1] 299 299 💬
|
| 1203 | AMIKACIN SULFATE | [1] Amikacin Amikacin | [2] Amikacin sulfate
Amikacin sulfate
,
Amikacin
💬
| - | - | [1] 299 299 💬
|
| 1204 | Amikacina liposomal (Arikace?) | - | - | - | - | [1] 299 299 💬
|
| 1205 | Amikacine nebulization | - | - | - | - | [1] 299 299 💬
|
| 1206 | Amikin, amiklin, amicacin, BB-K8, Biklin, Fabianol, Kaminax, Mikavir, Novamin, Pierami | - | - | - | - | [1] 299 299 💬
|
| 1207 | Amikin®, amiklin, amicacin, BB-K8, Biklin®, Fabianol®, Kaminax, Mikavir, Novamin®, Pierami | - | - | - | - | [1] 299 299 💬
|
| 1208 | AMILASA | - | - | - | - | [1] 299 299 💬
|
| 1209 | Amiloride | [1] Amiloride Amiloride | [2] Amiloride hydrochloride
Amiloride hydrochloride
,
Amiloride
💬
| [3] SCNN1A SCNN1A, SCNN1B, SCNN1G 💬
| [2] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | [5] 13 13, 67, 222, 225, 299 💬
|
| 1210 | Amiloride HCl | [1] Amiloride Amiloride | [2] Amiloride hydrochloride
Amiloride hydrochloride
,
Amiloride
💬
| [3] SCNN1A SCNN1A, SCNN1B, SCNN1G 💬
| [2] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | [1] 299 299 💬
|
| 1211 | Amiloride Hcl 5mg Tab | [1] Amiloride Amiloride | [2] Amiloride hydrochloride
Amiloride hydrochloride
,
Amiloride
💬
| [3] SCNN1A SCNN1A, SCNN1B, SCNN1G 💬
| [2] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | [1] 67 67 💬
|
| 1212 | Amiloride Hydrochloride | [1] Amiloride Amiloride | [2] Amiloride hydrochloride
Amiloride hydrochloride
,
Amiloride
💬
| [3] SCNN1A SCNN1A, SCNN1B, SCNN1G 💬
| [2] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | [1] 13 13 💬
|
| 1213 | AMILORIDE HYDROCHLORIDE, 2 H2O | [1] Amiloride Amiloride | [2] Amiloride hydrochloride
Amiloride hydrochloride
,
Amiloride
💬
| [3] SCNN1A SCNN1A, SCNN1B, SCNN1G 💬
| [2] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | [1] 13 13 💬
|
| 1214 | Amiloride Solution for Inhalation | [1] Amiloride Amiloride | [2] Amiloride hydrochloride
Amiloride hydrochloride
,
Amiloride
💬
| [3] SCNN1A SCNN1A, SCNN1B, SCNN1G 💬
| [2] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | [1] 299 299 💬
|
| 1215 | Amilostad HCT | - | - | - | - | [1] 13 13 💬
|
| 1216 | Amilostad HCT tablets | - | - | - | - | [1] 13 13 💬
|
| 1217 | Amino Acid Intake | - | - | - | - | [1] 113 113 💬
|
| 1218 | Amino acid supplement | - | - | - | - | [2] 6 6, 46 💬
|
| 1219 | Amino acids | [1] Amino acids Amino acids | - | - | - | [6] 6 6, 70, 90, 113, 240, 298 💬
|
| 1220 | Amino salicylic acid | [1] Salicylic acid Salicylic acid | [4] Salicylic acid
Salicylic acid
,
Sodium salicylate
,
Choline magnesium trisalicylate
,
Diethylamine salicylate
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 97 97 💬
|
| 1221 | Aminocaproic acid | [1] Aminocaproic acid Aminocaproic acid | [1] Aminocaproic acid
Aminocaproic acid
💬
| [2] PLAT PLAT, PLG 💬
| [8] Apelin signaling pathway Apelin signaling pathway, Complement and coagulation cascades, Fluid shear stress and atherosclerosis, Influenza A, Neuroactive ligand-receptor interaction, Prostate cancer, Staphylococcus aureus infection, Transcriptional misregulation in cancer 💬 | [1] 70 70 💬
|
| 1222 | Aminoglycoside | - | - | - | - | [1] 299 299 💬
|
| 1223 | Aminohippurate sodium | [1] Aminohippuric acid Aminohippuric acid | [2] Aminohippurate sodium
Aminohippurate sodium
,
Aminohippuric acid
💬
| - | - | [1] 67 67 💬
|
| 1224 | Aminohippurate Sodium Inj 20% | [1] Aminohippuric acid Aminohippuric acid | [2] Aminohippurate sodium
Aminohippurate sodium
,
Aminohippuric acid
💬
| - | - | [1] 67 67 💬
|
| 1225 | Aminolevulinic acid | [1] Aminolevulinic acid Aminolevulinic acid | [2] Aminolevulinic acid hydrochloride
Aminolevulinic acid hydrochloride
,
Aminolevulinic acid
💬
| - | - | [6] 34 34, 54, 96, 180, 254, 286 💬
|
| 1226 | Aminophylline | [1] Aminophylline Aminophylline | [2] Aminophylline
Aminophylline
,
Aminophylline dihydrate
💬
| [18] ADORA1 ADORA1, ADORA2B, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬
| [23] Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 63 63 💬
|
| 1227 | Aminopterin | [1] Aminopterin Aminopterin | [1] Aminopterin sodium
Aminopterin sodium
💬
| - | - | [1] 46 46 💬
|
| 1228 | AMINOSALICYLIC ACID | [1] Aminosalicylic acid Aminosalicylic acid | [1] Aminosalicylic acid
Aminosalicylic acid
💬
| - | - | [2] 96 96, 97 💬
|
| 1229 | Amiodarone | [1] Amiodarone Amiodarone | [2] Amiodarone hydrochloride
Amiodarone hydrochloride
,
Amiodarone
💬
| [17] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [36] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Cadherin signaling, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Hormone signaling, IgSF CAM signaling, Insulin secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [3] 28 28, 67, 127 💬
|
| 1230 | Amiodarone Hydrochloride Tablets | [1] Amiodarone Amiodarone | [2] Amiodarone hydrochloride
Amiodarone hydrochloride
,
Amiodarone
💬
| [17] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [36] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Cadherin signaling, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Hormone signaling, IgSF CAM signaling, Insulin secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 67 67 💬
|
| 1231 | Amiselimod | [1] Amiselimod Amiselimod | [1] Amiselimod
Amiselimod
💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 97 97 💬
|
| 1232 | AmiselimodProduct Code: MT-1303Pharmaceutical Form: CapsuleINN or Proposed INN: amiselimodOther descriptive name: MT-1303Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 0.2-Pharmaceutical form of the placebo: CapsuleRoute of administration of the placebo: Oral useProduct Name: AmiselimodProduct Code: MT-1303Pharmaceutical Form: CapsuleINN or Proposed INN: amiselimodOther descriptive name: MT-1303Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 0.4-Pharmaceutical form of the placebo: CapsuleRoute of administration of the placebo: Oral use | - | - | - | - | [1] 97 97 💬
|
| 1233 | Amisodin | - | - | - | - | [1] 2 2 💬
|
| 1234 | Amitriptylin-CT | [1] Amitriptyline Amitriptyline | [2] Amitriptyline hydrochloride
Amitriptyline hydrochloride
,
Amitriptyline
💬
| [2] SLC6A2 SLC6A2, SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 299 299 💬
|
| 1235 | Amitriptylin-ct Tabletten | [1] Amitriptyline Amitriptyline | [2] Amitriptyline hydrochloride
Amitriptyline hydrochloride
,
Amitriptyline
💬
| [2] SLC6A2 SLC6A2, SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 299 299 💬
|
| 1236 | Amitriptyline | [1] Amitriptyline Amitriptyline | [2] Amitriptyline hydrochloride
Amitriptyline hydrochloride
,
Amitriptyline
💬
| [2] SLC6A2 SLC6A2, SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [4] 96 96, 97, 226, 299 💬
|
| 1237 | Amitriptyline hydrochloride | [1] Amitriptyline Amitriptyline | [2] Amitriptyline hydrochloride
Amitriptyline hydrochloride
,
Amitriptyline
💬
| [2] SLC6A2 SLC6A2, SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 97 97 💬
|
| 1238 | Amitriptyline/Gabapentin | [2] Amitriptyline Amitriptyline, Gabapentin | [3] Gabapentin
Gabapentin
,
Amitriptyline hydrochloride
,
Amitriptyline
💬
| [7] CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1, SLC6A2, SLC6A4 💬
| [11] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 226 226 💬
|
| 1239 | Amivita | - | - | - | - | [1] 2 2 💬
|
| 1240 | Amlenetug | - | - | - | - | [1] 17 17 💬
|
| 1241 | Amlitelimab | [1] Amlitelimab Amlitelimab | [1] Amlitelimab
Amlitelimab
💬
| [1] TNFSF4 TNFSF4 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [1] 51 51 💬
|
| 1242 | Amlodipine | [1] Amlodipine Amlodipine | [4] Amlodipine besylate
Amlodipine besylate
,
Amlodipine maleate
,
Amlodipine
,
Amlodipine benzoate
💬
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [6] 51 51, 67, 79, 113, 222, 298 💬
|
| 1243 | Amlodipine (drug) | [1] Amlodipine Amlodipine | [4] Amlodipine besylate
Amlodipine besylate
,
Amlodipine maleate
,
Amlodipine
,
Amlodipine benzoate
💬
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 298 298 💬
|
| 1244 | Amlodipine Gel | [1] Amlodipine Amlodipine | [4] Amlodipine besylate
Amlodipine besylate
,
Amlodipine maleate
,
Amlodipine
,
Amlodipine benzoate
💬
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬
|
| 1245 | Amlodipine/Atorvastatin | [2] Amlodipine Amlodipine, Atorvastatin | [6] Amlodipine besylate
Amlodipine besylate
,
Atorvastatin calcium
,
Amlodipine maleate
,
Amlodipine
,
Atorvastatin
,
Amlodipine benzoate
💬
| [5] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S, HMGCR 💬
| [40] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Terpenoid backbone biosynthesis, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 79 79 💬
|
| 1246 | Ammonia | [1] Ammonia Ammonia | [1] Ammonia solution, strong
Ammonia solution, strong
💬
| - | - | [6] 6 6, 17, 86, 88, 251, 296 💬
|
| 1247 | Ammonium (15N) chloride | - | - | - | - | [1] 251 251 💬
|
| 1248 | Ammonium chloride | [1] Ammonium chloride Ammonium chloride | [1] Ammonium chloride
Ammonium chloride
💬
| - | - | [3] 96 96, 107, 251 💬
|
| 1249 | AMN107 | - | - | - | - | [2] 34 34, 86 💬
|
| 1250 | Amniotic Epithelial Cells | [1] Amniotic Epithelial Cells Amniotic Epithelial Cells | - | - | - | [1] 26 26 💬
|
| 1251 | Amniotic Fluid Allograft | - | - | - | - | [1] 70 70 💬
|
| 1252 | Amniotic fluid or placental CD117 stem cells | - | - | - | - | [1] 13 13 💬
|
| 1253 | Amniotic membrane extract eye drops (AMEED) | - | - | - | - | [1] 53 53 💬
|
| 1254 | Amondys 45 | - | - | - | - | [1] 113 113 💬
|
| 1255 | AMOR-1 | - | - | - | - | [1] 235 235 💬
|
| 1256 | Amorphous calcium carbonate | [2] Calcium Calcium, Calcium carbonate | [2] Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | [1] 235 235 💬
|
| 1257 | Amoxapine | [1] Amoxapine Amoxapine | [1] Amoxapine
Amoxapine
💬
| [2] SLC6A2 SLC6A2, SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 46 46 💬
|
| 1258 | Amoxapine & dipyridamole | [2] Amoxapine Amoxapine, Dipyridamole | [2] Amoxapine
Amoxapine
,
Dipyridamole
💬
| [4] PDE4A PDE4A, PDE5A, SLC6A2, SLC6A4 💬
| [8] Morphine addiction Morphine addiction, Neuroactive ligand signaling, Parathyroid hormone synthesis, secretion and action, Purine metabolism, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 46 46 💬
|
| 1259 | Amoxicilina | [1] Amoxicillin Amoxicillin | [3] Amoxicillin
Amoxicillin
,
Amoxicillin sodium
,
Amoxicillin
💬
| - | - | [1] 46 46 💬
|
| 1260 | Amoxicillin | [1] Amoxicillin Amoxicillin | [3] Amoxicillin
Amoxicillin
,
Amoxicillin sodium
,
Amoxicillin
💬
| - | - | [9] 6 6, 46, 63, 94, 96, 97, 222, 223, 299 💬
|
| 1261 | Amoxicillin 50 mg/kg/day in 2 divided doses for 14 days. | [1] Amoxicillin Amoxicillin | [3] Amoxicillin
Amoxicillin
,
Amoxicillin sodium
,
Amoxicillin
💬
| - | - | [1] 63 63 💬
|
| 1262 | Amoxicillin and Clavulanic acid | [2] Amoxicillin Amoxicillin, Clavulanic acid | [5] Amoxicillin
Amoxicillin
,
Clavulanate potassium
,
Amoxicillin sodium
,
Amoxicillin
,
Clavulanic acid
💬
| - | - | [1] 299 299 💬
|
| 1263 | Amoxicillin and doxycyclin | [2] Amoxicillin Amoxicillin, Doxycycline | [8] Amoxicillin
Amoxicillin
,
Doxycycline
,
Doxycycline hyclate
,
Amoxicillin sodium
,
Doxycycline calcium
,
Amoxicillin
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | [1] 97 97 💬
|
| 1264 | Amoxicillin hydrate | [1] Amoxicillin Amoxicillin | [3] Amoxicillin
Amoxicillin
,
Amoxicillin sodium
,
Amoxicillin
💬
| - | - | [1] 63 63 💬
|
| 1265 | Amoxicillin, metronidazole and doxycycline | [3] Amoxicillin Amoxicillin, Doxycycline, Metronidazole | [10] Amoxicillin
Amoxicillin
,
Doxycycline
,
Metronidazole
,
Doxycycline hyclate
,
Amoxicillin sodium
,
Doxycycline calcium
,
Metronidazole hydrochloride
,
Amoxicillin
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | [1] 97 97 💬
|
| 1266 | AMP-110 | - | - | - | - | [1] 46 46 💬
|
| 1267 | Amphotericin B | [1] Amphotericin B Amphotericin B | [1] Amphotericin B
Amphotericin B
💬
| - | - | [3] 96 96, 97, 299 💬
|
| 1268 | AMPHOTERICINE B, LIPOSOME | - | - | - | - | [1] 60 60 💬
|
| 1269 | Ampicillin | [1] Ampicillin Ampicillin | [3] Ampicillin
Ampicillin
,
Ampicillin hydrate
,
Ampicillin sodium
💬
| - | - | [1] 120 120 💬
|
| 1270 | Ampreloxetine | [1] Ampreloxetine Ampreloxetine | [1] Ampreloxetine
Ampreloxetine
💬
| [2] SLC6A2 SLC6A2, SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [2] 6 6, 17 💬
|
| 1271 | Ampreloxetine chydrochloride | [1] Ampreloxetine Ampreloxetine | [1] Ampreloxetine
Ampreloxetine
💬
| [2] SLC6A2 SLC6A2, SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [2] 6 6, 17 💬
|
| 1272 | Ampreloxetine hydrochloride | [1] Ampreloxetine Ampreloxetine | [1] Ampreloxetine
Ampreloxetine
💬
| [2] SLC6A2 SLC6A2, SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [2] 6 6, 17 💬
|
| 1273 | Amprenavir | [1] Amprenavir Amprenavir | [1] Amprenavir
Amprenavir
💬
| - | - | [1] 265 265 💬
|
| 1274 | AMPYRA | - | - | - | - | [1] 13 13 💬
|
| 1275 | Ampyra first, | - | - | - | - | [1] 6 6 💬
|
| 1276 | AMS2434 (amino acids) | [1] Amino acids Amino acids | - | - | - | [1] 6 6 💬
|
| 1277 | AMSC | - | - | - | - | [1] 2 2 💬
|
| 1278 | AMT-101 | [1] AMT-101 AMT-101 | - | - | - | [2] 46 46, 97 💬
|
| 1279 | AMT-101 (oral) | [1] AMT-101 AMT-101 | - | - | - | [1] 97 97 💬
|
| 1280 | AMT-130 | [1] AMT-130 AMT-130 | - | - | - | [1] 8 8 💬
|
| 1281 | AMT-162 | [1] AMT-162 AMT-162 | - | - | - | [1] 2 2 💬
|
| 1282 | AMT-191 | - | - | - | - | [1] 19 19 💬
|
| 1283 | AMX0035 | - | - | - | - | [3] 2 2, 5, 233 💬
|
| 1284 | AMX0114 | - | - | - | - | [1] 2 2 💬
|
| 1285 | Amyl Nitrite | [2] Amyl Nitrite Amyl Nitrite, Nitrite | [1] Amyl nitrite
Amyl nitrite
💬
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
| [10] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 58 58 💬
|
| 1286 | Amyl nitrite inhalation | [2] Amyl Nitrite Amyl Nitrite, Nitrite | [1] Amyl nitrite
Amyl nitrite
💬
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
| [10] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 58 58 💬
|
| 1287 | AMYLASE | - | - | - | - | [1] 299 299 💬
|
| 1288 | Amyvid | - | - | - | - | [1] 127 127 💬
|
| 1289 | Amyvid radiopharmaceutical | - | - | - | - | [1] 13 13 💬
|
| 1290 | AMZ002 | [1] AMZ002 AMZ002 | - | - | - | [1] 145 145 💬
|
| 1291 | AMZ002 injectable solution, 0.5mg/mL | [1] AMZ002 AMZ002 | - | - | - | [1] 145 145 💬
|
| 1292 | AN100226 | - | - | - | - | [2] 13 13, 96 💬
|
| 1293 | AN100226, BG00002 | - | - | - | - | [1] 13 13 💬
|
| 1294 | ANA001XHCl (Syntagon) or VEXA-04 (Patheon) | - | - | - | - | [1] 156 156 💬
|
| 1295 | ANACETRAPIB | [1] Anacetrapib Anacetrapib | [1] Anacetrapib
Anacetrapib
💬
| [1] CETP CETP 💬
| [1] Cholesterol metabolism Cholesterol metabolism 💬 | [1] 79 79 💬
|
| 1296 | Anaerobically Cultivated Human Intestinal Microbiota | - | - | - | - | [1] 51 51 💬
|
| 1297 | Anaerobically Cultivated medium | - | - | - | - | [1] 51 51 💬
|
| 1298 | Anakinra | [1] Anakinra Anakinra | [1] Anakinra
Anakinra
💬
| [2] IL1R1 IL1R1, IL1R2 💬
| [15] Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | [22] 2 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬
|
| 1299 | Anakinra (Kineret®) | [1] Anakinra Anakinra | [1] Anakinra
Anakinra
💬
| [2] IL1R1 IL1R1, IL1R2 💬
| [15] Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | [1] 46 46 💬
|
| 1300 | Anakinra (r-metHuIL-1ra) | [1] Anakinra Anakinra | [1] Anakinra
Anakinra
💬
| [2] IL1R1 IL1R1, IL1R2 💬
| [15] Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | [1] 46 46 💬
|
| 1301 | Anakinra / kineret | [1] Anakinra Anakinra | [1] Anakinra
Anakinra
💬
| [2] IL1R1 IL1R1, IL1R2 💬
| [15] Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | [1] 107 107 💬
|
| 1302 | Anakinra and PEG sTNF-R1 | [1] Anakinra Anakinra | [1] Anakinra
Anakinra
💬
| [2] IL1R1 IL1R1, IL1R2 💬
| [15] Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | [1] 46 46 💬
|
| 1303 | Analgesics | - | - | - | - | [1] 298 298 💬
|
| 1304 | Analysis of gamma globulin | - | - | - | - | [1] 84 84 💬
|
| 1305 | ANASTROZOLE | [1] Anastrozole Anastrozole | [1] Anastrozole
Anastrozole
💬
| [1] CYP19A1 CYP19A1 💬
| [2] Ovarian steroidogenesis Ovarian steroidogenesis, Steroid hormone biosynthesis 💬 | [3] 78 78, 86, 193 💬
|
| 1306 | Anatomical Landmark-guided Suprascapular Nerve Block | - | - | - | - | [1] 149 149 💬
|
| 1307 | ANAVEX2-73 | [1] Blarcamesine Blarcamesine | [2] Blarcamesine
Blarcamesine
,
Blarcamesine hydrochloride
💬
| [6] CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, SIGMAR1 💬
| [15] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | [2] 6 6, 156 💬
|
| 1308 | ANAVEX2-73 (blarcamesine) | [1] Blarcamesine Blarcamesine | [2] Blarcamesine
Blarcamesine
,
Blarcamesine hydrochloride
💬
| [6] CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, SIGMAR1 💬
| [15] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | [1] 156 156 💬
|
| 1309 | ANAVEX2-73 oral liquid | - | - | - | - | [1] 156 156 💬
|
| 1310 | ANB019 | - | - | - | - | [1] 37 37 💬
|
| 1311 | AND (Andrographolide) | [1] Andrographolide Andrographolide | - | - | - | [1] 97 97 💬
|
| 1312 | Andecaliximab | [1] Andecaliximab Andecaliximab | [1] Andecaliximab
Andecaliximab
💬
| [1] MMP9 MMP9 💬
| [16] Bladder cancer Bladder cancer, Diabetic cardiomyopathy, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Hepatitis B, IL-17 signaling pathway, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Pathways in cancer, Phagocytosis, Prostate cancer, Proteoglycans in cancer, Relaxin signaling pathway, TNF signaling pathway, Transcriptional misregulation in cancer 💬 | [5] 46 46, 96, 97, 272, 299 💬
|
| 1313 | AndoSan | - | - | - | - | [2] 96 96, 97 💬
|
| 1314 | AndroGel 1 % Topical Gel | - | - | - | - | [1] 13 13 💬
|
| 1315 | Androgel 10 grams of gel containing 100 mg of testosterone | [1] Testosterone Testosterone | [1] Testosterone
Testosterone
💬
| [1] AR AR 💬
| [4] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | [1] 13 13 💬
|
| 1316 | Androgens | - | - | - | - | [1] 60 60 💬
|
| 1317 | ANDROGRAPHIS PANICULATA | - | - | - | - | [1] 97 97 💬
|
| 1318 | ANDROGRAPHIS PANICULATA (ethanol extract) | [1] Ethanol Ethanol | [2] Alcohol
Alcohol
,
Ethanol
💬
| - | - | [1] 97 97 💬
|
| 1319 | Andrographolide | [1] Andrographolide Andrographolide | - | - | - | [1] 97 97 💬
|
| 1320 | Andrographolides | - | - | - | - | [1] 13 13 💬
|
| 1321 | Anesthetic Topical Adhesive Synera | - | - | - | - | [1] 13 13 💬
|
| 1322 | Anfibatide | [1] Anfibatide Anfibatide | - | - | - | [1] 64 64 💬
|
| 1323 | ANG-3070 | - | - | - | - | [1] 85 85 💬
|
| 1324 | ANG003 | - | - | - | - | [1] 299 299 💬
|
| 1325 | ANG003 Dose A | - | - | - | - | [1] 299 299 💬
|
| 1326 | ANG003 Dose B | - | - | - | - | [1] 299 299 💬
|
| 1327 | Angiotensin blockade | - | - | - | - | [1] 66 66 💬
|
| 1328 | Angiotensin II | [1] Angiotensin II Angiotensin II | [3] Angiotensin II
Angiotensin II
,
Angiotensin II
,
Angiotensin II acetate
💬
| [2] AGTR1 AGTR1, AGTR2 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 66 66, 222 💬
|
| 1329 | Angiotensin ll Antagonists, plain | - | - | - | - | [1] 57 57 💬
|
| 1330 | Angiotensin receptor blockers | - | - | - | - | [1] 46 46 💬
|
| 1331 | Angiotensin-(1-7) | - | - | - | - | [1] 17 17 💬
|
| 1332 | Angiotensin-converting enzyme (ACE) inhibitor | - | - | - | - | [1] 224 224 💬
|
| 1333 | Angiotensin-converting enzyme inhibitor(ACEI) | - | - | - | - | [1] 224 224 💬
|
| 1334 | Angiotensin-receptor blocker (ARB) | - | - | - | - | [1] 218 218 💬
|
| 1335 | ANHIDROUS SODIUM SULFATE | [1] Sodium sulfate Sodium sulfate | [2] Anhydous sodium sulfate
Anhydous sodium sulfate
,
Sodium sulfate
💬
| - | - | [1] 97 97 💬
|
| 1336 | Anhydrous Amiloride Hydrochloride | [1] Amiloride Amiloride | [2] Amiloride hydrochloride
Amiloride hydrochloride
,
Amiloride
💬
| [3] SCNN1A SCNN1A, SCNN1B, SCNN1G 💬
| [2] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | [1] 225 225 💬
|
| 1337 | ANHYDROUS CARBIDOPA | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬
| [1] DDC DDC 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬
|
| 1338 | ANHYDROUS SODIUM SULFATE | [1] Sodium sulfate Sodium sulfate | [2] Anhydous sodium sulfate
Anhydous sodium sulfate
,
Sodium sulfate
💬
| - | - | [1] 97 97 💬
|
| 1339 | ANI (Analgesia/Nociception Index) monitoring | - | - | - | - | [1] 22 22 💬
|
| 1340 | ANIFROLUMAB | [1] Anifrolumab Anifrolumab | [1] Anifrolumab
Anifrolumab
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [6] 46 46, 48, 49, 50, 51, 53 💬
|
| 1341 | Anifrolumab (MEDI-546) | [1] Anifrolumab Anifrolumab | [1] Anifrolumab
Anifrolumab
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 46 46 💬
|
| 1342 | Anifrolumab 1000 mg | [1] Anifrolumab Anifrolumab | [1] Anifrolumab
Anifrolumab
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 49 49 💬
|
| 1343 | Anifrolumab 300 mg | [1] Anifrolumab Anifrolumab | [1] Anifrolumab
Anifrolumab
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 49 49 💬
|
| 1344 | ANIMAL TISSUE EXTRACTS | - | - | - | - | [1] 60 60 💬
|
| 1345 | Anit human granulocyt-macrophage colony-stimulating factor (GM-CSF)monoclonal | - | - | - | - | [1] 46 46 💬
|
| 1346 | Anito-cel | - | - | - | - | [1] 11 11 💬
|
| 1347 | ANK-700 | - | - | - | - | [1] 13 13 💬
|
| 1348 | Anle138b | - | - | - | - | [1] 6 6 💬
|
| 1349 | Anlotinib | [1] Anlotinib Anlotinib | [1] Catequentinib
Catequentinib
💬
| [10] FGFR1 FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬
| [39] Acute myeloid leukemia Acute myeloid leukemia, Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [1] 85 85 💬
|
| 1350 | ANPD001 | - | - | - | - | [1] 6 6 💬
|
| 1351 | Anrukinzumab | [1] Anrukinzumab Anrukinzumab | [1] Anrukinzumab
Anrukinzumab
💬
| [1] IL13 IL13 💬
| [8] Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 | [1] 97 97 💬
|
| 1352 | Anselamimab | [1] Anselamimab Anselamimab | [1] Anselamimab
Anselamimab
💬
| - | - | [1] 28 28 💬
|
| 1353 | Anti BAFF (B cell activating factor) | - | - | - | - | [1] 49 49 💬
|
| 1354 | Anti Beta7 | - | - | - | - | [1] 97 97 💬
|
| 1355 | Anti CD19 CAR NK cells | - | - | - | - | [1] 46 46 💬
|
| 1356 | Anti CD3 monoclonal antibody | - | - | - | - | [1] 97 97 💬
|
| 1357 | Anti Haemophilus influeanze vaccination | - | - | - | - | [1] 62 62 💬
|
| 1358 | Anti human granulocyte-macrophage colo | - | - | - | - | [1] 46 46 💬
|
| 1359 | Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF) MONOCLONAL | - | - | - | - | [1] 46 46 💬
|
| 1360 | Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF) monoclonal antibody | - | - | - | - | [1] 46 46 💬
|
| 1361 | Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF)monoclonal | - | - | - | - | [1] 46 46 💬
|
| 1362 | Anti IL 6 mAb | - | - | - | - | [1] 46 46 💬
|
| 1363 | Anti IL-1beta antibody | - | - | - | - | [1] 46 46 💬
|
| 1364 | Anti IL-1beta antibody, subclass IgG4 | - | - | - | - | [1] 46 46 💬
|
| 1365 | Anti IL-1ß antibody | - | - | - | - | [1] 46 46 💬
|
| 1366 | Anti IL-1ß antibody, subclass IgG4 | - | - | - | - | [1] 46 46 💬
|
| 1367 | Anti LP40 antibody, subclass IgG4 | - | - | - | - | [1] 49 49 💬
|
| 1368 | Anti LP40 antibody, subclass IgG4 LA294 | - | - | - | - | [2] 13 13, 46 💬
|
| 1369 | Anti LP40 anticuerpo, subclase IgG4 | - | - | - | - | [1] 49 49 💬
|
| 1370 | Anti Lymphotoxin Alpha | - | - | - | - | [1] 46 46 💬
|
| 1371 | Anti Thymocyte Globulin | - | - | - | - | [1] 51 51 💬
|
| 1372 | Anti TNF | - | - | - | - | [1] 96 96 💬
|
| 1373 | Anti TNF + Meth | - | - | - | - | [1] 46 46 💬
|
| 1374 | Anti TNF Alfa. | - | - | - | - | [1] 96 96 💬
|
| 1375 | Anti TNF alpha agent | - | - | - | - | [1] 271 271 💬
|
| 1376 | Anti TNF alpha therapy | - | - | - | - | [1] 271 271 💬
|
| 1377 | Anti TNF humanized antibody Fab fragment-PEG conjugate | - | - | - | - | [1] 96 96 💬
|
| 1378 | Anti TNF therapy including infliximab | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 1379 | Anti-(complement C5a) IgG4 chimeric monoclonal antibody | - | - | - | - | [1] 269 269 💬
|
| 1380 | Anti-(human tumor necrosis factor) immunoglobulin G (human-mouse monoclonal cA2 heavy chain) | - | - | - | - | [1] 271 271 💬
|
| 1381 | Anti-(misfolded human superoxide dismutase 1) human IgG1m3 monoclonal antibody | - | - | - | - | [1] 2 2 💬
|
| 1382 | Anti-arrhythmic Drugs (AADs) | - | - | - | - | [1] 84 84 💬
|
| 1383 | Anti-BAFFR antibody | - | - | - | - | [1] 95 95 💬
|
| 1384 | Anti-BAFFR CART | - | - | - | - | [1] 13 13 💬
|
| 1385 | Anti-BCMA-CD19 CAR-T cells | - | - | - | - | [1] 300 300 💬
|
| 1386 | Anti-BCMA/CD70 CAR-T cells | - | - | - | - | [1] 222 222 💬
|
| 1387 | Anti-BCMA/CD70-CAR-T cells | - | - | - | - | [1] 49 49 💬
|
| 1388 | Anti-Beta Interferon (PF-06823859) | - | - | - | - | [1] 50 50 💬
|
| 1389 | Anti-blood dendritic cell antigen 2 | - | - | - | - | [1] 49 49 💬
|
| 1390 | Anti-C5 antibody | - | - | - | - | [4] 11 11, 14, 62, 109 💬
|
| 1391 | Anti-C5aR | - | - | - | - | [1] 46 46 💬
|
| 1392 | Anti-CD19 CAR NK cells (KN5501) | - | - | - | - | [2] 49 49, 63 💬
|
| 1393 | Anti-CD19 CAR T cell therapy | - | - | - | - | [5] 48 48, 49, 50, 51, 53 💬
|
| 1394 | Anti-CD19 CAR-NK cells | - | - | - | - | [1] 49 49 💬
|
| 1395 | Anti-CD19 CAR-T cells | [1] Anti-CD19 CAR-T cells Anti-CD19 CAR-T cells | - | - | - | [6] 46 46, 49, 50, 51, 53, 222 💬
|
| 1396 | Anti-CD19 CART cells will be given IV at split doses. | - | - | - | - | [1] 46 46 💬
|
| 1397 | Anti-CD19 IL-10/IL15 CAR-NK | - | - | - | - | [4] 48 48, 49, 51, 53 💬
|
| 1398 | Anti-CD19 UCAR-T cells | - | - | - | - | [1] 50 50 💬
|
| 1399 | Anti-CD19-CAR-T cells | - | - | - | - | [4] 48 48, 49, 51, 53 💬
|
| 1400 | Anti-CD19-CD3E-CAR-T cells | - | - | - | - | [4] 48 48, 49, 51, 53 💬
|
| 1401 | Anti-CD19/70 CAR T cells (CHT105) | - | - | - | - | [1] 49 49 💬
|
| 1402 | Anti-CD19/BCMA CAR gene vector injection will be injected intravenously on a one-time basis. | - | - | - | - | [1] 63 63 💬
|
| 1403 | Anti-CD19/BCMA CAR NK cells | - | - | - | - | [1] 66 66 💬
|
| 1404 | Anti-CD19/BCMA CAR NK cells (KN5601) | - | - | - | - | [2] 66 66, 222 💬
|
| 1405 | Anti-CD19/BCMA U CAR T cells | - | - | - | - | [4] 46 46, 49, 51, 53 💬
|
| 1406 | Anti-CD19/BCMA-UCAR-T cells | - | - | - | - | [4] 46 46, 49, 50, 51 💬
|
| 1407 | Anti-CD20 antibodies | - | - | - | - | [1] 223 223 💬
|
| 1408 | Anti-CD20 antibody | - | - | - | - | [2] 13 13, 64 💬
|
| 1409 | Anti-CD20 B cell depletion with Truxima | - | - | - | - | [1] 49 49 💬
|
| 1410 | Anti-CD20 mAB | - | - | - | - | [1] 13 13 💬
|
| 1411 | Anti-CD20 Monoclonal Antibody | - | - | - | - | [1] 13 13 💬
|
| 1412 | Anti-CD20 monoclonal antibody and the BTK inhibitor | - | - | - | - | [2] 61 61, 63 💬
|
| 1413 | Anti-CD20 MS treatment | - | - | - | - | [1] 13 13 💬
|
| 1414 | Anti-CD20 small modular immunopharmaceutical, WYE-400087 | - | - | - | - | [1] 46 46 💬
|
| 1415 | Anti-CD20 therapies (Ocrelizumab, Rituximab, Ofatumumab) | [3] Ocrelizumab Ocrelizumab, Ofatumumab, Rituximab | [3] Rituximab
Rituximab
,
Ocrelizumab
,
Ofatumumab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 💬
|
| 1416 | Anti-CD25 Humanized Monoclonal Antibody | - | - | - | - | [1] 13 13 💬
|
| 1417 | Anti-CD28dAb | - | - | - | - | [3] 49 49, 53, 160 💬
|
| 1418 | Anti-CD3 Monoclonal antibody | - | - | - | - | [2] 96 96, 97 💬
|
| 1419 | Anti-CD38 antibody Injection | - | - | - | - | [3] 48 48, 61, 63 💬
|
| 1420 | Anti-CD38 Monoclonal Antibody | - | - | - | - | [1] 28 28 💬
|
| 1421 | Anti-CD40L | - | - | - | - | [1] 63 63 💬
|
| 1422 | Anti-CD40LdAb | - | - | - | - | [1] 63 63 💬
|
| 1423 | Anti-CD45 | - | - | - | - | [2] 65 65, 285 💬
|
| 1424 | Anti-CD52 monoclonal antibody | - | - | - | - | [1] 13 13 💬
|
| 1425 | Anti-CT51 antigen mAb | - | - | - | - | [1] 51 51 💬
|
| 1426 | Anti-cytokine antibodies | - | - | - | - | [1] 97 97 💬
|
| 1427 | Anti-D | - | - | - | - | [1] 63 63 💬
|
| 1428 | Anti-GM-CSF receptor alpha | - | - | - | - | [1] 46 46 💬
|
| 1429 | Anti-human CCL24 monoclonal antibody (CM-101) | [1] CM-101 CM-101 | - | - | - | [1] 94 94 💬
|
| 1430 | Anti-human immunoglobulin, equine | - | - | - | - | [1] 60 60 💬
|
| 1431 | Anti-Human Interleukin-23 Monoclonal Antibody | - | - | - | - | [1] 271 271 💬
|
| 1432 | Anti-human T-lymphocyte immunoglobulin from horse | - | - | - | - | [1] 60 60 💬
|
| 1433 | ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN FROM RABBITS | - | - | - | - | [1] 51 51 💬
|
| 1434 | Anti-human thymocyte immunoglobulin, equine | - | - | - | - | [1] 60 60 💬
|
| 1435 | Anti-Human Thymocyte Immunoglobulin, Rabbit | [1] Rabbit Rabbit | - | - | - | [1] 60 60 💬
|
| 1436 | Anti-hypertensive medications | - | - | - | - | [1] 67 67 💬
|
| 1437 | Anti-IL-12 | - | - | - | - | [2] 13 13, 96 💬
|
| 1438 | Anti-IL-20 | - | - | - | - | [1] 46 46 💬
|
| 1439 | Anti-IL-20 (109-0012) | - | - | - | - | [1] 46 46 💬
|
| 1440 | Anti-IL-23 monoclonal antibody | - | - | - | - | [1] 96 96 💬
|
| 1441 | Anti-IL-36R monoclonal antibody | - | - | - | - | [1] 37 37 💬
|
| 1442 | Anti-IL-6 mAb | - | - | - | - | [2] 46 46, 96 💬
|
| 1443 | Anti-IL12/23 or anti-IL23 - Risankizumab | [1] Risankizumab Risankizumab | [1] Risankizumab
Risankizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 💬
|
| 1444 | Anti-IL12/23 or anti-IL23 - Ustekinumab | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 💬
|
| 1445 | Anti-IL6 | - | - | - | - | [1] 46 46 💬
|
| 1446 | Anti-inflammatory diet | - | - | - | - | [1] 96 96 💬
|
| 1447 | Anti-inflammatory drugs | - | - | - | - | [1] 46 46 💬
|
| 1448 | Anti-integrin - Vedolizumab IV | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 96 96 💬
|
| 1449 | Anti-integrin - Vedolizumab IV and SC | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 96 96 💬
|
| 1450 | Anti-integrin alphaV mAb | - | - | - | - | [1] 51 51 💬
|
| 1451 | Anti-integrin antibodies | - | - | - | - | [1] 97 97 💬
|
| 1452 | Anti-Interferon-gamma monoclonal antibody | - | - | - | - | [1] 96 96 💬
|
| 1453 | Anti-interleukin 5 (IL-5) humanized monoclonal | - | - | - | - | [2] 44 44, 45 💬
|
| 1454 | Anti-interleukin-1B monoclonal antibody | - | - | - | - | [1] 106 106 💬
|
| 1455 | Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human | - | - | - | - | [2] 96 96, 97 💬
|
| 1456 | Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody | - | - | - | - | [2] 96 96, 97 💬
|
| 1457 | Anti-Interleukin-6 Monoclonal | - | - | - | - | [1] 46 46 💬
|
| 1458 | Anti-Interleukin-6 Monoclonal Antibody | - | - | - | - | [2] 46 46, 96 💬
|
| 1459 | Anti-IP-10 Antibody | - | - | - | - | [1] 97 97 💬
|
| 1460 | Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody | - | - | - | - | [1] 49 49 💬
|
| 1461 | Anti-MAdCAM antibody | - | - | - | - | [2] 96 96, 97 💬
|
| 1462 | Anti-Mullerian hormone (AMH) level | - | - | - | - | [1] 13 13 💬
|
| 1463 | Anti-myostati | - | - | - | - | [1] 113 113 💬
|
| 1464 | Anti-Myostatin Adnectin | - | - | - | - | [1] 113 113 💬
|
| 1465 | Anti-pandemic H1N1 influenza vaccine | - | - | - | - | [7] 46 46, 48, 49, 50, 51, 53, 107 💬
|
| 1466 | Anti-Parkinson medication | - | - | - | - | [5] 5 5, 6, 7, 8, 17 💬
|
| 1467 | Anti-Parkinsonian Drugs | - | - | - | - | [1] 6 6 💬
|
| 1468 | Anti-pseudomonas IgY gargle | - | - | - | - | [1] 299 299 💬
|
| 1469 | Anti-reflux pharmacotherapy | - | - | - | - | [1] 299 299 💬
|
| 1470 | ANTI-SCLEROSTIN MONOCLONAL ANTIBODY | - | - | - | - | [1] 274 274 💬
|
| 1471 | Anti-Thymocyte Globulin | - | - | - | - | [19] 11 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 63, 65, 164, 283, 284, 285 💬
|
| 1472 | Anti-thymocyte globulin (ATG) | - | - | - | - | [1] 164 164 💬
|
| 1473 | Anti-thymocyte globulin (horse) | - | - | - | - | [1] 60 60 💬
|
| 1474 | Anti-Thymocyte Globulin (Rabbit) | [1] Rabbit Rabbit | - | - | - | [3] 60 60, 96, 285 💬
|
| 1475 | Anti-Thymocyte Globulin, Rabbit | [1] Rabbit Rabbit | - | - | - | [1] 51 51 💬
|
| 1476 | Anti-TL1A | - | - | - | - | [1] 97 97 💬
|
| 1477 | Anti-TL1A monoclonal antibody, high dose | - | - | - | - | [2] 96 96, 97 💬
|
| 1478 | Anti-TL1A monoclonal antibody, low dose | - | - | - | - | [2] 96 96, 97 💬
|
| 1479 | Anti-TL1A monoclonal antibody, medium dose | - | - | - | - | [2] 96 96, 97 💬
|
| 1480 | Anti-TNF | - | - | - | - | [4] 46 46, 96, 107, 271 💬
|
| 1481 | Anti-TNF agents | - | - | - | - | [1] 271 271 💬
|
| 1482 | Anti-TNF biologics | - | - | - | - | [2] 46 46, 271 💬
|
| 1483 | Anti-TNF Biologics Therapy | - | - | - | - | [1] 46 46 💬
|
| 1484 | Anti-TNF discontinuation: Physiological saline solution | - | - | - | - | [2] 96 96, 97 💬
|
| 1485 | Anti-TNF Drug | - | - | - | - | [2] 96 96, 97 💬
|
| 1486 | Anti-TNF humanized antibody Fab fragment - PEG conjugate | - | - | - | - | [1] 46 46 💬
|
| 1487 | Anti-TNF humanized antibody Fab' fragment - PEG conjugate | - | - | - | - | [1] 46 46 💬
|
| 1488 | Anti-TNF suspended perioperatively | - | - | - | - | [1] 46 46 💬
|
| 1489 | Anti-TNF therapy | - | - | - | - | [3] 46 46, 96, 97 💬
|
| 1490 | Anti-TNF therapy (etanercept or adalimumab) | [2] Adalimumab Adalimumab, Etanercept | [2] Etanercept
Etanercept
,
Adalimumab
💬
| [2] LTA LTA, TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 271 💬
|
| 1491 | Anti-TNF-alpha | - | - | - | - | [1] 46 46 💬
|
| 1492 | Anti-TNF: Infliximab (Infusion) | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 1493 | Anti-TNF:Adalimumab (Subcutaneus) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 1494 | Anti-TNFa continued perioperatively | - | - | - | - | [1] 46 46 💬
|
| 1495 | Anti-Tumor Necrosing Factor (TNF) Therapy | - | - | - | - | [1] 46 46 💬
|
| 1496 | Anti-Tumor Necrosis Factor | - | - | - | - | [1] 271 271 💬
|
| 1497 | Anti-tumor necrosis factor alpha agents | - | - | - | - | [1] 97 97 💬
|
| 1498 | Anti-Tumor Necrosis Factor Alpha Drug (Product) | - | - | - | - | [1] 46 46 💬
|
| 1499 | Anti-tumor necrosis factor alpha monoclonal antibody | - | - | - | - | [1] 107 107 💬
|
| 1500 | Anti-tumour necrosis factor a antibodies | - | - | - | - | [1] 96 96 💬
|
| 1501 | Anti-von Willebrand Factor Nanobody | - | - | - | - | [1] 64 64 💬
|
| 1502 | Anti-von Willebrand Factor Nanobody, Caplacizumab | [1] Caplacizumab Caplacizumab | [1] Caplacizumab
Caplacizumab
💬
| [1] VWF VWF 💬
| [9] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Integrin signaling, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | [1] 64 64 💬
|
| 1503 | Anti-von Willebrand Factor Nanobody, INN = Caplacizumab | [1] Caplacizumab Caplacizumab | [1] Caplacizumab
Caplacizumab
💬
| [1] VWF VWF 💬
| [9] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Integrin signaling, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | [1] 64 64 💬
|
| 1504 | Antiarrhythmic drugs | - | - | - | - | [1] 58 58 💬
|
| 1505 | Antibiotic | - | - | - | - | [1] 299 299 💬
|
| 1506 | Antibiotic cocktail | - | - | - | - | [1] 97 97 💬
|
| 1507 | Antibiotic Regimen | - | - | - | - | [1] 84 84 💬
|
| 1508 | Antibiotics | - | - | - | - | [1] 96 96 💬
|
| 1509 | Anticholinergic | - | - | - | - | [1] 118 118 💬
|
| 1510 | Anticholinergic medication | - | - | - | - | [1] 13 13 💬
|
| 1511 | Anticoagulant treatment Rivaroxaban | [1] Rivaroxaban Rivaroxaban | [1] Rivaroxaban
Rivaroxaban
💬
| [1] F10 F10 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 58 58 💬
|
| 1512 | Anticoagulation | - | - | - | - | [1] 49 49 💬
|
| 1513 | Anticorpo Monoclonale antagonista del Fattore XIIa | - | - | - | - | [1] 85 85 💬
|
| 1514 | Anticorpo monoclonale anti GM-CSF umano | - | - | - | - | [1] 46 46 💬
|
| 1515 | Anticorpo monoclonale anti IL-23 | - | - | - | - | [1] 96 96 💬
|
| 1516 | Anticorpo monoclonale anti-IL-23 | - | - | - | - | [1] 96 96 💬
|
| 1517 | Anticorpo monoclonale umano anti-Interleuchina-23 Immunoglobulina G2 (IgG2) | - | - | - | - | [1] 96 96 💬
|
| 1518 | Anticorps monoclonaux | - | - | - | - | [1] 222 222 💬
|
| 1519 | Anticuerpo monoclonal anti-humano recombinante humanizado, receptor de IL-6R. | - | - | - | - | [1] 46 46 💬
|
| 1520 | Anticuerpo monoclonal anti-LINGO-1 humano | - | - | - | - | [1] 13 13 💬
|
| 1521 | Anticuerpo monoclonal humano recombinante para la IL-1beta de la clase IgG1/K | - | - | - | - | [1] 106 106 💬
|
| 1522 | Antiepileptic drug (1 to 3 only) | - | - | - | - | [1] 158 158 💬
|
| 1523 | Antifibrotic drugs (nidanib or pirfenidone) | [1] Pirfenidone Pirfenidone | [1] Pirfenidone
Pirfenidone
💬
| [6] CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| [83] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 51 51 💬
|
| 1524 | Antigen-specific T cells CART/CTL and DCvac | - | - | - | - | [1] 34 34 💬
|
| 1525 | ANTIGENO SUPERFICIE HEPATITIS B | - | - | - | - | [1] 97 97 💬
|
| 1526 | Antihistamine | - | - | - | - | [3] 13 13, 19, 46 💬
|
| 1527 | Antihistamine (cetirizine or equivalent) | [1] Cetirizine Cetirizine | [2] Cetirizine hydrochloride
Cetirizine hydrochloride
,
Cetirizine
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 35 35 💬
|
| 1528 | Antihuman granulocyte-macrophage colony-stimulating factor (GM-CSF) monoclonal | - | - | - | - | [1] 46 46 💬
|
| 1529 | Antihypertensive drugs | - | - | - | - | [1] 67 67 💬
|
| 1530 | Antilymphocyte serum | - | - | - | - | [1] 60 60 💬
|
| 1531 | Antimicrobial therapy: Co-trimoxazole or Doxycycline | [1] Doxycycline Doxycycline | [5] Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | [1] 85 85 💬
|
| 1532 | Antimycotic | - | - | - | - | [1] 13 13 💬
|
| 1533 | Antioxidant Cocktail | - | - | - | - | [1] 299 299 💬
|
| 1534 | Antioxidant diet | - | - | - | - | [1] 97 97 💬
|
| 1535 | Antioxidant plus Pregabalin | [1] Pregabalin Pregabalin | [1] Pregabalin
Pregabalin
💬
| [4] CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬
| [7] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬 | [1] 298 298 💬
|
| 1536 | Antioxidant Supplement | - | - | - | - | [1] 299 299 💬
|
| 1537 | Antioxidants | - | - | - | - | [3] 90 90, 298, 310 💬
|
| 1538 | Antiparkinsonian Agent(s) | - | - | - | - | [1] 6 6 💬
|
| 1539 | Antiphospholipid antibody tests | - | - | - | - | [1] 48 48 💬
|
| 1540 | Antiplatelet Drug | - | - | - | - | [1] 48 48 💬
|
| 1541 | Antiplatelets | - | - | - | - | [1] 124 124 💬
|
| 1542 | Antipsychotic drugs inducing hyperprolactinemia | - | - | - | - | [1] 74 74 💬
|
| 1543 | Antipyretic | - | - | - | - | [2] 19 19, 257 💬
|
| 1544 | Antiretroviral/Anti HIV | - | - | - | - | [1] 265 265 💬
|
| 1545 | Antisense oligonucleotide | - | - | - | - | [1] 5 5 💬
|
| 1546 | Antisense oligonucleotide targeting the ATM gene | - | - | - | - | [1] 65 65 💬
|
| 1547 | Antistaminici H1 - H2 | - | - | - | - | [1] 299 299 💬
|
| 1548 | Antistaminico | - | - | - | - | [1] 28 28 💬
|
| 1549 | Antithymocyte | - | - | - | - | [1] 13 13 💬
|
| 1550 | Antithymocyte Globulin | - | - | - | - | [3] 60 60, 65, 284 💬
|
| 1551 | Antithymocyte Globulin (ATG) | - | - | - | - | [1] 60 60 💬
|
| 1552 | Antithymocyte globulin (Rabbit) | [1] Rabbit Rabbit | - | - | - | [1] 60 60 💬
|
| 1553 | ANTITHYMOCYTE IMMUNOGLOBULIN | - | - | - | - | [1] 13 13 💬
|
| 1554 | Antithymocyte immunoglobulin (rabbit) | [1] Rabbit Rabbit | - | - | - | [2] 13 13, 96 💬
|
| 1555 | Antituberculous therapy along with steroids | - | - | - | - | [1] 84 84 💬
|
| 1556 | Antiviral therapy | - | - | - | - | [2] 28 28, 60 💬
|
| 1557 | Antivirale ad uso diretto | - | - | - | - | [1] 107 107 💬
|
| 1558 | ANTOX | - | - | - | - | [1] 298 298 💬
|
| 1559 | ANTOX (vers) 1.2 | - | - | - | - | [1] 298 298 💬
|
| 1560 | ANTOX (vers.)1.2 | - | - | - | - | [1] 298 298 💬
|
| 1561 | Antox tablets(Mepaco) | - | - | - | - | [1] 63 63 💬
|
| 1562 | Antox version 1.2 | - | - | - | - | [1] 298 298 💬
|
| 1563 | Antrodia cinnamomea Products | - | - | - | - | [1] 18 18 💬
|
| 1564 | ANVS401 | - | - | - | - | [1] 6 6 💬
|
| 1565 | ANX005 | - | - | - | - | [3] 2 2, 8, 61 💬
|
| 1566 | Anxiety/depression and work and activities | - | - | - | - | [1] 13 13 💬
|
| 1567 | Any biologic treatment for psoriasis | - | - | - | - | [1] 37 37 💬
|
| 1568 | Any other approved Antiepileptic Drug | - | - | - | - | [1] 144 144 💬
|
| 1569 | AOC 1001 | [1] AOC 1001 AOC 1001 | [1] Delpacibart
Delpacibart
💬
| [1] TFRC TFRC 💬
| [6] Endocytosis Endocytosis, Ferroptosis, HIF-1 signaling pathway, Hematopoietic cell lineage, TGF-beta signaling pathway, Virion - Lassa virus and SFTS virus 💬 | [1] 113 113 💬
|
| 1570 | AOC 1001 (del-desiran) | [1] AOC 1001 AOC 1001 | [1] Delpacibart
Delpacibart
💬
| [1] TFRC TFRC 💬
| [6] Endocytosis Endocytosis, Ferroptosis, HIF-1 signaling pathway, Hematopoietic cell lineage, TGF-beta signaling pathway, Virion - Lassa virus and SFTS virus 💬 | [1] 113 113 💬
|
| 1571 | AOC 1020 | - | - | - | - | [1] 113 113 💬
|
| 1572 | AOC 1044 | - | - | - | - | [1] 113 113 💬
|
| 1573 | AOC-1020 | [1] AOC-1020 AOC-1020 | - | - | - | [1] 113 113 💬
|
| 1574 | AODG (Apigenin-7-O-glucuronide) | [1] Apigenin Apigenin | - | - | - | [1] 97 97 💬
|
| 1575 | AP-101 | [1] AP-101 AP-101 | - | - | - | [1] 2 2 💬
|
| 1576 | AP-472 | - | - | - | - | [1] 6 6 💬
|
| 1577 | AP-CD/LD | - | - | - | - | [1] 6 6 💬
|
| 1578 | AP-PA02 | - | - | - | - | [1] 299 299 💬
|
| 1579 | AP01 | - | - | - | - | [3] 46 46, 51, 85 💬
|
| 1580 | AP02 | - | - | - | - | [1] 85 85 💬
|
| 1581 | AP09004 | - | - | - | - | [1] 6 6 💬
|
| 1582 | AP1189 | - | - | - | - | [2] 46 46, 222 💬
|
| 1583 | AP1189 Tablet | - | - | - | - | [1] 46 46 💬
|
| 1584 | AP1189, 100 mg | - | - | - | - | [1] 46 46 💬
|
| 1585 | AP1189, 40 mg | - | - | - | - | [1] 46 46 💬
|
| 1586 | AP1189, 60 mg | - | - | - | - | [1] 46 46 💬
|
| 1587 | AP1189, 70 mg | - | - | - | - | [1] 46 46 💬
|
| 1588 | AP1189, 80 mg | - | - | - | - | [1] 46 46 💬
|
| 1589 | AP1903 | - | - | - | - | [4] 60 60, 65, 285, 326 💬
|
| 1590 | AP1903 A594 | - | - | - | - | [3] 60 60, 285, 326 💬
|
| 1591 | Apabetalone | [1] Apabetalone Apabetalone | [1] Apabetalone
Apabetalone
💬
| - | - | [1] 86 86 💬
|
| 1592 | Apadamtase alfa | [1] Apadamtase alfa Apadamtase alfa | [2] Apadamtase alfa
Apadamtase alfa
,
Apadamtase alfa and cinaxadamtase alfa
💬
| [1] ADAMTS13 ADAMTS13 💬
| [1] Platelet activation Platelet activation 💬 | [1] 64 64 💬
|
| 1593 | Apademtase alfa | - | - | - | - | [1] 64 64 💬
|
| 1594 | APD334 | - | - | - | - | [5] 93 93, 96, 97, 98, 269 💬
|
| 1595 | APD334 L-arginine | [2] Arginine Arginine, L-arginine | [3] Arginine hydrochloride
Arginine hydrochloride
,
Arginine
,
Arginine hydrochloride
💬
| - | - | [1] 97 97 💬
|
| 1596 | APD371 | - | - | - | - | [1] 96 96 💬
|
| 1597 | APD421 | - | - | - | - | [1] 107 107 💬
|
| 1598 | APD811 | - | - | - | - | [1] 86 86 💬
|
| 1599 | Apelin | [1] Apelin Apelin | - | - | - | [1] 86 86 💬
|
| 1600 | APG-115 | - | - | - | - | [1] 34 34 💬
|
| 1601 | APG-2575 | - | - | - | - | [1] 49 49 💬
|
| 1602 | Apheresis | - | - | - | - | [1] 60 60 💬
|
| 1603 | Apheresis catheter placement | - | - | - | - | [1] 96 96 💬
|
| 1604 | API-AAT | - | - | - | - | [1] 231 231 💬
|
| 1605 | API-AAT, AD00370, ARC-AAT, API drug Substance | - | - | - | - | [1] 231 231 💬
|
| 1606 | Apigenin | [1] Apigenin Apigenin | - | - | - | [3] 6 6, 46, 97 💬
|
| 1607 | Apigenin and glycyrrhizin | [1] Apigenin Apigenin | - | - | - | [1] 46 46 💬
|
| 1608 | Apitegromab | [1] Apitegromab Apitegromab | [1] Apitegromab
Apitegromab
💬
| [1] MSTN MSTN 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [2] 3 3, 113 💬
|
| 1609 | Apitox - pure honeybee toxin | - | - | - | - | [1] 13 13 💬
|
| 1610 | Apixaban | [1] Apixaban Apixaban | [1] Apixaban
Apixaban
💬
| [1] F10 F10 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [6] 48 48, 96, 97, 222, 223, 279 💬
|
| 1611 | Apixaban (Eliquis) | [1] Apixaban Apixaban | [1] Apixaban
Apixaban
💬
| [1] F10 F10 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 279 279 💬
|
| 1612 | Apixaban 2.5 milligram | [1] Apixaban Apixaban | [1] Apixaban
Apixaban
💬
| [1] F10 F10 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [2] 96 96, 97 💬
|
| 1613 | Apixaban 5 MG | [1] Apixaban Apixaban | [1] Apixaban
Apixaban
💬
| [1] F10 F10 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 222 222 💬
|
| 1614 | APL-130277 | - | - | - | - | [1] 6 6 💬
|
| 1615 | APL-1401 | - | - | - | - | [1] 97 97 💬
|
| 1616 | APL-2 | - | - | - | - | [6] 2 2, 61, 62, 66, 222, 223 💬
|
| 1617 | APL-9796 | - | - | - | - | [1] 86 86 💬
|
| 1618 | APL180 | - | - | - | - | [1] 79 79 💬
|
| 1619 | APL2 | - | - | - | - | [1] 222 222 💬
|
| 1620 | APLA12 | - | - | - | - | [1] 46 46 💬
|
| 1621 | Aplindore | [1] Aplindore Aplindore | [1] Aplindore fumarate
Aplindore fumarate
💬
| [2] DRD2 DRD2, DRD3 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1622 | Aplindore MR tablets | [1] Aplindore Aplindore | [1] Aplindore fumarate
Aplindore fumarate
💬
| [2] DRD2 DRD2, DRD3 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1623 | APO-go | - | - | - | - | [1] 6 6 💬
|
| 1624 | APO-go® | - | - | - | - | [1] 6 6 💬
|
| 1625 | APO-P001 | - | - | - | - | [1] 2 2 💬
|
| 1626 | APOKINON | - | - | - | - | [1] 6 6 💬
|
| 1627 | APOKYN | - | - | - | - | [1] 6 6 💬
|
| 1628 | Apomor | - | - | - | - | [1] 6 6 💬
|
| 1629 | APOMORFINA CLORIDRATO | [1] Apomorphine Apomorphine | [2] Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| [2] DRD1 DRD1, DRD2 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1630 | Apomorp | - | - | - | - | [1] 6 6 💬
|
| 1631 | Apomorphine | [1] Apomorphine Apomorphine | [2] Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| [2] DRD1 DRD1, DRD2 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [3] 5 5, 6, 7 💬
|
| 1632 | Apomorphine 0.25% (2.5mg/ml) | [1] Apomorphine Apomorphine | [2] Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| [2] DRD1 DRD1, DRD2 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1633 | Apomorphine Cartridge | [1] Apomorphine Apomorphine | [2] Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| [2] DRD1 DRD1, DRD2 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1634 | Apomorphine HCl injection | [1] Apomorphine Apomorphine | [2] Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| [2] DRD1 DRD1, DRD2 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1635 | APOMORPHINE HYDROCHLORIDE | [1] Apomorphine Apomorphine | [2] Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| [2] DRD1 DRD1, DRD2 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1636 | Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed | [1] Apomorphine Apomorphine | [2] Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| [2] DRD1 DRD1, DRD2 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1637 | Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed | [1] Apomorphine Apomorphine | [2] Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| [2] DRD1 DRD1, DRD2 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1638 | Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed | [1] Apomorphine Apomorphine | [2] Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| [2] DRD1 DRD1, DRD2 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1639 | Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed | [1] Apomorphine Apomorphine | [2] Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| [2] DRD1 DRD1, DRD2 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1640 | APOMORPHINE HYDROCHLORIDE HEMIHYDRATE | [1] Apomorphine Apomorphine | [2] Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| [2] DRD1 DRD1, DRD2 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1641 | Apomorphine Hydrocloride | [1] Apomorphine Apomorphine | [2] Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| [2] DRD1 DRD1, DRD2 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1642 | Apomorphine Hydrocloride Hemihydrate | [1] Apomorphine Apomorphine | [2] Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| [2] DRD1 DRD1, DRD2 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1643 | Apomorphine infusion | [1] Apomorphine Apomorphine | [2] Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| [2] DRD1 DRD1, DRD2 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1644 | Apomorphine Injectable Solution | [1] Apomorphine Apomorphine | [2] Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| [2] DRD1 DRD1, DRD2 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1645 | Apomorphine Nasal Powder | [1] Apomorphine Apomorphine | [2] Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| [2] DRD1 DRD1, DRD2 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1646 | Apomorphine pump | [1] Apomorphine Apomorphine | [2] Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| [2] DRD1 DRD1, DRD2 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1647 | APORON | - | - | - | - | [1] 6 6 💬
|
| 1648 | ApoTamox 10mg | - | - | - | - | [1] 111 111 💬
|
| 1649 | Appendectomy | - | - | - | - | [1] 97 97 💬
|
| 1650 | Apple | [1] Apple Apple | - | - | - | [3] 2 2, 58, 70 💬
|
| 1651 | Apple Watch and App | [1] Apple Apple | - | - | - | [1] 70 70 💬
|
| 1652 | Application of Adalimumab | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 1653 | Application of T-lymphocytes | - | - | - | - | [1] 25 25 💬
|
| 1654 | Apply VEREGEN ® 10 % on a randomized area and the moisturizing cream of the other side | - | - | - | - | [1] 160 160 💬
|
| 1655 | Approved Hypertrophic Cardiomyopathy drug treatments | - | - | - | - | [1] 58 58 💬
|
| 1656 | APR-2020 | [1] APR-2020 APR-2020 | - | - | - | [1] 284 284 💬
|
| 1657 | Apraclonidine | [1] Apraclonidine Apraclonidine | [2] Apraclonidine hydrochloride
Apraclonidine hydrochloride
,
Apraclonidine
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬
|
| 1658 | Apraclonidine Hcl 0.5% Oph Soln | [1] Apraclonidine Apraclonidine | [2] Apraclonidine hydrochloride
Apraclonidine hydrochloride
,
Apraclonidine
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬
|
| 1659 | Apratastat | [1] Apratastat Apratastat | [1] Apratastat
Apratastat
💬
| [2] ADAM17 ADAM17, MMP13 💬
| [9] Alzheimer disease Alzheimer disease, Coronavirus disease, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, IL-17 signaling pathway, Notch signaling pathway, Parathyroid hormone synthesis, secretion and action, Relaxin signaling pathway, TNF signaling pathway 💬 | [1] 46 46 💬
|
| 1660 | Aprednisolon | - | - | - | - | [1] 63 63 💬
|
| 1661 | Apremilast | [1] Apremilast Apremilast | [1] Apremilast
Apremilast
💬
| [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬
| [4] Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [8] 36 36, 46, 50, 56, 97, 107, 162, 271 💬
|
| 1662 | Apremilast (CC-10004) | [1] Apremilast Apremilast | [1] Apremilast
Apremilast
💬
| [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬
| [4] Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [1] 56 56 💬
|
| 1663 | Apremilast 10 mg | [1] Apremilast Apremilast | [1] Apremilast
Apremilast
💬
| [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬
| [4] Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [2] 56 56, 107 💬
|
| 1664 | Apremilast 20 mg | [1] Apremilast Apremilast | [1] Apremilast
Apremilast
💬
| [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬
| [4] Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [3] 46 46, 56, 107 💬
|
| 1665 | Apremilast 30 mg | [1] Apremilast Apremilast | [1] Apremilast
Apremilast
💬
| [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬
| [4] Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [3] 46 46, 56, 107 💬
|
| 1666 | Apremilast 30mg | [1] Apremilast Apremilast | [1] Apremilast
Apremilast
💬
| [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬
| [4] Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [1] 50 50 💬
|
| 1667 | Apremilast tablet 20 mg | [1] Apremilast Apremilast | [1] Apremilast
Apremilast
💬
| [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬
| [4] Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [1] 271 271 💬
|
| 1668 | Apremilast tablet 30 mg BID | [1] Apremilast Apremilast | [1] Apremilast
Apremilast
💬
| [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬
| [4] Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [1] 271 271 💬
|
| 1669 | Apremilast treatment | [1] Apremilast Apremilast | [1] Apremilast
Apremilast
💬
| [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬
| [4] Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [1] 36 36 💬
|
| 1670 | Apricot | [1] Apricot Apricot | - | - | - | [1] 13 13 💬
|
| 1671 | Apricot kernel oil | [2] Apricot Apricot, Apricot kernel oil | - | - | - | [1] 13 13 💬
|
| 1672 | APRINOX | - | - | - | - | [1] 67 67 💬
|
| 1673 | Apriso 0.375G ER CAP | - | - | - | - | [1] 97 97 💬
|
| 1674 | APRISO 375 mg extended-release capsules | - | - | - | - | [1] 97 97 💬
|
| 1675 | Aprokam | - | - | - | - | [1] 90 90 💬
|
| 1676 | Aprotinin | [1] Aprotinin Aprotinin | [1] Aprotinin
Aprotinin
💬
| - | - | [1] 28 28 💬
|
| 1677 | Aprovel | - | - | - | - | [1] 167 167 💬
|
| 1678 | Aprovel (150 mg) | - | - | - | - | [1] 222 222 💬
|
| 1679 | Aprovel 150 mg Tablets | - | - | - | - | [1] 222 222 💬
|
| 1680 | APROVEL*28CPR 150MG | - | - | - | - | [1] 57 57 💬
|
| 1681 | APT-1011 | - | - | - | - | [1] 98 98 💬
|
| 1682 | APT-1011 - 3 mg | - | - | - | - | [1] 98 98 💬
|
| 1683 | APT-1011 3 mg HS | - | - | - | - | [1] 98 98 💬
|
| 1684 | APVO210 | - | - | - | - | [1] 97 97 💬
|
| 1685 | AQ280 | - | - | - | - | [1] 98 98 💬
|
| 1686 | AQ280 Capsule | - | - | - | - | [1] 98 98 💬
|
| 1687 | AQ280 Tablet for Oral Suspension | - | - | - | - | [1] 98 98 💬
|
| 1688 | AquADEK | - | - | - | - | [1] 299 299 💬
|
| 1689 | AquADEKs-2 | - | - | - | - | [1] 299 299 💬
|
| 1690 | Aquamin | - | - | - | - | [1] 97 97 💬
|
| 1691 | Aquamin® | - | - | - | - | [1] 97 97 💬
|
| 1692 | AQW051 | - | - | - | - | [1] 6 6 💬
|
| 1693 | AQX-1125 | - | - | - | - | [1] 226 226 💬
|
| 1694 | AQX-1125 100 mg | - | - | - | - | [1] 226 226 💬
|
| 1695 | AQX-1125 200 mg | - | - | - | - | [1] 226 226 💬
|
| 1696 | AR-42 | [1] AR-42 AR-42 | - | - | - | [1] 34 34 💬
|
| 1697 | AR101 | - | - | - | - | [1] 168 168 💬
|
| 1698 | AR392830 | - | - | - | - | [1] 86 86 💬
|
| 1699 | AR401959 L-arginine | [2] Arginine Arginine, L-arginine | [3] Arginine hydrochloride
Arginine hydrochloride
,
Arginine
,
Arginine hydrochloride
💬
| - | - | [3] 96 96, 97, 98 💬
|
| 1700 | ARA 290 | - | - | - | - | [1] 84 84 💬
|
| 1701 | Ara-C | - | - | - | - | [1] 65 65 💬
|
| 1702 | ARA290 | - | - | - | - | [1] 46 46 💬
|
| 1703 | Aramchol | [1] Aramchol Aramchol | - | - | - | [2] 94 94, 265 💬
|
| 1704 | Aramchol meglumine | [2] Aramchol Aramchol, Meglumine | [1] Meglumine
Meglumine
💬
| - | - | [1] 94 94 💬
|
| 1705 | ARAVA | - | - | - | - | [4] 46 46, 53, 54, 162 💬
|
| 1706 | Arava 20 mg filmdrasjerte tabletter | - | - | - | - | [1] 46 46 💬
|
| 1707 | Arava 20 mg Tablets (Aventis Pharmaceutical, Inc.) | - | - | - | - | [1] 46 46 💬
|
| 1708 | ARAVA® | - | - | - | - | [1] 46 46 💬
|
| 1709 | ARB | - | - | - | - | [1] 66 66 💬
|
| 1710 | ARB /Angiotensin Receptor Blocker | - | - | - | - | [1] 234 234 💬
|
| 1711 | Arbaclofen | [1] Arbaclofen Arbaclofen | [1] Arbaclofen
Arbaclofen
💬
| [2] GABBR1 GABBR1, GABBR2 💬
| [8] Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | [2] 13 13, 206 💬
|
| 1712 | Arbaclofen ER Tablets | [1] Arbaclofen Arbaclofen | [1] Arbaclofen
Arbaclofen
💬
| [2] GABBR1 GABBR1, GABBR2 💬
| [8] Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | [1] 13 13 💬
|
| 1713 | Arbaclofen Extended Release Tablets | [1] Arbaclofen Arbaclofen | [1] Arbaclofen
Arbaclofen
💬
| [2] GABBR1 GABBR1, GABBR2 💬
| [8] Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | [1] 13 13 💬
|
| 1714 | Arbaclofen Placarbil | [2] Arbaclofen Arbaclofen, Arbaclofen Placarbil | [2] Arbaclofen placarbil
Arbaclofen placarbil
,
Arbaclofen
💬
| [2] GABBR1 GABBR1, GABBR2 💬
| [8] Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | [1] 13 13 💬
|
| 1715 | Arbaclofen placarbil 15 mg BID | [2] Arbaclofen Arbaclofen, Arbaclofen Placarbil | [2] Arbaclofen placarbil
Arbaclofen placarbil
,
Arbaclofen
💬
| [2] GABBR1 GABBR1, GABBR2 💬
| [8] Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | [1] 13 13 💬
|
| 1716 | Arbaclofen placarbil 30 mg BID | [2] Arbaclofen Arbaclofen, Arbaclofen Placarbil | [2] Arbaclofen placarbil
Arbaclofen placarbil
,
Arbaclofen
💬
| [2] GABBR1 GABBR1, GABBR2 💬
| [8] Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | [1] 13 13 💬
|
| 1717 | Arbaclofen placarbil 45 mg BID | [2] Arbaclofen Arbaclofen, Arbaclofen Placarbil | [2] Arbaclofen placarbil
Arbaclofen placarbil
,
Arbaclofen
💬
| [2] GABBR1 GABBR1, GABBR2 💬
| [8] Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | [1] 13 13 💬
|
| 1718 | ARC 1779 | - | - | - | - | [1] 64 64 💬
|
| 1719 | ARC-AAT | - | - | - | - | [1] 231 231 💬
|
| 1720 | ARC-AAT Injection | - | - | - | - | [1] 231 231 💬
|
| 1721 | ARC1779 | - | - | - | - | [1] 64 64 💬
|
| 1722 | ARC1779 Injection | - | - | - | - | [1] 64 64 💬
|
| 1723 | ARC1905 | - | - | - | - | [1] 301 301 💬
|
| 1724 | ARC1905 20 MG/ML | - | - | - | - | [1] 301 301 💬
|
| 1725 | ARCOXIA | - | - | - | - | [2] 46 46, 271 💬
|
| 1726 | ARCOXIA 90 mg comprimidos recubiertos con película | - | - | - | - | [1] 271 271 💬
|
| 1727 | ARCT-032 | - | - | - | - | [1] 299 299 💬
|
| 1728 | ARCT-810 | [1] ARCT-810 ARCT-810 | - | - | - | [1] 251 251 💬
|
| 1729 | ARCT-810Product Code: [ARCT-810]Pharmaceutical Form: Concentrate for solution for injection/infusionCurrent Sponsor code: ARCT-810Other descriptive name: mRNA codificante per Ornitina transcarbamilasi modificataConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 1-Pharmaceutical form of the placebo: Solution for infusionRoute of administration of the placebo: Intravenous useProduct Name: Acetato di sodio (1,2-13C2)Product Code: [Non Applicabile]Pharmaceutical Form: Powder for oral solutionCAS Number: 56374-56-2Current Sponsor code: Acetato di sodio (1,2-13C2)Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 250- | [1] ARCT-810 ARCT-810 | - | - | - | [1] 251 251 💬
|
| 1730 | ARD-101 | - | - | - | - | [1] 193 193 💬
|
| 1731 | ARD-3150 | - | - | - | - | [1] 299 299 💬
|
| 1732 | ARD-885 Tablets | - | - | - | - | [1] 46 46 💬
|
| 1733 | Arginine | [1] Arginine Arginine | [3] Arginine hydrochloride
Arginine hydrochloride
,
Arginine
,
Arginine hydrochloride
💬
| - | - | [16] 2 2, 21, 46, 57, 58, 67, 72, 96, 97, 98, 113, 210, 223, 225, 251, 299 💬
|
| 1734 | Arginine and citrulline supplementations | [2] Arginine Arginine, Citrulline | [5] Arginine hydrochloride
Arginine hydrochloride
,
Arginine
,
Arginine hydrochloride
,
L-Citrulline
,
Citrulline malate
💬
| - | - | [1] 21 21 💬
|
| 1735 | Argininhydrochlorid | - | - | - | - | [1] 65 65 💬
|
| 1736 | ARGX-113 | - | - | - | - | [5] 11 11, 14, 35, 53, 63 💬
|
| 1737 | ARGX-113Pharmaceutical Form: Concentrate for solution for infusion | - | - | - | - | [1] 11 11 💬
|
| 1738 | ARGX-117 | - | - | - | - | [1] 14 14 💬
|
| 1739 | ARGX-117 IV | - | - | - | - | [1] 14 14 💬
|
| 1740 | ARGX-119 | [1] ARGX-119 ARGX-119 | - | - | - | [3] 2 2, 3, 12 💬
|
| 1741 | ARGX-119 IV | [1] ARGX-119 ARGX-119 | - | - | - | [1] 3 3 💬
|
| 1742 | ARICEPT | - | - | - | - | [3] 6 6, 13, 124 💬
|
| 1743 | Aricept 10 mg | - | - | - | - | [1] 13 13 💬
|
| 1744 | Aricept 10 mg filmdragerade tabletter | - | - | - | - | [1] 13 13 💬
|
| 1745 | Aricept 5 mg | - | - | - | - | [1] 13 13 💬
|
| 1746 | Aricept 5 mg filmdragerade tabletter | - | - | - | - | [1] 13 13 💬
|
| 1747 | Aricept 5 mg-Filmtabletten | - | - | - | - | [1] 6 6 💬
|
| 1748 | ARICEPT 5*28 CPR 5 MG | - | - | - | - | [1] 124 124 💬
|
| 1749 | Aricept 5mg-Filmtabletten | - | - | - | - | [1] 6 6 💬
|
| 1750 | Aridol or Osmohale | - | - | - | - | [1] 299 299 💬
|
| 1751 | ARIKACE™ | - | - | - | - | [1] 299 299 💬
|
| 1752 | Arikayce™ | - | - | - | - | [1] 299 299 💬
|
| 1753 | Arikayce™ 140 mg | - | - | - | - | [1] 299 299 💬
|
| 1754 | Arikayce™ 560 mg | - | - | - | - | [1] 299 299 💬
|
| 1755 | Arikayce™ 70 mg | - | - | - | - | [1] 299 299 💬
|
| 1756 | Arimidex | - | - | - | - | [1] 78 78 💬
|
| 1757 | Arimidex (Anastrozole) | [1] Anastrozole Anastrozole | [1] Anastrozole
Anastrozole
💬
| [1] CYP19A1 CYP19A1 💬
| [2] Ovarian steroidogenesis Ovarian steroidogenesis, Steroid hormone biosynthesis 💬 | [1] 78 78 💬
|
| 1758 | ARIMOCLOMOL | [1] Arimoclomol Arimoclomol | [2] Arimoclomol
Arimoclomol
,
Arimoclomol citrate
💬
| - | - | [3] 2 2, 15, 19 💬
|
| 1759 | Arimoclomol (hard gelatine capsule) | [1] Arimoclomol Arimoclomol | [2] Arimoclomol
Arimoclomol
,
Arimoclomol citrate
💬
| - | - | [1] 19 19 💬
|
| 1760 | Arimoclomol (HPMC capsule) | [1] Arimoclomol Arimoclomol | [2] Arimoclomol
Arimoclomol
,
Arimoclomol citrate
💬
| - | - | [1] 19 19 💬
|
| 1761 | Arimoclomol citrate | [1] Arimoclomol Arimoclomol | [2] Arimoclomol
Arimoclomol
,
Arimoclomol citrate
💬
| - | - | [2] 15 15, 19 💬
|
| 1762 | ARINA-1 | - | - | - | - | [2] 228 228, 299 💬
|
| 1763 | Aripiprazole | [1] Aripiprazole Aripiprazole | [1] Aripiprazole
Aripiprazole
💬
| [4] DRD2 DRD2, DRD3, HTR1A, HTR2A 💬
| [14] Alcoholism Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | [3] 6 6, 74, 206 💬
|
| 1764 | Aritinercept | - | - | - | - | [1] 11 11 💬
|
| 1765 | Arm 1 - GEH120714 (18F) Injection | - | - | - | - | [1] 13 13 💬
|
| 1766 | Arm 2 | - | - | - | - | [1] 97 97 💬
|
| 1767 | Arm B: Rituxan®/Mabthera® | - | - | - | - | [1] 46 46 💬
|
| 1768 | Arm1 | - | - | - | - | [1] 97 97 💬
|
| 1769 | Armodafinil | [1] Armodafinil Armodafinil | [1] Armodafinil
Armodafinil
💬
| [1] SLC6A3 SLC6A3 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [3] 6 6, 13, 84 💬
|
| 1770 | ARN-6039 | - | - | - | - | [1] 13 13 💬
|
| 1771 | Arnovie101 Infusion Intravenous | - | - | - | - | [2] 49 49, 61 💬
|
| 1772 | ARO-AAT | [1] Fazirsiran Fazirsiran | - | - | - | [1] 231 231 💬
|
| 1773 | ARO-AAT Injection | - | - | - | - | [1] 231 231 💬
|
| 1774 | ARO-ANG 3 Injection | - | - | - | - | [1] 79 79 💬
|
| 1775 | ARO-ANG3 | - | - | - | - | [1] 79 79 💬
|
| 1776 | ARO-ATXN2 Injection | - | - | - | - | [1] 18 18 💬
|
| 1777 | ARO-C3 | - | - | - | - | [2] 66 66, 223 💬
|
| 1778 | ARO-CFB | - | - | - | - | [1] 66 66 💬
|
| 1779 | ARO-DM1 Intravenous (IV) Infusion | - | - | - | - | [1] 113 113 💬
|
| 1780 | ARO-DM1 subcutaneous (SC) injection | - | - | - | - | [1] 113 113 💬
|
| 1781 | ARO-DUX4 for Injection | - | - | - | - | [1] 113 113 💬
|
| 1782 | ARO-ENaC | - | - | - | - | [1] 299 299 💬
|
| 1783 | ARO-MMP7 Inhalation Solution | - | - | - | - | [1] 85 85 💬
|
| 1784 | ARO-SOD1 Injection | - | - | - | - | [1] 2 2 💬
|
| 1785 | ARRY-371797 | - | - | - | - | [2] 57 57, 271 💬
|
| 1786 | ARRY-371797 (PF-07265803) | - | - | - | - | [1] 57 57 💬
|
| 1787 | ARRY-371797, p38 inhibitor | - | - | - | - | [3] 46 46, 57, 271 💬
|
| 1788 | ARRY-371797, p38 inhibitor, oral | - | - | - | - | [1] 57 57 💬
|
| 1789 | ARRY-438162 | - | - | - | - | [1] 46 46 💬
|
| 1790 | ARRY-438162, MEK inhibitor | - | - | - | - | [1] 46 46 💬
|
| 1791 | ART-123 | - | - | - | - | [1] 85 85 💬
|
| 1792 | ART002g1 Injection | - | - | - | - | [1] 79 79 💬
|
| 1793 | ART621 | - | - | - | - | [1] 46 46 💬
|
| 1794 | Artamin 150 mg | - | - | - | - | [1] 171 171 💬
|
| 1795 | Artamin 250 mg | - | - | - | - | [1] 171 171 💬
|
| 1796 | Artesuante | - | - | - | - | [1] 85 85 💬
|
| 1797 | Artesunate | [1] Artesunate Artesunate | [1] Artesunate
Artesunate
💬
| - | - | [4] 18 18, 66, 86, 96 💬
|
| 1798 | Artesunate Oral Product | [1] Artesunate Artesunate | [1] Artesunate
Artesunate
💬
| - | - | [1] 18 18 💬
|
| 1799 | Arthroscopic synovectomy of the wrist | - | - | - | - | [1] 46 46 💬
|
| 1800 | Arthroscopic synovial tissue biopsy | - | - | - | - | [1] 46 46 💬
|
| 1801 | Arthroscopy & saline irrigation alone | - | - | - | - | [1] 46 46 💬
|
| 1802 | Articular punction, salivary samples, blood sample | - | - | - | - | [1] 107 107 💬
|
| 1803 | Artificial Saliva | - | - | - | - | [1] 53 53 💬
|
| 1804 | Artilog | - | - | - | - | [1] 46 46 💬
|
| 1805 | Arundic Acid | [1] Arundic acid Arundic acid | [1] Arundic acid
Arundic acid
💬
| - | - | [1] 2 2 💬
|
| 1806 | Arylsulfatase A | - | - | - | - | [1] 19 19 💬
|
| 1807 | Arzerra | - | - | - | - | [3] 13 13, 222, 223 💬
|
| 1808 | ARZERRA - 100 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONE(VETRO) - 5 ML(20MG/ML) 3 FLACONI | - | - | - | - | [2] 13 13, 222 💬
|
| 1809 | ARZERRA - 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 50 ML (20 MG/ML) 1 FLACONCINO + 2 KIT DI PROLUNGA | - | - | - | - | [1] 13 13 💬
|
| 1810 | ArzerraProduct Name: ofatumumabProduct Code: OMB157Pharmaceutical Form: Solution for injection in pre-filled syringeINN or Proposed INN: OFATUMUMABCAS Number: 679818-59-8Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 50-Pharmaceutical form of the placebo: Solution for injection in pre-filled syringeRoute of administration of the placebo: Subcutaneous useTrade Name: KesimptaProduct Name: ofatumumabProduct Code: OMB157Pharmaceutical Form: Solution for injection in pre-filled penINN or Proposed INN: OFATUMUMABCAS Number: 679818-59-8Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 50- | - | - | - | - | [1] 13 13 💬
|
| 1811 | Arzerra® | - | - | - | - | [1] 13 13 💬
|
| 1812 | AS2 | - | - | - | - | [1] 6 6 💬
|
| 1813 | ASA | - | - | - | - | [1] 13 13 💬
|
| 1814 | ASACOL | - | - | - | - | [1] 97 97 💬
|
| 1815 | Asacol (mesalamine) | - | - | - | - | [1] 97 97 💬
|
| 1816 | Asacol (mesalamine) Delayed-release Tablets | - | - | - | - | [1] 97 97 💬
|
| 1817 | Asacol 400 mg | - | - | - | - | [1] 97 97 💬
|
| 1818 | Asacol 400 mg (mesalamine) | - | - | - | - | [1] 97 97 💬
|
| 1819 | Asacol 400 mg tablet | - | - | - | - | [1] 97 97 💬
|
| 1820 | Asacol 400mg tablet | - | - | - | - | [1] 97 97 💬
|
| 1821 | Asacol 800 mg (mesalamine) | - | - | - | - | [1] 97 97 💬
|
| 1822 | Asacol 800 mg tablet | - | - | - | - | [1] 97 97 💬
|
| 1823 | Asacol 800mg tablet | - | - | - | - | [1] 97 97 💬
|
| 1824 | Asacol Delayed Release Tablets | - | - | - | - | [1] 97 97 💬
|
| 1825 | Asacol Delayed-Release Tablets | - | - | - | - | [1] 97 97 💬
|
| 1826 | Asacol® | - | - | - | - | [1] 97 97 💬
|
| 1827 | Asacol® 400 mg | - | - | - | - | [1] 97 97 💬
|
| 1828 | ASASANTIN Retard | - | - | - | - | [1] 51 51 💬
|
| 1829 | Asasantin Retard ® | - | - | - | - | [1] 51 51 💬
|
| 1830 | ASB-683699 | - | - | - | - | [1] 13 13 💬
|
| 1831 | ASC | - | - | - | - | [1] 97 97 💬
|
| 1832 | ASC42 10 mg | - | - | - | - | [1] 93 93 💬
|
| 1833 | ASC42 15 mg | - | - | - | - | [1] 93 93 💬
|
| 1834 | ASC42 5 mg | - | - | - | - | [1] 93 93 💬
|
| 1835 | Ascal(r) / carbasalate calcium | [1] Calcium Calcium | - | - | - | [1] 46 46 💬
|
| 1836 | Asceniv™ | - | - | - | - | [1] 65 65 💬
|
| 1837 | Asclera | - | - | - | - | [1] 34 34 💬
|
| 1838 | Ascorbic acid | [1] Ascorbic acid Ascorbic acid | [1] Ascorbic acid
Ascorbic acid
💬
| - | - | [4] 10 10, 97, 206, 298 💬
|
| 1839 | Ascorbic acid (Vitamin C) | [1] Ascorbic acid Ascorbic acid | [1] Ascorbic acid
Ascorbic acid
💬
| - | - | [1] 10 10 💬
|
| 1840 | Ascorbic Acid (Vitamin C) and Alpha-tocopherol (Vitamin E) | [3] Ascorbic acid Ascorbic acid, Tocopherol, Vitamin E | [3] Ascorbic acid
Ascorbic acid
,
Vitamin E
,
Tocopherol
💬
| - | - | [1] 206 206 💬
|
| 1841 | Ascorbic acid vit C | [1] Ascorbic acid Ascorbic acid | [1] Ascorbic acid
Ascorbic acid
💬
| - | - | [1] 10 10 💬
|
| 1842 | ASCs | - | - | - | - | [3] 53 53, 96, 97 💬
|
| 1843 | ASCs (Cx401, company code) | - | - | - | - | [1] 97 97 💬
|
| 1844 | ASCs: Adipose derived Stem Cells | - | - | - | - | [1] 96 96 💬
|
| 1845 | ASCs:adipose derived stem cells | - | - | - | - | [1] 97 97 💬
|
| 1846 | Asendis 50 mg | - | - | - | - | [1] 46 46 💬
|
| 1847 | ASF-1096 Cream 0.25% | - | - | - | - | [1] 49 49 💬
|
| 1848 | ASF-1096 Cream 0.5% | - | - | - | - | [1] 49 49 💬
|
| 1849 | ASF-1096 Cream 1.0% | - | - | - | - | [1] 49 49 💬
|
| 1850 | Asfotas Alfa | - | - | - | - | [1] 172 172 💬
|
| 1851 | ASFOTASE ALFA | [1] Asfotase alfa Asfotase alfa | [1] Asfotase alfa
Asfotase alfa
💬
| [1] ALPL ALPL 💬
| [3] Folate biosynthesis Folate biosynthesis, Phagocytosis, Thiamine metabolism 💬 | [1] 172 172 💬
|
| 1852 | Asfotase Alfa (ALXN1215) | [1] Asfotase alfa Asfotase alfa | [1] Asfotase alfa
Asfotase alfa
💬
| [1] ALPL ALPL 💬
| [3] Folate biosynthesis Folate biosynthesis, Phagocytosis, Thiamine metabolism 💬 | [1] 172 172 💬
|
| 1853 | ASK Nr. 21972 | - | - | - | - | [2] 5 5, 6 💬
|
| 1854 | ASK8007 | - | - | - | - | [1] 46 46 💬
|
| 1855 | ASP015K | - | - | - | - | [2] 46 46, 97 💬
|
| 1856 | ASP015K hydrobromide | - | - | - | - | [1] 46 46 💬
|
| 1857 | ASP015K hydrobromide, AS1940150-BR, JKT-201A, 4-{[(1R,2s,3S,5s,7s)-5-Hydroxy-2-adamantyl]amino}-1H-pyrrolo[2,3-b]pyridine-5-carboxamide monohydrobromide | - | - | - | - | [1] 46 46 💬
|
| 1858 | ASP1707 | - | - | - | - | [1] 46 46 💬
|
| 1859 | ASP2408 | - | - | - | - | [1] 46 46 💬
|
| 1860 | ASP2409 | - | - | - | - | [1] 46 46 💬
|
| 1861 | ASP3291 | - | - | - | - | [1] 97 97 💬
|
| 1862 | ASP3652 | - | - | - | - | [1] 226 226 💬
|
| 1863 | ASP5094 | - | - | - | - | [1] 46 46 💬
|
| 1864 | ASP5502 | - | - | - | - | [1] 53 53 💬
|
| 1865 | ASP6294 | - | - | - | - | [1] 226 226 💬
|
| 1866 | Aspaveli | - | - | - | - | [4] 2 2, 61, 62, 223 💬
|
| 1867 | Aspergillus oryzae | [1] Aspergillus oryzae Aspergillus oryzae | - | - | - | [1] 97 97 💬
|
| 1868 | Aspirin | [1] Acetylsalicylic acid Acetylsalicylic acid | [1] Aspirin
Aspirin
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [10] 22 22, 34, 48, 49, 51, 63, 86, 158, 210, 231 💬
|
| 1869 | Aspirin 650mg Oral Capsule | - | - | - | - | [1] 13 13 💬
|
| 1870 | Aspirin 81 mg | - | - | - | - | [1] 48 48 💬
|
| 1871 | Aspirin 81Mg Ec Tab | - | - | - | - | [2] 96 96, 97 💬
|
| 1872 | Aspirin 81mg tablet | - | - | - | - | [1] 46 46 💬
|
| 1873 | Aspirin and meloxicam | [1] Meloxicam Meloxicam | [1] Meloxicam
Meloxicam
💬
| [1] PTGS2 PTGS2 💬
| [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 49 49 💬
|
| 1874 | Aspirin tablet | - | - | - | - | [1] 64 64 💬
|
| 1875 | Aspirin Tablets | [1] Acetylsalicylic acid Acetylsalicylic acid | [1] Aspirin
Aspirin
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 💬
|
| 1876 | Assessment of Biological factors | - | - | - | - | [1] 97 97 💬
|
| 1877 | Assessment of therapy complications | - | - | - | - | [1] 60 60 💬
|
| 1878 | Assigned Interventions CD19/BCMA CAR T-cells | - | - | - | - | [3] 49 49, 51, 53 💬
|
| 1879 | Assigned pulmonary hypertension medication | - | - | - | - | [1] 86 86 💬
|
| 1880 | AST-120 | - | - | - | - | [2] 96 96, 97 💬
|
| 1881 | Astaxanthin | [1] Astaxanthin Astaxanthin | - | - | - | [2] 2 2, 280 💬
|
| 1882 | AstroRx | - | - | - | - | [1] 2 2 💬
|
| 1883 | ASyn Mab | - | - | - | - | [1] 6 6 💬
|
| 1884 | At | - | - | - | - | [1] 79 79 💬
|
| 1885 | AT-02 | - | - | - | - | [1] 28 28 💬
|
| 1886 | AT-1501 | - | - | - | - | [1] 66 66 💬
|
| 1887 | AT-GTX-501 | - | - | - | - | [1] 19 19 💬
|
| 1888 | AT02 | - | - | - | - | [1] 28 28 💬
|
| 1889 | AT1001 | - | - | - | - | [1] 19 19 💬
|
| 1890 | AT1001 150 mg | - | - | - | - | [1] 19 19 💬
|
| 1891 | AT132 | - | - | - | - | [1] 111 111 💬
|
| 1892 | AT2101 | - | - | - | - | [1] 19 19 💬
|
| 1893 | AT2220 | [1] AT2220 AT2220 | - | - | - | [1] 256 256 💬
|
| 1894 | AT2221 | [1] Miglustat Miglustat | [1] Miglustat
Miglustat
💬
| [1] UGCG UGCG 💬
| [2] Cornified envelope formation Cornified envelope formation, Sphingolipid metabolism 💬 | [1] 256 256 💬
|
| 1895 | AT2221 65 mg Formulated Capsules | [1] Miglustat Miglustat | [1] Miglustat
Miglustat
💬
| [1] UGCG UGCG 💬
| [2] Cornified envelope formation Cornified envelope formation, Sphingolipid metabolism 💬 | [1] 256 256 💬
|
| 1896 | AT845 | [1] AT845 AT845 | - | - | - | [1] 256 256 💬
|
| 1897 | ATA-100 | [1] ATA-100 ATA-100 | - | - | - | [1] 113 113 💬
|
| 1898 | ATA-100 (AAV9 encoding FKRP gene) | [1] ATA-100 ATA-100 | - | - | - | [1] 113 113 💬
|
| 1899 | ATA-200 | - | - | - | - | [1] 113 113 💬
|
| 1900 | ATA188 | - | - | - | - | [1] 13 13 💬
|
| 1901 | ATA3219 | - | - | - | - | [1] 49 49 💬
|
| 1902 | Atacicept | [1] Atacicept Atacicept | [1] Atacicept
Atacicept
💬
| [2] TNFSF13 TNFSF13, TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [5] 13 13, 46, 49, 66, 222 💬
|
| 1903 | Atacicept 150 mg | [1] Atacicept Atacicept | [1] Atacicept
Atacicept
💬
| [2] TNFSF13 TNFSF13, TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [3] 13 13, 49, 66 💬
|
| 1904 | Atacicept 25 mg | [1] Atacicept Atacicept | [1] Atacicept
Atacicept
💬
| [2] TNFSF13 TNFSF13, TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [2] 13 13, 66 💬
|
| 1905 | Atacicept 75 mg | [1] Atacicept Atacicept | [1] Atacicept
Atacicept
💬
| [2] TNFSF13 TNFSF13, TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [3] 13 13, 49, 66 💬
|
| 1906 | Atacicept 75 milligram (mg) | [1] Atacicept Atacicept | [1] Atacicept
Atacicept
💬
| [2] TNFSF13 TNFSF13, TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 💬
|
| 1907 | Atacicept: with loading dose | [1] Atacicept Atacicept | [1] Atacicept
Atacicept
💬
| [2] TNFSF13 TNFSF13, TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 46 46 💬
|
| 1908 | ATALUREN | [1] Ataluren Ataluren | [1] Ataluren
Ataluren
💬
| - | - | [6] 19 19, 113, 140, 246, 299, 329 💬
|
| 1909 | Ataluren (PTC124®) | [1] Ataluren Ataluren | [1] Ataluren
Ataluren
💬
| - | - | [1] 299 299 💬
|
| 1910 | Ataluren 1000 mg | [1] Ataluren Ataluren | [1] Ataluren
Ataluren
💬
| - | - | [1] 113 113 💬
|
| 1911 | Ataluren 1000mg | [1] Ataluren Ataluren | [1] Ataluren
Ataluren
💬
| - | - | [1] 246 246 💬
|
| 1912 | Ataluren 125 mg | [1] Ataluren Ataluren | [1] Ataluren
Ataluren
💬
| - | - | [1] 113 113 💬
|
| 1913 | Ataluren 125mg | [1] Ataluren Ataluren | [1] Ataluren
Ataluren
💬
| - | - | [1] 246 246 💬
|
| 1914 | Ataluren 250 mg | [1] Ataluren Ataluren | [1] Ataluren
Ataluren
💬
| - | - | [1] 113 113 💬
|
| 1915 | Ataluren 250mg | [1] Ataluren Ataluren | [1] Ataluren
Ataluren
💬
| - | - | [1] 246 246 💬
|
| 1916 | Atazanavir | [1] Atazanavir Atazanavir | [2] Atazanavir sulfate
Atazanavir sulfate
,
Atazanavir
💬
| - | - | [1] 265 265 💬
|
| 1917 | Atazanavir (ATV) + ritonavir (RTV), continuation of backbone 2 nucleoside reverse transcriptase inhibitor (NRTIs) | [2] Atazanavir Atazanavir, Ritonavir | [3] Ritonavir
Ritonavir
,
Atazanavir sulfate
,
Atazanavir
💬
| - | - | [1] 265 265 💬
|
| 1918 | Atazanavir (Reyataz) | [1] Atazanavir Atazanavir | [2] Atazanavir sulfate
Atazanavir sulfate
,
Atazanavir
💬
| - | - | [1] 265 265 💬
|
| 1919 | Atazanavir/Ritonavir | [2] Atazanavir Atazanavir, Ritonavir | [3] Ritonavir
Ritonavir
,
Atazanavir sulfate
,
Atazanavir
💬
| - | - | [1] 265 265 💬
|
| 1920 | ATB200 | - | - | - | - | [1] 256 256 💬
|
| 1921 | ATENOLOL | [1] Atenolol Atenolol | [1] Atenolol
Atenolol
💬
| [1] ADRB1 ADRB1 💬
| [13] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 167 167 💬
|
| 1922 | Atenolol or Propranolol | [2] Atenolol Atenolol, Propranolol | [3] Atenolol
Atenolol
,
Propranolol hydrochloride
,
Propranolol
💬
| [3] ADRB1 ADRB1, ADRB2, ADRB3 💬
| [14] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 167 167 💬
|
| 1923 | Atezolizumab | [1] Atezolizumab Atezolizumab | [1] Atezolizumab
Atezolizumab
💬
| [1] CD274 CD274 💬
| [2] Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 | [1] 85 85 💬
|
| 1924 | ATG | - | - | - | - | [6] 13 13, 19, 60, 96, 222, 285 💬
|
| 1925 | ATG (rabbit) | [1] Rabbit Rabbit | - | - | - | [1] 11 11 💬
|
| 1926 | ATG conditioning regimen | - | - | - | - | [1] 60 60 💬
|
| 1927 | ATG+cyclosporine | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 60 60 💬
|
| 1928 | ATG+Rapamune+cyclosporine | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 60 60 💬
|
| 1929 | ATG-F | - | - | - | - | [2] 66 66, 223 💬
|
| 1930 | ATG-fresenius | - | - | - | - | [1] 60 60 💬
|
| 1931 | ATG/ALG | - | - | - | - | [1] 60 60 💬
|
| 1932 | Atgam | - | - | - | - | [1] 60 60 💬
|
| 1933 | ATGAM 50 mg/mL, solution à diluer pour perfusion | - | - | - | - | [1] 60 60 💬
|
| 1934 | ATGAM plus CsA with or without Eltrombopag | [1] Eltrombopag Eltrombopag | [2] Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 60 60 💬
|
| 1935 | ATH-063 | - | - | - | - | [2] 96 96, 97 💬
|
| 1936 | ATH-1017 | - | - | - | - | [1] 6 6 💬
|
| 1937 | ATH434 | [1] ATH434 ATH434 | - | - | - | [1] 17 17 💬
|
| 1938 | ATH434 dose level 1 | [1] ATH434 ATH434 | - | - | - | [1] 17 17 💬
|
| 1939 | ATH434 dose level 2 | [1] ATH434 ATH434 | - | - | - | [1] 17 17 💬
|
| 1940 | ATH434 Mesylate | [1] ATH434 ATH434 | - | - | - | [1] 17 17 💬
|
| 1941 | ATHENA CAR-T | - | - | - | - | [1] 49 49 💬
|
| 1942 | ATI-1013 | [1] ATI-1013 ATI-1013 | - | - | - | [1] 47 47 💬
|
| 1943 | ATI-1013 (0.2 g) | [1] ATI-1013 ATI-1013 | - | - | - | [1] 47 47 💬
|
| 1944 | ATI-1013 (0.8 g) | [1] ATI-1013 ATI-1013 | - | - | - | [1] 47 47 💬
|
| 1945 | ATI-1013 (3.2 g) | [1] ATI-1013 ATI-1013 | - | - | - | [1] 47 47 💬
|
| 1946 | ATI-450 | - | - | - | - | [2] 46 46, 106 💬
|
| 1947 | ATI-450 20 mg oral tablet BID | - | - | - | - | [1] 46 46 💬
|
| 1948 | ATI-450 50 mg oral tablet BID | - | - | - | - | [1] 46 46 💬
|
| 1949 | ATL 1102 | - | - | - | - | [1] 113 113 💬
|
| 1950 | ATL-001 (Ciclopirox oral solution) | [1] Ciclopirox Ciclopirox | [2] Ciclopirox olamine
Ciclopirox olamine
,
Ciclopirox
💬
| - | - | [1] 254 254 💬
|
| 1951 | ATL-2502 | - | - | - | - | [1] 97 97 💬
|
| 1952 | ATL1102 | [1] ATL1102 ATL1102 | - | - | - | [2] 13 13, 113 💬
|
| 1953 | ATL1102 25mg | [1] ATL1102 ATL1102 | - | - | - | [1] 113 113 💬
|
| 1954 | ATL1102 50mg | [1] ATL1102 ATL1102 | - | - | - | [1] 113 113 💬
|
| 1955 | ATL1103 | - | - | - | - | [1] 77 77 💬
|
| 1956 | ATLG administration | - | - | - | - | [1] 13 13 💬
|
| 1957 | ATM FOG in PD | - | - | - | - | [1] 6 6 💬
|
| 1958 | ATN-103 | - | - | - | - | [1] 46 46 💬
|
| 1959 | ATN-103 10 mg q4wks | - | - | - | - | [1] 46 46 💬
|
| 1960 | ATN-103 10 mg q8wks | - | - | - | - | [1] 46 46 💬
|
| 1961 | ATN-103 30 mg q4wks | - | - | - | - | [1] 46 46 💬
|
| 1962 | ATN-103 80 mg q4wks | - | - | - | - | [1] 46 46 💬
|
| 1963 | ATN-103 80 mg q8wks | - | - | - | - | [1] 46 46 💬
|
| 1964 | Atogepant | [1] Atogepant Atogepant | [1] Atogepant
Atogepant
💬
| [1] CALCRL CALCRL 💬
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬 | [1] 226 226 💬
|
| 1965 | Atomexetine | - | - | - | - | [1] 17 17 💬
|
| 1966 | Atomoxetina | - | - | - | - | [1] 230 230 💬
|
| 1967 | Atomoxetine | [1] Atomoxetine Atomoxetine | [2] Atomoxetine hydrochloride
Atomoxetine hydrochloride
,
Atomoxetine
💬
| [1] SLC6A2 SLC6A2 💬
| [2] Neuroactive ligand signaling Neuroactive ligand signaling, Synaptic vesicle cycle 💬 | [4] 6 6, 8, 13, 17 💬
|
| 1968 | Atorvastatin | [1] Atorvastatin Atorvastatin | [2] Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [21] 13 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬
|
| 1969 | Atorvastatin (approved) | [1] Atorvastatin Atorvastatin | [2] Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 79 79 💬
|
| 1970 | Atorvastatin (Lipitor) | [1] Atorvastatin Atorvastatin | [2] Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 79 79 💬
|
| 1971 | Atorvastatin (Lipitor)(Zarator in Iceland) | [1] Atorvastatin Atorvastatin | [2] Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 79 79 💬
|
| 1972 | Atorvastatin ,Zarator | [1] Atorvastatin Atorvastatin | [2] Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 79 79 💬
|
| 1973 | Atorvastatin 10mg | [1] Atorvastatin Atorvastatin | [2] Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 63 63 💬
|
| 1974 | Atorvastatin 20 Mg Oral Tablet | [1] Atorvastatin Atorvastatin | [2] Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 67 67 💬
|
| 1975 | Atorvastatin 20mg | [1] Atorvastatin Atorvastatin | [2] Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 63 63 💬
|
| 1976 | Atorvastatin 40 Mg Oral Tablet + N-acetylcysteine 400 mg Oral tablet | [2] Acetylcysteine Acetylcysteine, Atorvastatin | [3] Acetylcysteine
Acetylcysteine
,
Atorvastatin calcium
,
Atorvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 63 63 💬
|
| 1977 | Atorvastatin 80mg | [1] Atorvastatin Atorvastatin | [2] Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 97 97 💬
|
| 1978 | ATORVASTATIN CALCIUM | [2] Atorvastatin Atorvastatin, Calcium | [2] Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [3] 79 79, 97, 265 💬
|
| 1979 | Atorvastatin tablet 20 mg | [1] Atorvastatin Atorvastatin | [2] Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 46 46 💬
|
| 1980 | Atorvastatin/ Zarator | [1] Atorvastatin Atorvastatin | [2] Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 79 79 💬
|
| 1981 | Atorvastatina | - | - | - | - | [1] 79 79 💬
|
| 1982 | ATORVASTATINA CALCICA TRIHIDRATO | - | - | - | - | [1] 79 79 💬
|
| 1983 | Atosiban | [1] Atosiban Atosiban | [2] Atosiban
Atosiban
,
Atosiban acetate
💬
| [1] OXTR OXTR 💬
| [5] Calcium signaling pathway Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | [1] 118 118 💬
|
| 1984 | ATOVAQUONE | [1] Atovaquone Atovaquone | [1] Atovaquone
Atovaquone
💬
| - | - | [1] 61 61 💬
|
| 1985 | ATR-101 | - | - | - | - | [2] 75 75, 81 💬
|
| 1986 | ATR12-351 | - | - | - | - | [1] 160 160 💬
|
| 1987 | ATRA | - | - | - | - | [1] 63 63 💬
|
| 1988 | ATRASENTAN | [1] Atrasentan Atrasentan | [1] Atrasentan hydrochloride
Atrasentan hydrochloride
💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [3] 66 66, 218, 222 💬
|
| 1989 | Atropina | - | - | - | - | [1] 299 299 💬
|
| 1990 | Atropine | [1] Atropine Atropine | [2] Atropine
Atropine
,
Atropine sulfate
💬
| [5] CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
| [14] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | [1] 2 2 💬
|
| 1991 | ATTR-CM | - | - | - | - | [1] 28 28 💬
|
| 1992 | Atumelnant | [1] Atumelnant Atumelnant | [1] Atumelnant
Atumelnant
💬
| [1] MC2R MC2R 💬
| [6] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [2] 75 75, 81 💬
|
| 1993 | Atumelnant (CRN04894) | [1] Atumelnant Atumelnant | [1] Atumelnant
Atumelnant
💬
| [1] MC2R MC2R 💬
| [6] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 81 81 💬
|
| 1994 | ATV | - | - | - | - | [1] 265 265 💬
|
| 1995 | ATV-1601 | - | - | - | - | [1] 227 227 💬
|
| 1996 | ATX-01 | [1] ATX-01 ATX-01 | - | - | - | [1] 113 113 💬
|
| 1997 | ATX-MS-1467 | - | - | - | - | [1] 13 13 💬
|
| 1998 | Atypical Antipsychotics | - | - | - | - | [1] 6 6 💬
|
| 1999 | ATYR1923 | - | - | - | - | [1] 84 84 💬
|
| 2000 | ATYR1923 1.0 mg/kg | - | - | - | - | [1] 84 84 💬
|
| 2001 | ATYR1923 3.0 mg/kg | - | - | - | - | [1] 84 84 💬
|
| 2002 | ATYR1923 5.0 mg/kg | - | - | - | - | [1] 84 84 💬
|
| 2003 | ATYR1940 | [1] ATYR-1940 ATYR-1940 | - | - | - | [1] 113 113 💬
|
| 2004 | AUBAGIO | - | - | - | - | [1] 13 13 💬
|
| 2005 | AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BISTER (ALU/ALU) PERFORATO MONODOSE - 10 X 1 COMPRESSA | - | - | - | - | [1] 13 13 💬
|
| 2006 | AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (ALU/ALU) - 28 COMPRESSE | - | - | - | - | [1] 13 13 💬
|
| 2007 | Aubagio 14 mg film-coated tablets | - | - | - | - | [1] 13 13 💬
|
| 2008 | Aubagio 14MG TBL FLM | - | - | - | - | [1] 13 13 💬
|
| 2009 | AubagioProduct Name: TeriflunomidePharmaceutical Form: Capsule, hardINN or Proposed INN: TERIFLUNOMIDECAS Number: 108605-62-5Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 14-Pharmaceutical form of the placebo: Capsule, hardRoute of administration of the placebo: Oral use | - | - | - | - | [1] 13 13 💬
|
| 2010 | AubagioProduct Name: TeriflunomideProduct Code: HMR1726Pharmaceutical Form: Film-coated tabletINN or Proposed INN: TERIFLUNOMIDECAS Number: 108605-62-5Current Sponsor code: HMR1726Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 14-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral use | - | - | - | - | [1] 13 13 💬
|
| 2011 | Aubagio® | - | - | - | - | [1] 13 13 💬
|
| 2012 | AUC of MPA measure | - | - | - | - | [1] 51 51 💬
|
| 2013 | Augmentin | - | - | - | - | [1] 299 299 💬
|
| 2014 | Aurexis® (tefibazumab) | [1] Tefibazumab Tefibazumab | [1] Tefibazumab
Tefibazumab
💬
| - | - | [1] 299 299 💬
|
| 2015 | Auto Injector | - | - | - | - | [1] 46 46 💬
|
| 2016 | Auto-Injector Device (AID) | - | - | - | - | [1] 46 46 💬
|
| 2017 | Auto-titrating oxygen system | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [1] 85 85 💬
|
| 2018 | Autoantibody Reductive Therapy | - | - | - | - | [1] 85 85 💬
|
| 2019 | Autofluorescent detection + Injection of indocyanine green | [2] Indocyanine green Indocyanine green, Indocyanine green acid form | [1] Indocyanine green
Indocyanine green
💬
| - | - | [1] 235 235 💬
|
| 2020 | Autoinjector | - | - | - | - | [1] 46 46 💬
|
| 2021 | Autologous (self) mononuclear cells derived from umbilical cord blood | - | - | - | - | [1] 211 211 💬
|
| 2022 | Autologous adipose derived mesenchymal cells | - | - | - | - | [1] 13 13 💬
|
| 2023 | Autologous Adipose Derived MSCs (ADMSCs) | - | - | - | - | [1] 85 85 💬
|
| 2024 | Autologous adipose derived stem cells | - | - | - | - | [1] 46 46 💬
|
| 2025 | Autologous ADIpose derived stromal vascular fraction | - | - | - | - | [1] 96 96 💬
|
| 2026 | Autologous Adipose Mesenchymal Stem Cell Implantation | - | - | - | - | [1] 17 17 💬
|
| 2027 | Autologous Adipose-derived Mesenchymal Stromal Cells | - | - | - | - | [1] 2 2 💬
|
| 2028 | Autologous ADRCs injection Combined with Standard Therapy | - | - | - | - | [1] 51 51 💬
|
| 2029 | Autologous adult bone marrow mononuclear cells (BM-MNC) unexpanded | - | - | - | - | [1] 2 2 💬
|
| 2030 | Autologous adult bone marrow mononuclear cells unexpanded | - | - | - | - | [1] 2 2 💬
|
| 2031 | Autologous adult mesenchymal stem cells from bone marrow expanded and cryopreserved | - | - | - | - | [1] 13 13 💬
|
| 2032 | Autologous anti-BCMA chimeric antigen receptor T cells | - | - | - | - | [1] 63 63 💬
|
| 2033 | Autologous anti-CD19 CAR-T cells, intravenous single infusion at protocol-defined dose level (1 x 10^6 or 3 x 10^6 CAR-positive viable T cells/kg). | [1] Anti-CD19 CAR-T cells Anti-CD19 CAR-T cells | - | - | - | [1] 49 49 💬
|
| 2034 | Autologous apoptotic cells injection | - | - | - | - | [1] 46 46 💬
|
| 2035 | Autologous ASC | - | - | - | - | [1] 51 51 💬
|
| 2036 | Autologous Bone Marrow Derived Mononuclear Cells | - | - | - | - | [1] 57 57 💬
|
| 2037 | Autologous bone marrow mononuclear cell transplantation | - | - | - | - | [1] 113 113 💬
|
| 2038 | Autologous bone marrow mononucleated cells | - | - | - | - | [1] 2 2 💬
|
| 2039 | Autologous bone marrow transplantation | - | - | - | - | [2] 13 13, 28 💬
|
| 2040 | Autologous bone marrow-derived cells | - | - | - | - | [1] 57 57 💬
|
| 2041 | Autologous Bone Marrow-derived Mononuclear Cells | - | - | - | - | [1] 217 217 💬
|
| 2042 | Autologous Bone Marrow-Derived Mononuclear Stem Cells | - | - | - | - | [1] 13 13 💬
|
| 2043 | Autologous bone marrow-derived stem cells | - | - | - | - | [1] 2 2 💬
|
| 2044 | Autologous CD19-BCMA Dual-Target CAR T-Cell Therapy | - | - | - | - | [5] 13 13, 49, 51, 53, 61 💬
|
| 2045 | Autologous CD19-Targeted CAR-T Cells | - | - | - | - | [1] 49 49 💬
|
| 2046 | AUTOLOGOUS CD34+ CELLS TRANSDUCED EX-VIVO WITH THE PCCLCHIMGP91/VSVG LENTIVIRAL VECTOR | - | - | - | - | [1] 65 65 💬
|
| 2047 | AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH A LENTIVIRAL VECTOR CONTAINING THE HUMAN SGSH GENE | - | - | - | - | [1] 19 19 💬
|
| 2048 | Autologous CD34+ cells transduced with a lentiviral vector encoding the ARSA cDNA | - | - | - | - | [1] 19 19 💬
|
| 2049 | AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH LENTI-D VECTOR ENCODING ABCD1 CDNA | - | - | - | - | [1] 20 20 💬
|
| 2050 | Autologous CD34+ cells transduced with the G1XCGD lentiviral vector | - | - | - | - | [1] 65 65 💬
|
| 2051 | Autologous CD34+ cells transduced with the Lentiviral vector containing the human Wiskott Aldrich Sy | - | - | - | - | [1] 65 65 💬
|
| 2052 | Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with lentiviral vector that encodes for the human Wiskott Aldrich Syndrome (WAS) cDNA sequence | - | - | - | - | [1] 65 65 💬
|
| 2053 | Autologous CD34+ HSCs transduced ex vivo with EFS lentiviral vector encoding for the human ADA gene | - | - | - | - | [1] 65 65 💬
|
| 2054 | AUTOLOGOUS CD34+CELLS TRANSDUCED WITH THE W1.6_HWASP_WPRE (VSVG) LENTIVIRAL VECTOR | - | - | - | - | [1] 65 65 💬
|
| 2055 | Autologous CD34+HPC transplantation (HSCT) | - | - | - | - | [1] 49 49 💬
|
| 2056 | Autologous CD34-selected peripheral blood stem cells transplant | - | - | - | - | [1] 96 96 💬
|
| 2057 | Autologous CD4+T cells stimulated and expanded ex vivo by a MOG peptide modified by the introduction of a thioreductase motif into the flanking residues of the T cell epitope | - | - | - | - | [1] 13 13 💬
|
| 2058 | Autologous cell-based delivery | - | - | - | - | [1] 211 211 💬
|
| 2059 | Autologous dopaminergic cell implantation | - | - | - | - | [1] 6 6 💬
|
| 2060 | Autologous EBV specific CTL infusion | - | - | - | - | [1] 49 49 💬
|
| 2061 | Autologous ex vivo gene therapy products based on the EFS LV encoding for the human adenosine deaminase (ADA) gene (EFS-ADA LV) | [1] Adenosine Adenosine | [1] Adenosine
Adenosine
💬
| [4] ADORA1 ADORA1, ADORA2A, ADORA2B, ADORA3 💬
| [13] Alcoholism Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 2062 | Autologous haematopoietic stem cells transduced with lentiviral vector Lenti-D encoding the human ABCD1 cDNA | - | - | - | - | [1] 20 20 💬
|
| 2063 | Autologous HB-adMSCs | - | - | - | - | [1] 13 13 💬
|
| 2064 | Autologous Hematopoietic Stem Cell | - | - | - | - | [1] 13 13 💬
|
| 2065 | Autologous hematopoietic stem cell transplant | - | - | - | - | [1] 13 13 💬
|
| 2066 | Autologous Hematopoietic Stem Cell Transplantation | - | - | - | - | [7] 11 11, 13, 14, 28, 49, 51, 84 💬
|
| 2067 | Autologous hematopoietic stem cell transplantation (ASCT) | - | - | - | - | [1] 28 28 💬
|
| 2068 | Autologous hematopoietic stem cells | - | - | - | - | [1] 13 13 💬
|
| 2069 | Autologous hMSCs | - | - | - | - | [1] 57 57 💬
|
| 2070 | Autologous Human Polyclonal Regulatory T Cells Injection (NP001 Cell Injection) | - | - | - | - | [1] 2 2 💬
|
| 2071 | Autologous induced neural stem cell-derived DA precursor cells | - | - | - | - | [1] 6 6 💬
|
| 2072 | Autologous mature tolerogenic monocyte-derived Dendritic Cells loaded with the B29 peptide of HSP70 | - | - | - | - | [1] 46 46 💬
|
| 2073 | Autologous Mesenchymal Cell Product | - | - | - | - | [1] 13 13 💬
|
| 2074 | Autologous mesenchymal stem cell transplantation | - | - | - | - | [1] 13 13 💬
|
| 2075 | Autologous mesenchymal stem cells | - | - | - | - | [5] 2 2, 6, 13, 17, 46 💬
|
| 2076 | Autologous Mesenchymal stem cells (MSCs) | - | - | - | - | [1] 2 2 💬
|
| 2077 | Autologous mesenchymal stem cells derived from bone marrow | - | - | - | - | [1] 85 85 💬
|
| 2078 | Autologous mesenchymal stromal cell | - | - | - | - | [2] 96 96, 298 💬
|
| 2079 | Autologous mesenchymal stromal cells (MSC) | - | - | - | - | [1] 222 222 💬
|
| 2080 | Autologous midbrain dopamine neurons | [1] Dopamine Dopamine | [2] Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 2081 | Autologous MSC-NTF cells | - | - | - | - | [1] 2 2 💬
|
| 2082 | Autologous myelin-derived peptide-pulsed tolerogenic dendritic cells | - | - | - | - | [1] 13 13 💬
|
| 2083 | Autologous ovalbumin-specific type 1 regulatory T lymphocytes expanded population | - | - | - | - | [1] 96 96 💬
|
| 2084 | Autologous peripheral blood stem cell transplantation | - | - | - | - | [9] 28 28, 40, 41, 42, 45, 46, 49, 63, 283 💬
|
| 2085 | Autologous Plasmablasts | - | - | - | - | [1] 19 19 💬
|
| 2086 | Autologous Plasmablasts (B cells) | - | - | - | - | [1] 19 19 💬
|
| 2087 | Autologous Regulatory ?-cells | - | - | - | - | [1] 51 51 💬
|
| 2088 | Autologous serum | - | - | - | - | [1] 53 53 💬
|
| 2089 | Autologous Serum 20% | - | - | - | - | [2] 38 38, 53 💬
|
| 2090 | Autologous Serum 50% | - | - | - | - | [1] 53 53 💬
|
| 2091 | Autologous serum tears combined with 0.05% cyclosporin eye drop | - | - | - | - | [1] 53 53 💬
|
| 2092 | Autologous Stem Cell | - | - | - | - | [1] 8 8 💬
|
| 2093 | Autologous stem cell therapy | - | - | - | - | [1] 57 57 💬
|
| 2094 | Autologous stem cell transplant | - | - | - | - | [4] 28 28, 53, 56, 96 💬
|
| 2095 | Autologous Stem Cell Transplantation | - | - | - | - | [4] 13 13, 28, 56, 96 💬
|
| 2096 | Autologous stem cell transplantation (ASCT) | - | - | - | - | [1] 28 28 💬
|
| 2097 | Autologous Stem Cells | - | - | - | - | [2] 13 13, 51 💬
|
| 2098 | Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells | - | - | - | - | [1] 51 51 💬
|
| 2099 | Autologous Stromal Vascular Fraction (SVF) | - | - | - | - | [1] 85 85 💬
|
| 2100 | Autologous stromal vascular fraction cells | - | - | - | - | [1] 46 46 💬
|
| 2101 | AUTOLOGOUS T-LYMPHOCYTES | - | - | - | - | [1] 13 13 💬
|
| 2102 | Autologous T-regulatory lymphocytes | - | - | - | - | [1] 2 2 💬
|
| 2103 | Autologous Tissue-Engineered Vascular Graft | - | - | - | - | [1] 210 210 💬
|
| 2104 | Autologous Umbilical Cord Blood | - | - | - | - | [2] 211 211, 294 💬
|
| 2105 | Autologous VitD3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides (tolDC-VitD3) | - | - | - | - | [1] 13 13 💬
|
| 2106 | Autologous-autologous tandem hematopoietic stem cell transplantation | - | - | - | - | [1] 28 28 💬
|
| 2107 | Automated abdominal binder | - | - | - | - | [1] 17 17 💬
|
| 2108 | Autonomic testing on and off levodopa | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 2109 | AV-101 | [1] AV-101 AV-101 | - | - | - | [2] 6 6, 86 💬
|
| 2110 | AV-101Pharmaceutical Form: Inhalation powder, hard capsuleINN or Proposed INN: ImatinibCAS Number: 152459-95-5Current Sponsor code: AV-101Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 5-Product Name: AV-101Pharmaceutical Form: Inhalation powder, hard capsuleINN or Proposed INN: ImatinibCAS Number: 152459-95-5Current Sponsor code: AV-101Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 17.5-Product Name: AV-101Pharmaceutical Form: Inhalation powder, hard capsuleINN or Proposed INN: ImatinibCAS Number: 152459-95-5Current Sponsor code: AV-101Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 35- | - | - | - | - | [1] 86 86 💬
|
| 2111 | AV1451 Tau | - | - | - | - | [3] 6 6, 17, 127 💬
|
| 2112 | AV605 | - | - | - | - | [1] 13 13 💬
|
| 2113 | Avacincaptad pegol | [1] Avacincaptad pegol Avacincaptad pegol | [1] Avacincaptad pegol sodium
Avacincaptad pegol sodium
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 301 301 💬
|
| 2114 | Avacopan | [1] Avacopan Avacopan | [1] Avacopan
Avacopan
💬
| [1] C5AR1 C5AR1 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Staphylococcus aureus infection 💬 | [4] 43 43, 44, 66, 223 💬
|
| 2115 | Avalglucosidase Alfa | [1] Avalglucosidase alfa Avalglucosidase alfa | [1] Avalglucosidase alfa
Avalglucosidase alfa
💬
| [1] GAA GAA 💬
| [3] Galactose metabolism Galactose metabolism, Lysosome biogenesis, Starch and sucrose metabolism 💬 | [1] 256 256 💬
|
| 2116 | Avalglucosidase alfa (GZ402666) | [1] Avalglucosidase alfa Avalglucosidase alfa | [1] Avalglucosidase alfa
Avalglucosidase alfa
💬
| [1] GAA GAA 💬
| [3] Galactose metabolism Galactose metabolism, Lysosome biogenesis, Starch and sucrose metabolism 💬 | [1] 256 256 💬
|
| 2117 | Avalglucosidase Alfa (NeoGAA) | [1] Avalglucosidase alfa Avalglucosidase alfa | [1] Avalglucosidase alfa
Avalglucosidase alfa
💬
| [1] GAA GAA 💬
| [3] Galactose metabolism Galactose metabolism, Lysosome biogenesis, Starch and sucrose metabolism 💬 | [1] 256 256 💬
|
| 2118 | Avalglucosidase alfa-NGPT (GZ402666) | [1] Avalglucosidase alfa Avalglucosidase alfa | [1] Avalglucosidase alfa
Avalglucosidase alfa
💬
| [1] GAA GAA 💬
| [3] Galactose metabolism Galactose metabolism, Lysosome biogenesis, Starch and sucrose metabolism 💬 | [1] 256 256 💬
|
| 2119 | Avalglucosidase alfa-NGPT (GZ402666) IV | [1] Avalglucosidase alfa Avalglucosidase alfa | [1] Avalglucosidase alfa
Avalglucosidase alfa
💬
| [1] GAA GAA 💬
| [3] Galactose metabolism Galactose metabolism, Lysosome biogenesis, Starch and sucrose metabolism 💬 | [1] 256 256 💬
|
| 2120 | Avalglucosidasi alfa | - | - | - | - | [1] 256 256 💬
|
| 2121 | Avalotcagene ontaparvovec | [1] Avalotcagene ontaparvovec Avalotcagene ontaparvovec | - | - | - | [1] 251 251 💬
|
| 2122 | AVALOX - 400 | - | - | - | - | [1] 6 6 💬
|
| 2123 | Avandia administration for 6-12 weeks | - | - | - | - | [1] 265 265 💬
|
| 2124 | AVANDIA*28CPR RIV 4MG | - | - | - | - | [1] 77 77 💬
|
| 2125 | AVASTIN | - | - | - | - | [1] 227 227 💬
|
| 2126 | AVASTIN 25 mg/ml - Konzentrat zur Herstellung einer Infusionsloesung | - | - | - | - | [1] 227 227 💬
|
| 2127 | Avatrombopag | [1] Avatrombopag Avatrombopag | [2] Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [2] 60 60, 63 💬
|
| 2128 | Avatrombopag (proposed) | [1] Avatrombopag Avatrombopag | [2] Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 2129 | Avatrombopag +rhTPO | [1] Avatrombopag Avatrombopag | [2] Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 60 60 💬
|
| 2130 | Avatrombopag 20 MG | [1] Avatrombopag Avatrombopag | [2] Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 60 60 💬
|
| 2131 | Avatrombopag 20 MG Oral Tablet | [1] Avatrombopag Avatrombopag | [2] Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [2] 60 60, 63 💬
|
| 2132 | AVATROMBOPAG MALEATE | [1] Avatrombopag Avatrombopag | [2] Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 2133 | Avatrombopag Oral Tablet | [1] Avatrombopag Avatrombopag | [2] Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 2134 | Avatrombopag tablets | [1] Avatrombopag Avatrombopag | [2] Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 2135 | Avatrombopag+All trans retinoic acid | [1] Avatrombopag Avatrombopag | [2] Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 2136 | Avaxim Pediatric® | - | - | - | - | [2] 96 96, 107 💬
|
| 2137 | Avaxim ® (adult) | - | - | - | - | [2] 96 96, 107 💬
|
| 2138 | AVB-101 | [1] AVB-101 AVB-101 | - | - | - | [1] 127 127 💬
|
| 2139 | AVB-114 | - | - | - | - | [1] 96 96 💬
|
| 2140 | AVB-S6-500 | - | - | - | - | [1] 66 66 💬
|
| 2141 | AVCN583601 (3% Cannabidiol cream) | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 36 36 💬
|
| 2142 | Avdoralimab | [1] Avdoralimab Avdoralimab | - | - | - | [1] 162 162 💬
|
| 2143 | Avdoralimab (IPH5401) | [1] Avdoralimab Avdoralimab | - | - | - | [1] 162 162 💬
|
| 2144 | AVE8112 | - | - | - | - | [1] 6 6 💬
|
| 2145 | Avelox- Moxifloxacin | [1] Moxifloxacin Moxifloxacin | [3] Moxifloxacin hydrochloride
Moxifloxacin hydrochloride
,
Moxifloxacin
,
Moxifloxacin hydrochloride monohydrate
💬
| - | - | [1] 46 46 💬
|
| 2146 | Avelox® | - | - | - | - | [1] 46 46 💬
|
| 2147 | Avenciguat | [1] Avenciguat Avenciguat | [1] Avenciguat
Avenciguat
💬
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
| [10] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬
|
| 2148 | Avenciguat (BI 685509) | [1] Avenciguat Avenciguat | [1] Avenciguat
Avenciguat
💬
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
| [10] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬
|
| 2149 | AVI-4658 | - | - | - | - | [1] 113 113 💬
|
| 2150 | AVI-4658 (Eteplirsen) | [1] Eteplirsen Eteplirsen | [1] Eteplirsen
Eteplirsen
💬
| [1] DMD DMD 💬
| [5] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | [1] 113 113 💬
|
| 2151 | AVI-4658 (PMO) | - | - | - | - | [1] 113 113 💬
|
| 2152 | AVI-4658 for Injection | - | - | - | - | [1] 113 113 💬
|
| 2153 | Avian polyclonal IgY antibody against PA | - | - | - | - | [1] 299 299 💬
|
| 2154 | Avibactam | [1] Avibactam Avibactam | [1] Avibactam sodium
Avibactam sodium
💬
| - | - | [1] 299 299 💬
|
| 2155 | AVID200 | - | - | - | - | [1] 51 51 💬
|
| 2156 | Aviptadil | [1] Aviptadil Aviptadil | [1] Aviptadil
Aviptadil
💬
| - | - | [4] 49 49, 51, 84, 86 💬
|
| 2157 | AVONEX | - | - | - | - | [2] 13 13, 97 💬
|
| 2158 | Avonex (IFNbeta-1-a, Biogen Netherlands B.V) | - | - | - | - | [1] 13 13 💬
|
| 2159 | Avonex (IFNß-1-a, Biogen Netherlands B.V) | - | - | - | - | [1] 13 13 💬
|
| 2160 | Avonex (Interferon beta 1a) | - | - | - | - | [1] 13 13 💬
|
| 2161 | Avonex (interferon beta-1a), Biogen Idec Ltd | [1] Interferon beta-1a Interferon beta-1a | [1] Interferon beta-1a
Interferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 2162 | AVONEX - 30 MCG (6 MILIONI UI) POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 4 FLACONI CON DISPOSITIVO BIOSET + 4 SIRINGHE PRERIEMPITE USO INTRAMUSCOLARE | - | - | - | - | [1] 13 13 💬
|
| 2163 | Avonex 30 microgram/0.5 ml Solution for Injection | - | - | - | - | [1] 13 13 💬
|
| 2164 | AVONEX 30 microgramos/0,5 ml (Interferón Beta - 1a) Solución inyectable | - | - | - | - | [1] 13 13 💬
|
| 2165 | Avonex 30 microgramos/0.5 ml Solución para inyección | - | - | - | - | [1] 13 13 💬
|
| 2166 | AVONEX 30 µg/0,5 ml solution for injection | - | - | - | - | [1] 13 13 💬
|
| 2167 | Avonex and Topamax | - | - | - | - | [1] 13 13 💬
|
| 2168 | AVONEX IM 4SIR 30MCG/0,5ML 4AG | - | - | - | - | [1] 13 13 💬
|
| 2169 | Avonex prefilled syringe via manual IM injection | - | - | - | - | [1] 13 13 💬
|
| 2170 | AVONEX*IM 4SIR 30MCG/0,5ML+4AG | - | - | - | - | [1] 13 13 💬
|
| 2171 | Avonex/Betaseron/Copaxone/Rebif | - | - | - | - | [1] 13 13 💬
|
| 2172 | Avonex/Zocor | - | - | - | - | [1] 13 13 💬
|
| 2173 | AVONEXPharmaceutical Form: Solution for injectionOther descriptive name: INTERFERON BETA-1AConcentration unit: µg microgram(s)Concentration type: equalConcentration number: 30-Pharmaceutical form of the placebo: Solution for injectionRoute of administration of the placebo: Intramuscular use | - | - | - | - | [1] 13 13 💬
|
| 2174 | AVONEX® | - | - | - | - | [1] 13 13 💬
|
| 2175 | Avonex® monotherapy (6.0 MIU administered i.m. each week) | - | - | - | - | [1] 13 13 💬
|
| 2176 | Avoralstat | [1] Avoralstat Avoralstat | - | - | - | [1] 65 65 💬
|
| 2177 | AVP-923 | - | - | - | - | [3] 2 2, 6, 13 💬
|
| 2178 | AVP-923-45 | - | - | - | - | [1] 6 6 💬
|
| 2179 | AVR-RD-01 | [1] AVR-RD-01 AVR-RD-01 | - | - | - | [1] 19 19 💬
|
| 2180 | AVR-RD-02 | [1] AVR-RD-02 AVR-RD-02 | - | - | - | [1] 19 19 💬
|
| 2181 | AVT02 (Alvotech Biosimilar to Adalimumab) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4] 46 46, 96, 97, 271 💬
|
| 2182 | AVT05 | - | - | - | - | [1] 46 46 💬
|
| 2183 | AVT05 (proposed biosimilar to golimumab) | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 2184 | AVT16 | - | - | - | - | [1] 97 97 💬
|
| 2185 | AVTX-803 | - | - | - | - | [1] 65 65 💬
|
| 2186 | AVTX-803 (L-Fucose) | [1] Fucose Fucose | [1] Elfucose
Elfucose
💬
| - | - | [1] 65 65 💬
|
| 2187 | AVX 470 | - | - | - | - | [1] 97 97 💬
|
| 2188 | AVXS-101 | - | - | - | - | [1] 3 3 💬
|
| 2189 | AVXS-101 (previously known as scAAV9.CB.SMN) | - | - | - | - | [1] 3 3 💬
|
| 2190 | AX 250 | - | - | - | - | [1] 19 19 💬
|
| 2191 | Axatilimab | [1] Axatilimab Axatilimab | [1] Axatilimab
Axatilimab
💬
| [1] CSF1R CSF1R 💬
| [11] Acute myeloid leukemia Acute myeloid leukemia, Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, MAPK signaling pathway, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 85 85 💬
|
| 2192 | Axially Oscillating Sphere dry powder inhaler (AOS DPI) | - | - | - | - | [1] 86 86 💬
|
| 2193 | Axitinib | [1] Axitinib Axitinib | [1] Axitinib
Axitinib
💬
| [3] FLT1 FLT1, FLT4, KDR 💬
| [17] Breast cancer Breast cancer, Cadherin signaling, Calcium signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, IgSF CAM signaling, Integrin signaling, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Rheumatoid arthritis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [1] 34 34 💬
|
| 2194 | AXO-AAV-GM2 | - | - | - | - | [1] 19 19 💬
|
| 2195 | AXO-AAV-GM2 High Dose | - | - | - | - | [1] 19 19 💬
|
| 2196 | AXO-AAV-GM2 Low Dose | - | - | - | - | [1] 19 19 💬
|
| 2197 | AXO-AAV-GM2 Middle Dose | - | - | - | - | [1] 19 19 💬
|
| 2198 | AXO-AAV-GM2 Starting Dose | - | - | - | - | [1] 19 19 💬
|
| 2199 | AZ-3102 | - | - | - | - | [1] 19 19 💬
|
| 2200 | AZ-3102 (Dose 1) | - | - | - | - | [1] 19 19 💬
|
| 2201 | AZ-3102 (Dose 2) | - | - | - | - | [1] 19 19 💬
|
| 2202 | AZA | - | - | - | - | [4] 11 11, 40, 96, 97 💬
|
| 2203 | AZA capsules | - | - | - | - | [1] 96 96 💬
|
| 2204 | Azacitidine | [1] Azacitidine Azacitidine | [1] Azacitidine
Azacitidine
💬
| [3] DNMT1 DNMT1, DNMT3A, DNMT3B 💬
| [3] Cysteine and methionine metabolism Cysteine and methionine metabolism, Efferocytosis, MicroRNAs in cancer 💬 | [1] 34 34 💬
|
| 2205 | AzaFol | - | - | - | - | [1] 41 41 💬
|
| 2206 | AZAFOR - 50 MG COMPRESSE RIVESTITE CON FILM 50 COMPRESSE IN BLISTER PVC/PVDC/AL | - | - | - | - | [1] 97 97 💬
|
| 2207 | AZAFOR 50mg | - | - | - | - | [1] 97 97 💬
|
| 2208 | AZAPRED | - | - | - | - | [1] 85 85 💬
|
| 2209 | Azathioprin | - | - | - | - | [3] 46 46, 54, 96 💬
|
| 2210 | Azathioprin-ratiopharm 25 mg | - | - | - | - | [1] 96 96 💬
|
| 2211 | Azathioprin-ratiopharm 25mg Filmtabletten | - | - | - | - | [1] 96 96 💬
|
| 2212 | Azathioprin-ratiopharm 50 mg Filmtabletten | - | - | - | - | [1] 96 96 💬
|
| 2213 | Azathioprin-ratiopharm® 25 mg Filmtabletten | - | - | - | - | [1] 44 44 💬
|
| 2214 | Azathioprine | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [26] 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 57, 63, 65, 66, 84, 85, 93, 94, 95, 96, 97, 162, 223, 300 💬
|
| 2215 | Azathioprine (AZA) | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [5] 13 13, 19, 49, 55, 97 💬
|
| 2216 | Azathioprine (AZA) caps | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [1] 96 96 💬
|
| 2217 | Azathioprine (AZA) or 6-mercaptopurine (6-MP) | [2] Azathioprine Azathioprine, Mercaptopurine | [4] Mercaptopurine
Mercaptopurine
,
Azathioprine
,
Azathioprine sodium
,
Mercaptopurine
💬
| [1] HPRT1 HPRT1 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [2] 96 96, 97 💬
|
| 2218 | Azathioprine (Imuran) 50 mg Overencapsulated Tablet | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [1] 97 97 💬
|
| 2219 | Azathioprine + infliximab | [2] Azathioprine Azathioprine, Infliximab | [3] Azathioprine
Azathioprine
,
Infliximab
,
Azathioprine sodium
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 2220 | Azathioprine + Prednisolone | [2] Azathioprine Azathioprine, Prednisolone | [3] Azathioprine
Azathioprine
,
Prednisolone
,
Azathioprine sodium
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 95 95 💬
|
| 2221 | Azathioprine - ratiopharm 50 mg | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [1] 96 96 💬
|
| 2222 | Azathioprine / 6 Mercaptopurine | [2] Azathioprine Azathioprine, Mercaptopurine | [4] Mercaptopurine
Mercaptopurine
,
Azathioprine
,
Azathioprine sodium
,
Mercaptopurine
💬
| [1] HPRT1 HPRT1 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [1] 96 96 💬
|
| 2223 | Azathioprine / Allopurinol | [2] Allopurinol Allopurinol, Azathioprine | [4] Allopurinol
Allopurinol
,
Azathioprine
,
Azathioprine sodium
,
Allopurinol sodium
💬
| [1] XDH XDH 💬
| [4] Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | [1] 97 97 💬
|
| 2224 | Azathioprine 25 mg | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [1] 44 44 💬
|
| 2225 | Azathioprine and Allopurinol | [2] Allopurinol Allopurinol, Azathioprine | [4] Allopurinol
Allopurinol
,
Azathioprine
,
Azathioprine sodium
,
Allopurinol sodium
💬
| [1] XDH XDH 💬
| [4] Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | [1] 97 97 💬
|
| 2226 | AZATHIOPRINE BP | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [1] 97 97 💬
|
| 2227 | Azathioprine in case of endoscopic recurrence | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [1] 96 96 💬
|
| 2228 | Azathioprine individualised dose | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [1] 96 96 💬
|
| 2229 | Azathioprine of 150 [75 | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [1] 57 57 💬
|
| 2230 | Azathioprine or 6-mercaptopurine | [2] Azathioprine Azathioprine, Mercaptopurine | [4] Mercaptopurine
Mercaptopurine
,
Azathioprine
,
Azathioprine sodium
,
Mercaptopurine
💬
| [1] HPRT1 HPRT1 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [2] 96 96, 97 💬
|
| 2231 | Azathioprine or adalimumab and infliximab | [3] Adalimumab Adalimumab, Azathioprine, Infliximab | [4] Azathioprine
Azathioprine
,
Adalimumab
,
Infliximab
,
Azathioprine sodium
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 2232 | Azathioprine OR Mesalazine | [2] Azathioprine Azathioprine, Mesalazine | [3] Azathioprine
Azathioprine
,
Mesalamine
,
Azathioprine sodium
💬
| - | - | [1] 96 96 💬
|
| 2233 | AZATHIOPRINE or METHOTREXATE | [2] Azathioprine Azathioprine, Methotrexate | [4] Methotrexate
Methotrexate
,
Azathioprine
,
Methotrexate sodium
,
Azathioprine sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [1] 96 96 💬
|
| 2234 | Azathioprine or Mycophenolate mofetil | [2] Azathioprine Azathioprine, Mycophenolate mofetil | [4] Azathioprine
Azathioprine
,
Mycophenolate mofetil
,
Azathioprine sodium
,
Mycophenolate mofetil hydrochloride
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [1] 162 162 💬
|
| 2235 | Azathioprine weight-based dose | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [1] 96 96 💬
|
| 2236 | Azathioprine+enteral nutrition | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [1] 96 96 💬
|
| 2237 | Azathioprine/prednisone | [2] Azathioprine Azathioprine, Prednisone | [3] Azathioprine
Azathioprine
,
Prednisone
,
Azathioprine sodium
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 85 85 💬
|
| 2238 | Azatioprina | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [2] 96 96, 97 💬
|
| 2239 | AZATIOPRINA ASPEN - 50 COMPRESSE | - | - | - | - | [1] 96 96 💬
|
| 2240 | AZATIOPRINA HEX. 50CPR 50MG BL | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [1] 13 13 💬
|
| 2241 | AZD0120 | - | - | - | - | [4] 28 28, 46, 49, 51 💬
|
| 2242 | AZD0120 - Regimen 1 | - | - | - | - | [1] 13 13 💬
|
| 2243 | AZD0120 - Regimen 2 | - | - | - | - | [1] 13 13 💬
|
| 2244 | AZD0233 | - | - | - | - | [1] 57 57 💬
|
| 2245 | AZD0328 | - | - | - | - | [1] 6 6 💬
|
| 2246 | AZD0530 | - | - | - | - | [1] 272 272 💬
|
| 2247 | AZD0530 Difumarate | - | - | - | - | [1] 272 272 💬
|
| 2248 | AZD0780 | - | - | - | - | [1] 79 79 💬
|
| 2249 | AZD1163 | - | - | - | - | [1] 46 46 💬
|
| 2250 | AZD1236 | - | - | - | - | [1] 299 299 💬
|
| 2251 | AZD1613 - Part A | - | - | - | - | [1] 67 67 💬
|
| 2252 | AZD1613 - Part B | - | - | - | - | [1] 67 67 💬
|
| 2253 | AZD2014 | - | - | - | - | [1] 34 34 💬
|
| 2254 | AZD3241 | - | - | - | - | [2] 6 6, 17 💬
|
| 2255 | AZD3241 100mg | - | - | - | - | [1] 17 17 💬
|
| 2256 | AZD3241 300 mg BID | - | - | - | - | [1] 6 6 💬
|
| 2257 | AZD3241 300mg | - | - | - | - | [1] 17 17 💬
|
| 2258 | AZD3241 600 mg BID | - | - | - | - | [1] 6 6 💬
|
| 2259 | AZD3241 Alternative titration scheme with formulation 1 or 2 | - | - | - | - | [1] 6 6 💬
|
| 2260 | AZD3241 ER formulation 1 | - | - | - | - | [1] 6 6 💬
|
| 2261 | AZD3241 Extended release tablets 100 mg | - | - | - | - | [1] 6 6 💬
|
| 2262 | AZD3241 Extended release tablets 25 mg | - | - | - | - | [1] 6 6 💬
|
| 2263 | AZD4017 | - | - | - | - | [1] 75 75 💬
|
| 2264 | AZD4017 and prednisolone | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 75 75 💬
|
| 2265 | AZD4063 | - | - | - | - | [1] 57 57 💬
|
| 2266 | AZD4522 | - | - | - | - | [1] 79 79 💬
|
| 2267 | AZD4831 | - | - | - | - | [1] 86 86 💬
|
| 2268 | AZD5055 | - | - | - | - | [1] 85 85 💬
|
| 2269 | AZD5492 | - | - | - | - | [2] 46 46, 49 💬
|
| 2270 | AZD5634 | - | - | - | - | [1] 299 299 💬
|
| 2271 | AZD5634 for infusion | - | - | - | - | [1] 299 299 💬
|
| 2272 | AZD5634 for inhalation | - | - | - | - | [1] 299 299 💬
|
| 2273 | AZD5672 | - | - | - | - | [1] 46 46 💬
|
| 2274 | AZD6244 | - | - | - | - | [1] 34 34 💬
|
| 2275 | AZD6912 | - | - | - | - | [1] 46 46 💬
|
| 2276 | AZD7325 | - | - | - | - | [1] 206 206 💬
|
| 2277 | AZD7325 (High-Dose) | - | - | - | - | [1] 206 206 💬
|
| 2278 | AZD7325 (Low-Dose) | - | - | - | - | [1] 206 206 💬
|
| 2279 | AZD7798 | - | - | - | - | [1] 96 96 💬
|
| 2280 | AZD7986 | - | - | - | - | [2] 44 44, 299 💬
|
| 2281 | AZD8965 high dose | - | - | - | - | [1] 85 85 💬
|
| 2282 | AZD8965 low dose | - | - | - | - | [1] 85 85 💬
|
| 2283 | AZD8965 medium dose | - | - | - | - | [1] 85 85 💬
|
| 2284 | AZD9056 | - | - | - | - | [2] 46 46, 96 💬
|
| 2285 | AZD9056 hydrochloride | - | - | - | - | [1] 46 46 💬
|
| 2286 | AZD9567 | - | - | - | - | [1] 46 46 💬
|
| 2287 | AZD9567 10 mg | - | - | - | - | [1] 46 46 💬
|
| 2288 | AZD9567 125 mg | - | - | - | - | [1] 46 46 💬
|
| 2289 | AZD9567 155 mg | - | - | - | - | [1] 46 46 💬
|
| 2290 | AZD9567 20 mg | - | - | - | - | [1] 46 46 💬
|
| 2291 | AZD9567 40 mg | - | - | - | - | [1] 46 46 💬
|
| 2292 | AZD9567 80 mg | - | - | - | - | [1] 46 46 💬
|
| 2293 | AZD9567 Monohydrat | - | - | - | - | [1] 46 46 💬
|
| 2294 | AZD9567 monohydrate | - | - | - | - | [1] 46 46 💬
|
| 2295 | AZD9668 | - | - | - | - | [1] 299 299 💬
|
| 2296 | Azilect | - | - | - | - | [3] 5 5, 6, 17 💬
|
| 2297 | AZILECT 1 mg comprimidos | - | - | - | - | [2] 6 6, 17 💬
|
| 2298 | Azilect 1mg | - | - | - | - | [1] 6 6 💬
|
| 2299 | AZILECT® | - | - | - | - | [1] 6 6 💬
|
| 2300 | AZILECT® 1 mg Tabletten | - | - | - | - | [1] 2 2 💬
|
| 2301 | Azilsartan | [1] Azilsartan Azilsartan | [1] Azilsartan
Azilsartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 66 66 💬
|
| 2302 | Azithromcyin | - | - | - | - | [1] 299 299 💬
|
| 2303 | Azithromycin | [1] Azithromycin Azithromycin | [3] Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | [8] 13 13, 84, 85, 96, 222, 228, 299, 340 💬
|
| 2304 | Azithromycin (Zitromax°) | [1] Azithromycin Azithromycin | [3] Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | [1] 228 228 💬
|
| 2305 | Azithromycin + Metronidazole | [2] Azithromycin Azithromycin, Metronidazole | [5] Metronidazole
Metronidazole
,
Azithromycin hydrate
,
Metronidazole hydrochloride
,
Azithromycin
,
Azithromycin
💬
| - | - | [1] 96 96 💬
|
| 2306 | Azithromycin + N-acetylcystein + inhaled corticosteroid | [1] Azithromycin Azithromycin | [3] Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | [1] 228 228 💬
|
| 2307 | Azithromycin 250 mg tablets | [1] Azithromycin Azithromycin | [3] Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | [1] 299 299 💬
|
| 2308 | Azithromycin 250Mg Capsule | [1] Azithromycin Azithromycin | [3] Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | [1] 84 84 💬
|
| 2309 | Azithromycin 500 mg film-coated tablet | [1] Azithromycin Azithromycin | [3] Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | [1] 299 299 💬
|
| 2310 | AZITHROMYCIN DIHYDRATE | [1] Azithromycin Azithromycin | [3] Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | [2] 228 228, 299 💬
|
| 2311 | Azithromycin monohydrate | [1] Azithromycin Azithromycin | [3] Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | [2] 84 84, 340 💬
|
| 2312 | Azithromycin Pill | [1] Azithromycin Azithromycin | [3] Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | [1] 96 96 💬
|
| 2313 | AZITHROMYCINE | - | - | - | - | [1] 228 228 💬
|
| 2314 | AZITHROMYCINE 250 mg | - | - | - | - | [1] 228 228 💬
|
| 2315 | AZITHROMYCINE CF 250 mg | [1] Azithromycin Azithromycin | [3] Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | [1] 340 340 💬
|
| 2316 | AZITROMYCINE CF 250 mg | - | - | - | - | [1] 340 340 💬
|
| 2317 | AZLI | - | - | - | - | [1] 299 299 💬
|
| 2318 | AZLI 75 mg three times a day (TID) | - | - | - | - | [1] 299 299 💬
|
| 2319 | AZLI 75 mg three times daily (TID) | - | - | - | - | [1] 299 299 💬
|
| 2320 | AZLI 75 mg two times a day (BID)/ three times a day (TID) | - | - | - | - | [1] 299 299 💬
|
| 2321 | AZLI 75 mg two times a day (BID)/three times a day (TID) | - | - | - | - | [1] 299 299 💬
|
| 2322 | AZM | - | - | - | - | [1] 228 228 💬
|
| 2323 | AZP-3601 | - | - | - | - | [1] 235 235 💬
|
| 2324 | AZP-531 | - | - | - | - | [1] 193 193 💬
|
| 2325 | AZP2006 oral solution | - | - | - | - | [1] 5 5 💬
|
| 2326 | AZT/3TC | - | - | - | - | [1] 265 265 💬
|
| 2327 | Aztreonam | [1] Aztreonam Aztreonam | [2] Aztreonam
Aztreonam
,
Aztreonam lysine
💬
| - | - | [2] 228 228, 299 💬
|
| 2328 | Aztreonam for Inhalation (AI) | [1] Aztreonam Aztreonam | [2] Aztreonam
Aztreonam
,
Aztreonam lysine
💬
| - | - | [1] 299 299 💬
|
| 2329 | Aztreonam for Inhalation Solution | [1] Aztreonam Aztreonam | [2] Aztreonam
Aztreonam
,
Aztreonam lysine
💬
| - | - | [1] 299 299 💬
|
| 2330 | Aztreonam for Inhalation Solution (AZLI) | [1] Aztreonam Aztreonam | [2] Aztreonam
Aztreonam
,
Aztreonam lysine
💬
| - | - | [1] 299 299 💬
|
| 2331 | AZTREONAM LYSINE | [2] Aztreonam Aztreonam, Lysine | [6] Aztreonam
Aztreonam
,
Lysine acetate
,
Lysine hydrochloride
,
Lysine
,
Lysine hydrochloride
,
Aztreonam lysine
💬
| - | - | [1] 299 299 💬
|
| 2332 | Aztreonam Lysine for Inhalation | [2] Aztreonam Aztreonam, Lysine | [6] Aztreonam
Aztreonam
,
Lysine acetate
,
Lysine hydrochloride
,
Lysine
,
Lysine hydrochloride
,
Aztreonam lysine
💬
| - | - | [1] 299 299 💬
|
| 2333 | Aztreonam Lysine for Inhalation (AZLI) | [2] Aztreonam Aztreonam, Lysine | [6] Aztreonam
Aztreonam
,
Lysine acetate
,
Lysine hydrochloride
,
Lysine
,
Lysine hydrochloride
,
Aztreonam lysine
💬
| - | - | [1] 228 228 💬
|
| 2334 | Aztreonam solución para inhalación | [1] Aztreonam Aztreonam | [2] Aztreonam
Aztreonam
,
Aztreonam lysine
💬
| - | - | [1] 299 299 💬
|
| 2335 | Aztreonan lysine | [1] Lysine Lysine | [4] Lysine acetate
Lysine acetate
,
Lysine hydrochloride
,
Lysine
,
Lysine hydrochloride
💬
| - | - | [1] 299 299 💬
|
| 2336 | Aún no establecido | - | - | - | - | [1] 53 53 💬
|